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1 
Introduction 
1.1 Definition of the subject 
The objective of medical care has always been twofold: to prolong life and to 
enhance its quality. Until recently. the emphasis was on prevention of premature 
death. An impressive increase in general life expectancy (partly as a result of 
technical progress in medicine) has caused a paI1iai shift of emphasis, at least in the 
richer part of the world, towards the promotion of the quality of survival. This shift 
of purpose of medical care in the industrialized countries from curing acute, life-
threatening disease to caring for patients with chronic diseases has created a 
different perspective on the balance of positive and negative effects of medical 
interventions. This can be illustrated with three examples. 
Firstly, health status improvement, rather than prolonging life may be the primary 
aim of medical interventions nowadays, for example in the treatment of rheumatoid 
arthritis. The positive effects induced by relieving the pain should outweigh the 
possible negative side effects of the treatment (e.g., stomach complaints). If, in a 
second example, an intervention, for example treatment of cancer, is primarily 
intended to prolong life, a situation may occur in which the initial negative effects 
on health status effects must be weighted against the prolongation of survival. A 
third situation may be observed in emerging life-saving interventions, for example 
certain organ transplantations, the treatment of (otherwise lethal) congenital 
anomalies and of childhood cancer. The health status in the long term is gradually 
becoming the primary outcome criterion. 
An outcome measure is needed to complement survival time in the evaluation of 
the impact of disease and of the effects of medical interventions. Quality of life 
measures are currently fulfilling this role. Assessment of the quality of life in this 
context is the subject of this thesis. It has been recognized that a person's quality of 
life is contingent upon various factors, such as a social network, the physical 
environment, financial situation, religion, as well as health. The first section of this 
Introduction has limited the notion of 'quality of life' in outcome assessment in the 
medical context to 'health-related quality of life', or 'health status', defined as 
quality of life relating to disease and/or treatment. 
Health status measurement requires the application of principles from multiple 
disciplines, including the social sciences, medicine and economics. The input from 
the social sciences relates to methods of data-collection, instruments, and analytical 
techniques. Epidemiology has contributed to the field of health status measurement 
through the standard methodology for comparing medical interventions, i.e., the 
randomized controlled clinical trial. General prinCiples of clinical epidemiology 
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hold, irrespective of the outcome parameters being 'clinically' defined (e.g., tumour 
relapse) or in terms of 'patient outcome'. Because financial resources for providing 
health care have appeared to be limited, there was an obvious growing need for 
economic evaluation. ' ... No country in the world, even the richest, can afford to do 
all things that it is now possible to do to improve the health of their citizens. In that 
situation, it is no longer sufficient, in the competition for resources, solely to show 
that a particular intervention is beneficial, though that still is (or should be) a 
necessary condition for funding.' I 
The perspective of this thesis, however, is medical, be it on an aggregate level. 
Information on patients' outcomes (including health status) can be useful to 
determine what is generally the best treatment for specific groups of patients. At an 
even higher level of aggregation, outcome data should be part of the information 
used in decision-making in the allocation of resources, for example at national 
level. 
1.2 Objectives ofthe thesis 
This thesis addresses a number of related topics in health status measurement in the 
evaluation of the effects of disease and of medical care. Its main objectives are: 
I. To provide a general overview of the field of descriptive health status measure-
ment. 
2. To compare the contents and the relative perfonnance of a number of currently 
available measures for descriptive health status measurement, to demonstrate 
applications of descriptive health status measurement and to discuss the impor-
tance of standardization of research methods in health status measurement. 
3. To provide an overview of the current state of affairs in evaluative health status 
measurement, and to demonstrate empirical studies addressing the feasibility of 
collecting valuation data by self-assessment questionnaire. 
1.3 Structure of the thesis 
6 
The thesis consists of foul' parts. 
Part I (chapter 2) will provide the reader with a global overview of the field of 
health status measurement. This overview will include the relationship between 
conventional clinical parameters and health status measures, the distinction between 
descriptive and evaluative health status measurement, different perspectives on 
health status measurement and the consequences for research design, and finally 
arguments for standardization of research methodology in health status measure-
ment and a description of the state of affairs with respect to such standardization in 
the Netherlands. 
Part II (chapters 3 - 7) relates to descriptive health status measurement. Chapter 3 
consists of an overview of the generic instnunents that are currently available in the 
Netherlands, and ofa comparison of these instnnnents based on users' opinions and 
the literature. 
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Chapters 4 and 5 are based on empirical studies on the relative performance profiles 
of a number of measures for generic health status assessment. 
Chapter 4 contains a comparison of the Nottingham Health Profile and the Sickness 
Impact Profile when employed in a population of patients treated with renal 
dialysis. 
In chapter 5, four measures (the MOS Short Fonn-36, the Nottingham Health 
Profile, the COOPIWONCA charts and the EuroQol instrument) are compared 
when employed in a study of migraine sufferers and a control group. 
Chapters 6 and 7 present examples of applied health status measurement. Chapter 6 
reports on a survey describing the health status of a representative sample of 
migraine sufferers when compared to that of a matched control group. Special 
attention is paid to the role of comorbidity. Chapter 7 presents the results of a 
longitudinal evaluation of the health status effects of liver transplantation. 
Part III (chapters 8-10) relates to health state valuation research. Chapter 8 provides 
an introduction to the field of empirical valuation of health states. The chapter 
addresses issues such as the consequences of the current operationalization of the 
QAL Y -approach, in which health states are valued separately from their duration. 
Chapters 9 and 10 deal with empirical methodological research. Chapter 9 presents 
a pilot study investigating the feasibility of measuring valuations of health states 
among the general population in a postal survey. Chapter 10 attempts to analyse 
non-response and response behaviour in a survey aiming at the collection of 
valuations of health states in the general population. 
Part IV (Chapter II) presents a number of conclusions. 
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2 
Overview ofthe field of health status measurement 
Partly published as: 
Essink-Bot ML, Bonsel OJ. Towards standardization of instruments for health status 
assessment (Naar standaardisatie van het instrumentarium voar hef me/en van de 
gezondheidstoestand) (in Dutch; English abstract). Huisarts en Wetenschap 
1995; 38(3): 117-122. Reprinted with permission of the publisher. 
2.1 Introduction 
This chapter aims at providing a more detailed description of health status measure-
ment. Firstly, the relationship between 'conventional' clinical parameters and health 
outcome measures will be clarified (2.2). In section 2.3 three main types of instruments 
for descriptive health status measurement will be introduced. The paramount distinc-
tion between description and valuation of health status is explained. Section 2.4 
explains how these two concepts complement each other, and how their measurements 
are interrelated. Section 2.5 describes different perspectives on health status assessment 
and some of the consequences for research methodology. The position of 'time' in 
descriptive health status measurement is described briefly in section 2.6. The final 
section is dedicated to standardization of research instruments for health status 
assessment. 
2.2 The relationship between conventional clinical parameters and health 
status measures 
Nowadays the practice of health status assessment in medical evaluation research 
mainly relates to measuring the consequences of disease andlor treatment. The 
presence of disease may show itself at different levels, for example at the organ level, 
the level of the body system, and the level of a patient's functioning. The observation 
that medical diagnoses can be defined at different levels, e.g. at the level of the cell 
contents (e.g., a gene mutation), or at the level of disturbed functioning or well-being 
(e.g., fibromyalgia), may serve as an illustration. Distinguishing these levels of the 
consequences of disease and treatment implies that they have to be measured at these 
different levels. The level of interest determines which measure for health status is the 
most appropriate. 
Conceptual schemes may provide an ordering of the different levelsY One of the 
available schemes, the 'Disablement Process', will be explained below. It is essentially 
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similar to the International Classification of Impairments, Disabilities and Handicaps 
(ICIDH).' 
FIGURE 2.2 The Disablement Processl 
Pathology ~ Impairments --. Functional ----. Disability LImitations 
The first stage, 'Pathology' refers to functional or structural abnormalities at the level 
of the cell, for example, in biochemical processes or in genetic material. Detection 
often relies on evaluation of Illore manifest signs or symptoms. However, pathological 
abnormalities are increasingly detected directly as a consequence of technical diagnos-
tic refinements. A specific class of 'pathology' has been emerging in recent years, i.e. 
genetically determined susceptibility to specific diseases. 
'Impairments' are physiological and structural abnonnalities at the level of organs or 
body systems (e.g., circulation). The consequences of atherosclerosis may become 
manifest through dysfunction of the arterial blood circulation of the brain, the heart or 
the legs. At the level of impairments, these consequences can be measured by clinical 
examination, laboratory tests, imaging techniques, in short, 'conventional' clinical 
measures. 
'Functional limitations' are restrictions in perfOlming 'generic' physical and mental 
actions (when compared with 'normal' performance by one's age group). Examples 
include walking, bending, seeing, hearing, speaking, thinking, laughing, crying etc. 
These are, as stated by Verbrugge et ai, the basic interface between a person and the 
physical and social environment in which (s)he performs daily activities. Measures for 
functional limitations include performance tests and rep0l1s (by self or by a proxy) of 
performance of activities and the amount of difficulties experienced. 
'Disability' represents difficulty perfOlming activities in any domain of life due to a 
health problem. These domains cover for example work (paid and/or unpaid), house-
hold work, shopping, caring for children, hobbies, and travelling. Measuring disability 
requires respondents (or proxies) to answer questions on the difficulties experienced 
when performing specific activities. Alternatively, a subject's performance can be 
observed. 
The relationship between the various stages of the Disablement Process is not 
straightforward. This was empirically supported by study results among stroke patients, 
which showed a pattern of decreasing correlations between 'sh'oke scales' (neurologi-
cal impairments), the Barthel Index (functional limitations in the physical domain), the 
Rankin Scale (disability) and the Sickness Impact Profile (disability).' Pathology ilia), 
lead to impainnent (some abnormal cells turn out to be precursors of clinical cancer 
while others vanish). Impairment lIIay lead to functional limitations (although high 
blood pressure does not necessarily do so). Functional limitations ilia), lead to disabili-
ties (the one patient returns to work after a myocardial infarction while another, with a 
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medically comparable infarction, is permanently disabled). Therefore, the relationship 
between the levels can more accurately be described in terms of probabilities. 
Several types of factors, both intra individual and environmental, act as 'effect 
modifiers' along the way from pathology to disability. Examples of such factors are 
individual ability to adapt to illness (coping), environmental factors including housing 
situation and working situation, and factors intended to optimalize functioning, e.g., 
medical care, including rehabilitation. 
The fact that there is no straightforward relationship between 'objective disease' 
(pathology, impairment) and the functioning of patients has consequences for the 
choice of health status measures. Clinical variables, including for example results of 
laboratory blood tests, imaging techniques and biopsies, and parameters focusing on a 
patient's functioning should be seen as complementary, each useful in their own 
context. 'Conventional' medical techniques can, for example, be used to determine the 
diagnosis of a disease, to decide what stage the disease is at, to support treatment 
decisions because they provide prognostic information, to monitor the course of the 
disease and to evaluate treatment effectiveness at a pathophysiological level. 
Whether an intervention ultimately benefits a patient can be studied by evaluating 
patient's functioning in life, or 'patient outcome'. This applies when doctors treat 
individual patients as well as when medical interventions are evaluated at an aggregate 
level. Doctors should treat patients, not laboratory variables. 
The concept 'patient outcome' is usually operationalized by two variables, i.e. survival 
time and health status (referring to the levels of 'functionallirnitations' and 'disability' 
in the Disablement Process). The concept and the measurement of survival are rela-
tively straightforward. Health status, however, is a hypothetical concept without a 
direct empirical representation. The definition of domains is the first step to translation 
of such a concept into measurable tenns. Comprehensive domains of health status 
current-Iy include physical, psychological and social functioning. These domains 
should be subsequently operationalized to be measurable. It is agreed that the patient 
him/herself is generally the best source of information about hislher functioning in life. 
Data on a patient's functioning can be elicited by interview, self-assessment question-
naire or diary, or by observation. Due to the prevailing use of self-assessment question-
naires, the word 'measuring instrument' has become almost synonymous with 
'questionnaire' in health status assessment. Although the following is restricted to self-
assessment questionnaires for health status (with section 2.6 as an exception), this is 
not necessarily always the best method of data collection. Circumstances may occur in 
which self-assessment is not possible (for example, if the patient is a young child, or 
very ill, or illiterate). 
2.3 Types of questionnaires for descriptive health status measurement 
Three main types of questionnaires for health status assessment are distinguished: 
generic instnllnents, disease-specific instruments and domain-specific instruments. 
Generic instruments for health status measurement are, by definition, comprehensive 
and non disease-specific. The items of such generic measures cover at least the 
physical, psychological and social domain in a non disease-specific way. The premise 
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underlying generic questionnaires for health status measurement is that different 
diseases have different consequences, but that these show themselves as different 
pallel'lls of physical, psychological and social dysfunction. Generic questionnaires 
allow for comparison of health status data irrespective of diagnosis. The 
operationalization of the physical, psychological and social domains, as well as the 
choice of additional domains, may be different for different generic questionnaires. 
This may be explained by three reasons. Firstly, subtle differences in the concepts of 
health status that are used at the start of instnllnent development (e.g., more 
functionally oriented or more directed at perceptions of health status). Secondly, 
differences in the procedure of item selection, and thirdly different backgrounds of the 
researchers involved (psychology, sociology, economics, medical). Examples of 
generic instnlluents are the Sickness Impact Profile, the Nottingham Health Profile, the 
COOP/WONCA charts, the MOS-20, and the SFIRAND-36 (see Chapter 3). 
Disease-specific inslrumenls for health status measure the consequences of a specific 
disease or treatment. Treatment-specific measures for health status are often included 
in this group. Examples are cancer-specific instruments that contain detailed questions 
on the functional consequences of weight loss, hair loss, changes in body image etc; or 
instruments specifically designed for arthritis, with detailed questions on the 
consequences of joint pain, morning stiffness, etc. Many disease-specific instnJlllents 
were developed in cancer research, but instruments have been developed for many 
other diseases: for example, arthritis, asthma, hypertension, and 
diabetes. 5,6,7,8,9, IO,ll,12,1J,14 
Disease-specific measures usually show some overlap with generic measures. Some 
disease-specific measures may be viewed as narrowly focused generic instruments 
(e.g., measures designed for use with cardiovascular disease population or cancer 
populations). " 
Disease-specific questionnaires often contain questions on symptoms and complaints. 
It is considered that questions regarding symptoms ['Were you short of breath?' (see 
note)] aim at measuring state of health at the level of 'impairment' (in this case the 
functioning of the respiratory system). Such formalized diagnostic questions, which 
aim at assessing whether disease or side-effects of treatment are present, and if so, how 
severe, should strictly not be seen as disease-specific measures for heallh slalus as 
operationalized in this thesis. If breathlessness is present, its impact on a patient's 
functioning still remains to be determined, see for example Wijkstra. 16 For example, a 
diagnostic questiOlmaire for at1hritis could assess the degree of pain and morning 
stiffi]ess, whereas an arthritis-specific questionnaire for health status assessment would 
ask to what extent the pain, the morning stiffness affect the patient's functioning. 
Complaints (e.g., 'Were you bOlhered by shortness of breath?'), as opposed to 
symptoms, contain an additional element of subjective experience. 
Thirdly, domain-specific instruments measure the consequences of disease on a 
specific domain of health status, for example questionnaires on physical functioning, 
anxiety, depression, social relationships. Their use is not limited to a particular 
population. In this group of non-generic, non-disease specific instruments symptom-
specific instnnnents can be seen as a separate group. They measure the effects of a 
specific symptom (e.g. pain, fatigue) on health status. 
With respect to the context in which these three types of instruments may be most 
appropriately used, it may be said from a theoretical point of view that domain-specific 
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health status measures (either physical, psychological or social functioning) are 
important but on their own rarely satisfactOlY. This is because a moderate degree of 
dysfunction in any of these domains usually has functional consequences for the 
others. If more than one domain may be expected to be affected, the choice should be 
between a disease-specific multi-domain questionnaire or a generic one. This issue will 
be discussed in more detail in section 2.5. 
2.4 Description and valuation 
Conventional descriptive health status scores take the form of a profile of scores across 
the different dimensions of the instrument. We have to go a step further if we wish to 
aggregate the consequences for health status and survival time into one outcome 
measure. Such a combined outcome measure is needed, for example, in cost-
effectiveness analysis, assessment of the 'burden of disease' and in public health 
modelling. 17,18,19 
Suppose, for example, a measure has a physical dimension (A) with three levels 
(1 ~best, 2~intermediate, 3~worst) and a psychosocial dimension (B) with three analo-
gous levels. Assume a patient's score profile is A,B, while another patient's is A,B,. 
How can we judge whether the one patient is better off than the other? And if so, how 
much better? 
To answer these questions we need to summarize the profile scores of health status. 
Such summary scores are currently obtained through a procedure in which health state 
descriptions are valued. A general overview of the field of evaluative health status 
measurement is presented in Chapter 8, but a short explanation of the current three-
stage approach in empirical comprehensive outcome measurement is needed here as 
well. 
In the first phase, actual patients' health states, as occurring in populations or resulting 
from an intervention, must be described in formal, functional terms. The EuroQol 
system for the description of health status (see Chapter 10) may be seen as an example. 
This system consists of 5 dimensions, each comprising 3 ordered categories, thus 3' 
(~243) health state descriptions are theoretically possible. 
In the subsequent stage such health state descriptions are valued. The subjects who 
perform the valuation task are presented with a number of health state descriptions and 
are requested to rank these states according to the degree of (un)desirability and to 
indicate how good or how bad each of those states is for them. 
In the third stage, the resulting value weights for health states are combined with 
survival data (e.g., into quality adjusted life years or QALYs). In public health 
research, popUlation life years are often combined with quality data following the 
concept of 'Healthy Life Expectancy', in which a year lived in perfect health is valued 
'I' and a life-year with impairment (however defined) as '0'. By combining life-years 
with empirically collected values on health states the dichotomous value system of 
healthy life expectancy can be refined."·n." 
Important choices in the empirical collection of valuation data to be addressed in this 
chapter have to do with the descriptive system for health status and the subjects who 
perform the valuation task. For other issues the reader is referred to Chapter 8. 
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2.5 Different perspectives on health status assessment and their 
consequences 
Health status is generally measured in order to support a decision-making process. 
Information on (expected) survival benefits may be important at each level of decision-
making. However, this should be complemented by (different types of) health status 
information. 
As recognized by Sutherland and Till, health status information and the levels of 
decision-making (perspectives) interact: the level determines which type of measuring 
instrument is the most appropriate.2l In their paper, 3 levels of decision-making are 
distinguished, i.e. the micro (clinical) level, the meso (agency, institutional or regional) 
level and the meta (governmental) level. We will elaborate on the structure proposed 
by Sutherland and Till in the following by simplifying the distinction to essentially two 
levels of decision-making and relating the levels to methodological aspects of 
description and valuation of health status. 
The societal perspective may be found at the one end of a hypothetical scale of 
decision levels (see Figure 2.5.1). Decisions in the public domain concern the 
distribution of ftl1lds over areas such as education, housing, public transport and health 
care. The societal perspective raises questions which relate for example to the relative 
benefits of investments in education and health care. 
The individual patient's perspective may be found at the other end of the scale. 
Decisions to be taken ft'om this perspective relate to the choice of the best treatment for 
the individual patient. Information on the health status of an individual patient is useful 
for the patient and the physician to guide such decisions. 
Two perspectives are in-between. The first is the patient group perspective, which is 
essentially a higher level of the individual patient's perspective. Information on the 
relative benefits of two treatments for a circumscript group of patients may be used to 
guide decisions on the treatment to be preferred for that group of patients. In fact, it 
provides information on the health status effects to be expected for the individual 
patient. Research from the patient group perspective is referred to as medical 
evaluation research and the classical research design is the randomized controlled trial 
(RCT). Costs are not taken into account, at least not in analytical connection with 
effect measurement. This is because, as stated by Detsky, individual clinicians are 
appropriately concerned solely with the effectiveness of a specific intervention for their 
patients and are not concerned with the benefit derived from spending these resources 
on other patients." 
The second perspective which falls in-between the ends of the scale, the health-care 
policy perspective is essentially a narrowing of the societal perspective. Within the 
field of health care, decisions have to be taken regarding the distribution of ftmds, at a 
regional, local or institutional level. Research questions from this perspective relate for 
example to the relative effects of a screening programme for prostatic cancer and a 
programme to treat high blood cholesterol in middle-aged men with a drug. Evaluation 
research from the health care policy perspective is referred to as medical technology 
assessment (MTA). In MTA, costs and effects of different medical interventions are 
compared. In order to support decision-making in priority setting in health care, costs 
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and effects of an intervention have to be compared with the costs and effects of other 
interventions for the same patient group, as well as with costs and effects of 
interventions for other patient groups. The methodology of economic evaluation, an 
important pmt of MTA, consists largely of the implementation of economic research 
methods alongside RCTs.24•25,26," 
FIGURE 2.5.1 Perspectives on health status assessment 
Perspectives 
societal 
health care policy 
patient group 
individual patient 
Nowadays medical evaluation research and MTA have become closely related. Due to 
the apparent scarcity of health care resources combined with an apparently infinite 
demand, it is generally considered that the 'no matter what it costs' assumption of 
RCTs" has a limited scope. The first question raised when evaluating new medical 
treatment is whether it is better overall than the conventional treatment. [fthis question 
is answered positively, i.e. a new treatment has a net benefit over the old one, this 
generally raises the question as to whether the difference is worth the difference in 
costs. The consequence is that MTAs and clinical effectiveness studies are often 
performed in close connection. This adds special requirements to the research design. 
The level of decision-making (the perspective of a study) determines which type of 
measuring instrument is the most appropriate for description of health status (see 
Figure 2.5.2). For decisions at the individual patient level, the physician (and the 
patient) is interested in individual functioning and well-being. [f a formal measuring 
instrument is used to assess health status at this level, it should be patient-specific. This 
ensures that the extent perceived by the patient of symptoms or side-effects interfering 
with his/her functioning is assessed. An overview of instnnuents for individual health 
status assessment is beyond the scope of this thesis.28,29 
At a patient group level the aim is to gain insight into the functioning and the 
experiences of groups of patients with specific disease characteristics. Questionnaires 
must enable the description of the group under study and the comparison of results 
with those of a control group: a group of patients with comparable (disease and other) 
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characteristics. It is especially important that the domains that are relevant to the 
functioning of patients with that disease are covered in detail. For example, in a study 
comparing breast conserving therapy and mastectomy in early breast cancer, the 
inclusion of body image questions is desirable as it has been found to be relevant for 
the functioning and well-being of these patients." Disease- and treaonent-specific 
instruments were designed for use in this context. However, by using a diseaseaspecific 
instrument that covers only the domains that are expected to be affected by the disease 
and the treatment under slndy, changes in other domains may be overlooked. Therefore 
more general domains should be added to disease-specific ones in slndies conducted 
from the patient group perspective. 
FIGURE 2.5.2 Perspectives on health status assessment and their consequences for the choIce of 
instruments 
Perspectives 
societal 
health care pollcy 
patient group 
individual patient 
Instruments to 
measure health status 
global 
generic 
disease specific 
patient specific 
At the third level, i.e. the health-care policy level, the impact of different diseases and 
of different interventions on patient outcome should be compared. For example, 
comparing the effects of a screening programme for breast cancer to the effects of 
treating the clinically manifest disease, or comparing the effects of the screening 
programme to the effects of a liver transplantation programme." The measures used to 
enable such comparison should be non disease-specific and comprehensive, in other 
words} generic. 
As stated above, clinical trials (medical evaluation research) and MTAs are often 
conducted alongside each other.24,26,27 The general recommendation is to employ a 
combination of a generic instrument complemented with one or more diseasea and/or 
domain-specific instruments in medical evaluation research and in MTA. The generic 
results can be used to define the position of the patient group under study on the 
continuum ranging from the 'worst imaginable health state' to the 'best imaginable 
health state', and to relate the size of a treatment effect to this continuum. This is useful 
for comparisons with the effects of other interventions in similar or different patient 
groups. Results from the disease-, treatment- domain-, and symptom-specific 
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instnnnents are useful to focus on characteristics of special interest, for example from a 
clinical point of view, in a particular patient group. 
At the fourth level, the societal perspective, aspects other than health that contribute to 
overall quality of life are explicitly taken into account. The definition of 'quality of 
life' at this level has to be extended from the definition as used at the health care policy 
level and the patient group level, where 'non health-related' aspects of the quality of 
life are deliberately neglected. Respondents are asked about their health, education, 
housing, public transpOli, etc. in population based surveys. Obviously, health, as far as 
societal policy is concerned, is one issue among many others. With respect to health, a 
global score is generally asked for. Policy makers may use this information to obtain a 
domain specific and an overall view of the well-being or the level of (dys)-function of 
the population at large and of population subsets. Commonly used measures are those 
developed by Andrews & Withey and Campbell and coUeagues to assess the quality of 
American life,n,n 
Although the surveys are often named differently, most western countries have a 
nationwide survey to study the quality of life of their populations. Discussing health 
status assessment from the societal perspective is beyond the scope of this thesis. 
The perspectives on health status assessment as distinguished above also have 
consequences for the valuation stage, for example for the choice of the subjects who 
perform the valuation task. 
From the individual patient perspective the first question raised is, who should be 
involved in the decisions to be taken. Not every patient wants to take the lead or even 
to participate in the decision-making process."·J5 If not, the treating physician may 
decide. The best decision is the one that most reflects the individual patient's values 
withont being in conflict with values held by the physician. The patient's values do not 
necessarily have to be made explicit if (s)he is able to make hislher own decision. In 
cases where the patient wants to participate in the decision-making process but needs 
support, decision aids such as the board developed by Levine" may help the patient to 
become aware of hislher values with respect to the consequences of the different 
possible options and express them. The relevant information on the possible outcomes 
must come from data gathered in descriptive studies at a patient group level and from 
the clinician's clinical experience. 
Data describing the outcomes of different interventions among similar groups of 
patients must first be available, preferably from randomized clinical trials, before 
deciding upon a policy regarding groups of patients witl, similar disease characteristics 
(the patient group perspective). Clinicians may choose the treatment policy generally 
to be preferred without explicitly weighting the different consequences of different 
lines of action. However, decisions can nowadays be suppOlied by decision analytic 
approaches. For example, decision analysis was applied in the evaluation of various 
follow-up schedules for patients with colorectal cancer after intentionally curative 
surgery.37 For decisions on treatment strategies within a disease category, values for the 
different possible outcomes by representatives of the patient group involved may be 
used. ~ 
In a decision-making process at a health-care policy level, the relative effects of 
different kinds of programmes (e.g., preventive versus curative) for different disease 
groups (e.g., cancer versus heart disease) within different age- and sex groups are 
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compared in order to support the decision-making process in resource allocation. 
Implications for the valuation procedure are multiple. The values to be used should 
reflect the societal viewpoint, which is often operationalized by obtaining a 
representative sample from the general public, in their capacity as tax payers and as 
future patients, to perform the valuation task." 
Values of health states, combined with life-years form the basis of QAL Y calculations. 
The research field of evaluative health status measurement is complex. However, 
choosing to determine explicitly a set of relative values for different health outcomes 
and constructing a single outcome indicator provides opportunities to opening the 
'black box' of the decision-maker's relative values for public sCl1ltiny and influence." 
The experiences from the Oregon Medicaid Experiment show that the meaning of 
societal ratings on the desirability of health states (,values') needs careful 
explanation." Oregon proposed a social experiment in which combinations of medical 
conditions and treatments were prioritized. The experiment intended to include 
empirical valuations of health states as a basic element. The US Department of Health 
and Human Services (DHSS) rejected Oregon's application to proceed with the 
experiment because the Oregon preference survey 'quantified stereotypic assumptions 
about persons with disability'. The DHHS assumed that health preference data were 
discriminatory because the health states of people without disabilities and of those with 
disability would not be rated as the same." This statement shows clearly that the aim of 
the experiment was seriously misinterpreted and disclaims the notion that subjects who 
are at optimal health may need fewer health services than those who are less healthy. 
2.6 The position of 'time' 
'Time' occupies a special position in health status measurement. In the descriptive 
stage, time plays a role in the reference period of questionnaires (e.g., 'Think of the 
past day / week / month ... ') and in the timing of assessments. In the valuation stage, 
time is incorporated for example in the duration of the state to be valued. Time occurs 
explicitly in the final stage of outcome evaluation when health status valuation data are 
combined with survival data. The issue of time in descriptive health status assessment 
will be addressed below, while 'time' in evaluative health status measurement is 
addressed in chapter 8. 
The aim of descriptive health status measurement is to describe the course of health 
status over time. For each individual within a group of patients this may be 
operationalized by repetitive assessments that each refer to a defmed period of time 
during which health status is assumed to be stable. This implies that the results of each 
assessment should be globally representative of the distribution of health status during 
a given period. We are generally not interested in a unique point estimator. Therefore, 
many questionnaires use a reference period; for example, the COOP/wONCA charts 
refer to 'the past two weeks', the EORTC QLQ-C30 to 'the past week', the SF-36 to 
'the past four weeks', the SIP to 'today'. The time-frame of a questionnaire should 
theoretically be in accordance with the length of the period for which the assessment is 
assumed to be representative. However, from a psychometric point of view, short time 
frames are preferable if health status (,state') is to be differentiated from personality 
traits including complaint behaviour. This was illustrated by the results of a study that 
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showed that responses of subjects about their complaints with 'yesterday' as a time 
frame could be clearly differentiated trom their answers to questions relating to 
neuroticism (a personality trait). When this time span was enlarged from I to 3 days, 
responses to the complaint items could not be clearly differentiated from the measure 
of neuroticisl1l.40 
Establishing that assessments should be representative of periods of stable health status 
also has consequences for the number and timing of assessments. The commonly 
applied model of one assessment before and one assessment after an intervention is 
only justified if the individual shows a stable health status before the intervention, a 
reaction on treatment that is restricted to a well-defined period and a stable health 
status aftenvards. The reaction on treatment must be homogeneous in direction and in 
magnitude for all domains of health status. Moreover, the group of patients must be 
homogenous with respect to pre-intervention level of health status, reaction on 
treatment and post-intervention level (see Figure 2.6.1). 
In practice cases are commonly characterized by: 
different levels of health status among individuals before the intervention (see 
Figure 2.6.2); 
heterogenous reactions on treatment [referring to either inter-individual differences 
in the speed of the reaction (see Figure 2.6.3), or intra-individual differences in the 
reaction on treatment for different domains of health status (see Figure 2.6.4)]; 
different courses among individuals after the intervention [including for example, 
uncomplicated recovery, complicated recovery, and a declining course resulting in 
death (see Figure 2.6.5)]. 
General guidelines for the timing of assessments are difficult to give, but the 
commonly observed once before - once after model for data analysis is seldom valid." 
FIGURE 2.6.1 Course of health status over time (i): stable health status before treatment; 
homogenous reaction on treatment 
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FIGURE 2.6.2 
FIGURE 2.6.3 
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Course of health status over time (H): inter-individual differences in level of health 
status; homogenous reactions on treatment 
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FIGURE 2.6.4 
FIGURE 2.6.5 
Course of health status over time (iv): intra-individual differences in the reaction on 
treatment for different domains (Q) of health status 
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2.7 Standardization of research instruments for health status assessment 
Generally, methodological choices in designing a research project depend on the 
research question to be addressed. However, as explained below, there are arguments 
to strive for some level of standardization of research methodology. 
As stated in a section 2.5, the perspective (Le., the level of decision· making at which 
the information is to be used) determines the research question in health status assess-
ment, and consequently partly the research methods to be employed. If health status is 
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measured from the health care policy perspective, which is a societal perspective, 
comparability is an essential pal1 of the research question. The meaning of 
'comparability' in this context is twofold. Firstly, it refers to comparability across 
diagnoses and disease stages, requiring the use of generic health status measures. 
Secondly, comparability means a comparison with other studies that include health 
outcome measures. The latter requires much further standardization of the complete 
design of evaluation studies, including the choice of generic questiollllaires, the timing 
of assessments, the choice of valuation methods, the methods of data analysis, 
presentation of the results, etc. In ReTs conducted from the patient group perspective, 
comparability of results with other studies may be not strictly essential. However, it is 
considered efficient to additionally strive for some comparability in research from the 
patient group perspective. 
The way to achieve a higher degree of comparability of study results is to define and 
implement a cel1ain level of standardization. This implies some restriction of the 
individual freedom of researchers and research groups. 
The remainder of this chapter relates to standardization of generic instruments for 
health status assessment. Other aspects of research design that might be related to 
standardization, although equally important with respect to comparability of study 
results, are not discussed. 
2.7.1 Levels of standardization 
The prescription of one standard measuring instnllllent is the most rigid level of 
standardization that could be imagined. The present situation may be seen as the other, 
liberal, end of a hypothetic continuum. The choice of measuring instruments by the 
individual researcher 01' research group is presently based on a multitude of 
heterogenous considerations, including the research question, personal taste, tradition, 
fashion, and investments made by using an instrument in previous reseach. 
Assuming a foreign origin for most instruments for health status assessment, levels of 
standardization can be ranked as below. 
I. Standardized mles for the adaptation of foreign inshuments; free choice from the 
available instmments. 
2. One standardized version for each instrument; free choice. 
3. One standardized version for each instnJlllent; restriction of freedom of choice by 
recommending to choose at least one from a set of questionnaires. 
4. One standardized version for each instrument; recommendation to include a 
standard 'common core' instrument. 
5. One standard instnllllent; no other options. 
Reaching levels I 01' 2 would imply an improvement compared to the present situation, 
although this would not contribute very much to comparability of the results of 
different studies employing different health stahlS measures. It is shown in chapter 3 
that the generic instruments currently available in the Netherlands are rather different, 
precluding simple 'translation' of results from one instllnllent to another. Level 5 is of 
course undesirable as it 1V0uld destroy all creativity, consequently hampering scientific 
progress. 
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Level 4, representing the 'common core' option, apart from standardization of versions 
of questionnaires, is desirable and might seem to be feasible as well. Such a common 
core can be seen as a minimal level of standardization, providing at least the possibility 
to compare between patient groups and to locate these groups on the hypothetical 
continuum between 'the best imaginable health state' and 'the worst imaginable health 
state'. The development of the EuroQol instnnnent emanated fi'om the 'common core' 
principle." 
2.7.2 Ways towards standardization 
Several ways towards standardization, each differing in the amount of active effort 
required, can be discerned. The first is 'wait and see', as in the long nlll, the 'best' 
instrument will gain general acceptation and become the standard. The disadvantages 
of this passive strategy include the long time the waiting may take and the fact that 
factors other than scientific quality (for example, effective marketing) may determine 
the dissemination of an instmment. 
A second way is also passive. 'Creeping standardization' describes the process of 
copying of methodology without further reflection or testing of instnnnents. An 
instrument may be chosen automatically for use in a research project because 
everybody has used it, despite the lack of empirical research undertaken on the relative 
qualities of the instrument. 
A third strategy includes an active marketing approach. Given sufficient financial 
resources are available, an instrument may be developed, tested and become very 
popular in a short time, as has been demonstrated by the introduction of the SF-36. 
A fourth strategy provides researchers with guidelines as to the choice of instnnnents, 
which are based on scientific information and consensus reached among experts in the 
field. This strategy, which seems the most desirable, is being followed by the Dutch 
Working Group on Health Status Assessment, see the next section. 
2.7.3 Implementation of standards: Dutch Working Group on Health Statlls Assessment 
(Werkgroep Onderzoek Gezondheidstoestandmeting) 
In the context of the research programme 'Standardization in Medical Technology 
Assessment', funded by the Health Research Promotion Programme 
(Stimuleringsprogramma Gezondheidsonderzoek), a group of experts representing the 
field of health status assessment in the Netherlands have met at regular intervals in the 
Dutch Working Group on Health Status Assessment (Werkgroep Onderzoek 
Gezondheidstoestandmeting) since 1992. The aims of the Working Group are, firstly, 
to promote the use of health status measlll'es in clinical research; secondly, to bring 
about a certain level of standardization in order to increase the comparability of study 
results; thirdly, to establish a nationwide network for researchers engaged in health 
status measurement. As consensus appeared to be feasible on a number of topics 
considered essential for comparability, the Working Group intends to provide 
researchers with guidelines based on that consensus and the scientific 'state of the alt'. 
Important guidelines reached by the middle of 1994 were: 
I. When to include health status assessment in clinical research. The Working Group, 
following a recommendation of the National Cancer Institute of Canada", 
recommends to include a paragraph on health status assessment in all proposals for 
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medical evaluation research. This paragraph should explain why health status 
measurement is or is not included in the study. 
2. Generic measuring instruments. The Working Group recommends data collection 
for reference purposes with a ~common core' instrument in any medical evaluation 
project. The COOP/WONCA charts are recommended as the 'common core' 
instrument for 1994-1996. During this period the usefulness of the 'common core' 
and its contribution to the comparability of study results will be evaluated. 
Additionally, reliability and validity studies of the COOP/wONCA charts will be 
continued in a wide range of patient populations. 
Additionally, the Working Group intends to promote methodological research in the 
field of health status assessment and to collect and disseminate structured information 
on health status assessment. Information and guidelines will be disseminated by 
seminars, publications in the scientific press" and an instruction booklet for clinical 
researchers45 . 
Note 
I. This is an item from the EORTC QLQ-C30. 
References 
Verbrugge LM, JeUe AM. The disablement process. Soc Sci Med 1994;38:1-14. 
2 Wilson IB, Cleary PD. Linking clinical variables lVith health related quality of life. JAMA 
1995;273:59-65. 
3 World Health Organization, International classification of impairments, Disabilities, and 
Handicaps. Geneva, 1980. 
4 Haan R de, Horn J, Limburg M, Van def Meulen J, Bossuyt P. A comparison a/five stroke 
scales wilh measures of Disability, Handicap and Quality of Life. Stroke 1993;24:1178~ 
1181. 
5 Haes JCJM de, VanKnippenberg ICE, Neijt JP. Afeaslfring psychological and physical 
distress in cancer patients: st1'llcture alld application of the Rotterdam Symptom Checklist, 
Br J Cancer 1990;62: 1034-1038. 
6 Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European 
Organization for Research and Treatment of Cancer QLQ-C30: a quality-oflife instrument 
for use in international clinical trials in ollcology, J Nat Cancer lust 1993;85:365~376, 
7 Meenan RF, Gertman PM, Mason JH, l\leaslll'illg Health status in arthritis: the Arthritis 
Impact Aleasurement Scales. Arthritis Rheum 1980;23: 146-152. 
8 Taal E, Jacobs IW, Seydel ER, Wiegman 0, RaskeI' 11. Evaluation of the Dutch Arthritis 
Impact Measurement Scales in patients wilh rheumatoid arthritis. Brit I Rheumatol 
24 Overview ofthejield of health status measurement 
1989;28:487-49 J. 
9 Hyland ME, Finnis S, Irvine SH. A scale Jor assessing quality oj life in adult asthma 
sufferers. J Psychosomatic Research 1991;35:99-110. 
10 Juniper EF, Guyatt GH, Epstein RS et aL Evaluation ojimpairmelll a/health-related qualify 
of life in asthma: develpment of a questionnaire for use in clinical trials, Thorax 
1992;47:76-83. 
11 Rutten-van M51ken MPMH, Custers F, Doorslaer EKA van, Jansen MCM, Heurman L, 
Maesen FPV et al. Comparing the peljOl'mOnce of Jour different instruments in evaluating 
the effects a/solmetera! on asthma quality aflife. Eur Resp J 1995; forthcoming. 
12 'Vijkstra Pl, Verger! EM Ten, Van Altena R, Otten V, Postma DS, Kraan J, Kaeter OR. 
Reliability and validity of the chronic respiratOlY questionnaire (CRQ). Thorax 
1994;49:465-467. 
13 Fletcher AE, Chester PC, Hawkins CMA, Latham AN, Pike LA, Bulpitt Cl. The effects of 
verapamil and propranolol on quality oj lift in hypertension. J Human Hypertens 
1989;3: 125-130. 
14 Grootenhuis PA, Snoek FJ, Heine RJ, Bouter LM. Development oj a Type 2 Diabetes 
Symptom Checklist: a measure oj symptom severity. Diabetic Medicine 1994; 11 :253-261. 
15 Aaronson NK. Qllantitative issues ill healtli-refated quality of life assessment. Health Policy 
1988; 10:217-230. 
16 Wijkstra PJ, Vergert EM Ten, Van Altena R, Otten V, Postma DS, Keaan j, Koeter OR. 
Reliability and validity oj tlie chronic I'espiratmy questionnaire (CRQ). Thorax 1994;49:465-
467. 
17 Drummond MF, Stoddart GL, Torrance OW. Methods/or the economic evaluatioll ofllealth 
care programmes. Oxford: Oxford University Press, 1987, 
18 World Bank. World Development Report 1993: investing ill health - lVOl'ld development indi-
cators, Oxford: Oxford University Press, 1993. 
19 Ruwaard D, Kramers PON, eds, Volksgezondheid Toekomst Verkellning. Den Haag: SOU, 
1993. 
20 Mackenbach JP. The future of public health in general, alld 'healthy life expectancy' in 
particular, (Dc toekomst van de voiksgezondheid in het aigemeen, en de 'gezonde 
levensverwachting' in het bijzonder; in Dutch). Ned Tijdschr Geneeskd 1994; 138(21): 1053-
1055. 
21 Barendregt H, Bonneux L. Changes in incidence and survival of cardiovascular disease and 
their impact on disease prevalence and health expectancy. (De invloed van veranderingen in 
incidentie en overleving van cardiovasculaire zickten op ziekteprevalentie en gezonde 
levensverwachting; in Dutch, English abstract), Tijdschr Soc Oezolldheidszorg 
1994;72(8):429-433. 
Overview of the field of health status measurement 25 
22 Murray CJL. Quantifying the burden of disease: the technical basis for disability-adjusted 
life years, Bulletin of the WHO, 1994;72(3):429-445, 
23 Sutherland HJ, TiJI JE. Quality of life assessments and levels of dec ion making: 
differentiating objectives, Quality of Life Research 1993;2:297-303, 
24 Detsky AS, Naglie IG. A clinician's guide to cost-effectiveness analysis. Ann Int Med 
1990; 113: 147-154, 
25 Bonsel GJ. 1\ledical Technology Assessment crossing YOllr path. (Als Medical Technology 
Assessment uw pad kruist, in Dutch).Tijdsch Soc Gezondheidszorg 1992;70:487-489. 
26 Drummond MF, Davies L. Economic analysis alongside clinical/rials. Int J TA in Health 
Care 1991;7:561-573, 
27 Bonsel GJ, Rutten FFH, Uyl-de Oroot CA. Measurement and valuatioll of quality of life ill 
economic appraisal of cancel' treatment. Eur J Cancel' 1994;30A( I): 111-117. 
28 O'Boyle CA, McGee H, Hickey A, O'Malley K, Joyce CRB, Individllal Qllality of life in 
patients undergoillg hip replacement. Lancet 1992;339: 1 088-1 091. 
29 McGee HM, O'Boyle CA, Hickey A, O'Malley K, Joyce CRB, Assessing Ihe qllalily of life 
of the individual: the SEIQOL with a healthy and a gastroenterology unit population. 
Psycho1 Mcd 1991;21:749-759, 
30 Kiebert OM, Haes JC de, Velde CJ van de. The impact of breast-conserving treatment and 
mastectomy 011 the quality of life of early-stage breast cancer patients: a review. J Clin 
Oncol 1991 ;9(6): 1 059-1070, 
31 Haes JCJM de, Koning HJ de, Oortmarssen OJ van, Agt HME van, Bmyn AE de, Maas PJ 
van del'. The impact of a breast cancel' screenillg programme on QALYs. lnt J Cancer 
1991 ;49:538-544, 
32 Andrews FM, Withey SB. Social indicators of well-being. New YorK: Plenum Press, 1976. 
33 Campbell A, Converse PE. The Qualify of American life. New York: Russell Sage 
Foundation, 1976. 
34 Sutherland HJ, Llewellyn-Thomas HA, Lockwood GA, Tritchler DL, Till JE, Callcer 
patients: their desire for information and participation in treatment decisions. J Royal Soc 
Medicine 1989;82:260-263, 
35 Blanchard CO, Labrecque MS, Ruckdeschcl IC, Blanchard EB. Information and decision-
making preferences of hospitalized adult cancer patients. Soc Sci Med 1988;27( II): 1139-
1145, 
36 Levine MN, Gafni A, Markham B, McFarlane D. A bedside decision instrument /0 elicit a 
patient's preference concerning adiuvant chemotherapy for breast cancer. Ann Int Med 
1992; 117(1 ):53-58, 
26 Overview of the field of health status measurement 
37 Bruinvels DJ. Follow~lIp of patients with colorectal cancer. Dissertation, Leiden, The 
Netherlands, 1995. 
38 Hadom DC. The role of public values in setting health care priorities. Soc Sci Mcd 
1991 ;32:773·781. 
39 Kaplan RM. Valuejudgmellt ill the Oregon Medicaid E'<periment. Med Care 1994;32:975~ 
988. 
40 Huisman SJ, Van Dam FSAM, Aaronson NK, Hanewald GJFP. On measuring complaints of 
cancer patients: some remarks on the time span of the questioll. In: The quality of life of 
cancer patients. NK Aaronson, J Beckman, eds. New York: Raven Press, 1987. 
41 Bonsel OJ. Alethods of medical technology assessment with an application to liver 
transplantation. Thesis. Rotterdam, 1991. 
42 EuroQol Oroup. EuroQol ~ a new facility for the measurement of health~related quality of 
lift. Health Policy 1990; 16: 199·208. 
43 Osoba D. The quality of life committee of the clinical trials group of the National Cancer 
Institute of Canada: organization alldfimctions. Quality of Life Research 1992; I :211~218. 
44 Essink~Bot ML. The Dutch Working Group on Health Status Assessment; standardisation of 
health~related quality of life research. (De Werkgroep Onderzoek Oezondheidstocstand~ 
meting; standaardisatie van onderzoek naar met gezondheid samcnhangende kwalitcit van 
leven; in Dutch). Ned Tijdschr Geneeskd 1994; 138: 1484·1486. 
45 Essink~Bot ML, Haes JCJM de. A short guide to quality of lift ill medical research. 
(Kwaliteit van leven in medisch onderzoek ~ een kortc inleiding; in Dutch). In preparation. 
OWJ'view a/the field of health status measurement 27 

3 
An overview of six generic instruments for health status 
assessment 
Partly published as: 
Essink-Bot ML, BOllsel GJ. Towards standardization of instruments for health 
status assessment (Naar slandaardisatie van het instrumentarium voor het me/en 
van de gezondheidstoestand) (in Dutch; English abstract). Huisarts en Wetenschap, 
1995; 38(3}: /17-122. Reprinted with permissioll of the publisher. 
3.1 Introduction 
Generic instnuuents for health status are, by defmition, comprehensive and 11011-
disease specific. An instnnnent is defined as 'comprehensive' if at least the physi-
cal, the psychological and the social domains are covered. The items of a generic 
health status instrument cover these domains in a non disease-specific way. This 
combination of characteristics makes generic instnnnents especially suitable for 
comparison of study results between different disease stages and diagnostic groups. 
The present chapter consists of a comparison of the contents and testing propelties 
of six generic questionnaires that are currently available in the Netherlands. The 
comparison, presented below, was based on the available literature, own research 
and on expert judgements of the users of the questionnaires. 
3.2 Six generic instruments for health status assessment 
Six generic questionnaires for health status assessment available and commonly 
used in the Netherlands will be inh'odnced and compared below. The selection 
includes the Sickness Impact Profile (SIP), the Nottingham Health Profile (NHP), 
the COOP/WONCA-charts, the 20124-item instnlluent from the Medical Outcomes 
Study (MOS-20/24), the MOS 36-item Short Form Health Survey (SF-36) I RAND 
36-item Health survey 1.0 (RAND-36) and the EuroQol instrument. References 
refer to Dutch adaptations of the questionnaires. 
The Sickness Impact Profile was developed in the US between 1972 and 1981 in 
order to assess the consequences of disease and treatment in functional terms. Items 
were selected from a pool of statements describing sickness-related changes in 
behaviour. These statements were obtained from patients, health-care professionals, 
individuals caring for patients and apparently healthy subjects.' The 136 items 
belong to 12 scales (see Table 3.2). Apart from a 12-dimensional profile score, the 
SIP is capable of generating a 'physical' subscore (3 scales), a 'psychosocial' 
subscore (4 scales) and a total score. The time-ITame of tlre SIP-items is 'today'. 
Examples of SIP items are shown in Chapter 4. In the self-assessment version of 
Six generic instruments 29 
the SIP, the respondent is requested to tick the statements that apply to him/her in 
relation to his/her health. The SIP was adapted for use in the Netherlands by 
researchers of the Utrecht Institite for General Practice. In the Dutch situation the 
SIP has been extensively used in rehabilitation studies, neurology, and in general 
practice. A shortened SIP (68 items) with comparable qualities has recently become 
avalaible.2,3,4,5 
The Nottingham Health Profile was developed during 1977-1981 in Great Britain 
as a measure for perceived health. Items were selected from an item-pool that was 
created by interviewing patients with a variety of chronic ailments.6 The NHP was 
intended for use in population surveys. It consists of two patis. Part I consists of38 
dichotomous items, covering the scales as listed in Table 3.2. Examples of NHP-I 
items are shown in Chapter 4. Part 2 consists of seven items on problems because 
of health in specified areas of life (for example, paid employment, household work, 
social life). The time reference period in the NHP is 'at the moment'. Several Dutch 
NHP versions are available. The NHP-Dutch Adaptation by Bonsel et al. has been 
tested in several patient populations. An agreement was reached with the authors of 
the other Dutch version of the NHP to strive for one documented Dutch NHPY 
De COOPIWONCA-charts were developed to assess health status of patients in 
primary care. Several well-established instnllnents were used as a source for the 
contellts of the charts. There are 6 charts covering the domains mentioned in Table 
3.2. A Pain chali is optionally available. Each item has five function levels which 
are illustmted with pictogrammes. These pictogrammes may be useful aids for 
groups with low reading ability and/or low mastery of the Dutch language. The 
time-frame refers to the 'past two weeks'. There is one Dutch standard version.''!o 
The 20124-item instrument fi'om the Medical Outcomes Study is a sunllualY version 
of the RAND Health Insurance Study Questionnaire which was used in the US in 
the RAND Health Insurance Experiment to study the health status effects of types 
of health insurance. In the Medical Outcomes Study rramework of health indicators 
the two theoretical dimensions of health, i.e., physical and mental, are defined in 
terms of a variety of indicators. After a content area was specified, items were 
written to operationalize each concept." The content of the MOS-20 was chosen to 
represent only the most important health concepts. The items of a dimension were 
selected to meet minimum standards of precision for purposes of group compari-
sons." The time reference periods in the items of the MOS-20 are one month or 
three months. An 'acute version' with shorter reference periods is available. The 20 
items cover 6 scales (see Table 3.2J.l2 The most important difference between the 
two existing Dutch versions [by Kempen (NCG, Groningen) and De Haes (AMC, 
Amsterdam), respectively] is the addition of 4 items on Vitality in de latter version, 
making it a MOS-24. 
The MOS 36-itelll Short Form Health Survey I RAND 36-item Health survey 1.0 is a 
36-item version of the same instrument. The longer 36-item version was developed 
to improve some shortcomings that were observed when employing the MOS-20." 
For example, a floor phenomenon was found, i.e., a lower ability of the MOS-20 to 
discriminate among health states of seriously ill patients. I' Two US originals exist, 
which are so similar that we regard them as identical. The same applies to the two 
co-existing Dutch versions, which are referred to as the SF-36 and the RAND-36 
respectively. Any further reference to the SF-36 in the following will also apply to 
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the RAND-36. The 36 items cover 8 scales (see Table 3.2). The item of Reported 
Health Transition is scored separately.!'·!6 An example of a SF-36 item is: 'During 
the past 4 weeks, how much of the time has your physical health or emotional 
problems uinterfered with your social activities (like visiting with friends, relatives, 
etc.)?' An 'acute version' with a reference period of I week is available. 
The EuroQol classification consists of five items (see Table 3.2). The choice of the 
dimensions was guided by a careful review of existing descriptive health status 
measures. Each item comprises the following levels: no problems - some problems 
- extreme problems. Additionally, evaluation of own health is assessed with a visual 
analogue scale ('thermometer') ranging from 0 (worst imaginable health state) to 
100 (best imaginable health state). The time-frame of the EuroQol instrument is 
'today' . 
EuroQol health state descriptions can be linked directly to empirical valuations of 
health states by the general public, a feature which makes it especially interesting 
for use in economic evaluations of health care interventionsY The EuroQol 
instrument was developed by the international EuroQol Group and is intended 'to 
complement other qnality-of-Iife measures and to facilitate the collection of a 
common dataset for reference purposes'.!' There is one Dutch standard original 
available. 
3.3 Qualitative comparison of the contents 
A qualitative comparison of the item-content was carried out on the multi-item 
scales of the SIP, NHP, MOS-20/24, SF-36, and on the items of the 
COOP/WONCA charts and the EuroQol. Scaleslitems were considered comparable 
if their content was judged to refer to the same general health domain; see Table 
3.2. 
The physical domain is operationalized with an emphasis on walking (SIP-
Ambulation, NHP, EuroQol) or as overall physical functioning (COOPIWONCA, 
MOS-20124, SF-36). The SIP adds a dimension labeled 'Mobility' which relates to 
'range of action" an issue that goes uncovered in the other five questionnaires. The 
psychological domain is similarly present in the six instruments. The same holds 
for role functioning, which is however somehow underrepresented in the NHP. 
Social Isolation(NllP) relates to the ability to make contact with other people and was 
considered to belong to the psychological rather than the role domain. 
A pain dimension is absent in the SIP and in the COOPIWONCA chatts (though 
optionally available in the latter). Pain(Mos.20), Bodily pain(sF-") and Pain(NHP) do not 
refer to somatic sensations other than pain. Dimensions relating to overall health 
are available in 4 out of 6 questionnaires. Some instruments contain unique 
dimensions (Sleep(NtIP), Alertness(s!p), Communication(s!p». The SF-36 and MOS-24 
are the only instruments to address the concept of positive health (items worded as 
'full of pep' in the Vitality-scale). NHP(Eo"gy) is not an indicator of positive health as 
all items are phrased negatively ('tired all the time', 'everything is an effort', 'soon 
I1mning out of energy'). 
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This leads us to the following conclusions. Broadly speaking, all six instruments 
address two basic health domains, i.e., physical and psychosocial functioning. 
However, each approaches these domains areas from a somewhat different perspec-
tive. Similarity in scale labels sometimes hides dissimilarities in content. The 
reverse (similar content, dissimilar labels) also occurs. 
TABLE 3.2 Qua1ilaUve comparison of questlonnalre content of SIP, NHP, COOPIWONCA charts, MOS~ 
20/24, SF-36, EuroQol 
,-
SIP NHP COOPIWONCA MOS-20/24 SF-36 EUROQOL 
-- --
Physical fitness Physical Physical 
--
functioning functioning 
AmbulaUon Physical -- -- -- Mobitity 
Mobility 
Mobility -- -- -- -- --
Emotion Emotional Feelings Menial Menial health Anxietyl 
reactions + health depression 
Social 
Isolation 
Household -- Daily Activities Role Role-physical + Dally activities 
management + Social functioning Role-emotional 
+ Social Activities + Social + Social 
interaction + Functioning functioning 
Work + 
Recreation and 
pastimes 
-- Pain -- Pain Bodily pain Painl 
discomfort 
--
-- Overall health Current General health Valuation own 
health perceptions health 
perceptions 
Bodycare and --
--
• . Self care 
movement + 
Eating 
-- Energy -- Vitality (24) Vitality --
Sleep and rest Sleep 
-- -- -- --
--
-- Change In 
-- R€ported health --
health transition (1 
(2 weeks) year) 
Alertness 
-- --
--
--
--
Communication 
--
--
--
-- --
~ ~ .. "-. "----
;0 ftem In the Physical Function!~~ scale __ 
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3.4 General criteria for the quality of health stattls measures 
We discern three types of criteria for quality of health status measurement instIll-
ments, i.e., practical, technical and conceptual criteria. Each will be addressed 
below. 
Practical criteria that determine the feasibility and consequentially the applicability 
of questionnaires, can be summarized as 'respondent burden'. 'Length', or the 
number of items of a questionnaire, represents only one aspect of respondent 
burden. Other aspects, including the degree of complexity and required reading 
ability should be taken into account as well. Moreover, the feasibility of a question-
naire is population specific. Empirical health status measurement is generally 
feasible even for seriously ill patients if good explanations about the aims and the 
necessity of the research are provided to patients, physicians and nursing staff, and 
provided that the whole procedure is extremely user friendly. Computer-assisted 
interviewing may offer special advantages, for example by providing invisible 
routing procedures. 
Technical criteria relate to reliability, both in terms of internal consistency and of 
test-retest-, inter-observer-, and intra-observer-reliability (the latter two not applica-
ble for self-assessment instnllnents). These are considered technical criteria because 
there is a general consensus about appropriate testing procedures and statistics 
(although the use of the intraclass correlation coefficient might be further encour-
aged)." An issue deserving special attention with respect to instruments for health 
status measurement is that reliability estimates obtained in one population may not 
be generalized to other populations with different characteristics regarding, for 
example, age, sex and disease-severity distributions. 
Conceptual criteria relate to validity, or the extent to which the instrument mea-
sures the characteristic as intended. Three types of validity are distinguished in 
classical test theory: criterion validity, content validity, construct validity. Determi-
nation of criterion validity requires a measurable superior reference criterion, which 
is generally not available for health status measurement. Content validity refers to 
theoretical testing of the contents of an insh'lIInent (i.e., representative coverage of 
all relevant domains). ConstIllct validity requires empirical testing of a priori 
hypotheses about the relationship of the instIllment under study with instruments of 
proven validity. For health status instnnnents, this generally takes the form of 
testing the instnllnent's ability to discriminate among 'known groups' (,clinical 
validity') and of comparing data from the new instIllment with simultaneously 
obtained data from other health status measures. 
A special feature of validity testing of health status instruments is, again, its 
population specificity. An instrument which measures health status adequately in a 
relatively healthy population still remains to be validated in seriously ill popula-
tions. An aspect of validity deserving flllther research is responsiveness to (clinical) 
change over time, or 'longitudinal validity'.20 This issue should be preceded by 
determination of test-retest reliability." If a measure is known to be stable over 
time when health status did not change, it is usenll to investigate if the instrument is 
able to reflect actual changes over time. The ability to discriminate between groups 
at one moment in time does not garantuee a good responsiveness over time. 
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Generally, validity testing should be seen as a continuous proces, that yields 
indications about the degree of confidence we can place on inferences that are made 
about people based on their scores from an instrument." 
3.5 Qualitative comparison of questionnaire properties 
Some properties of the questionnaires are listed in Table 3.5. The data in the table 
represent combined literature data on the Dutch versions of the questionnaires and 
expert opinions from members of the Dutch Working Group on Health Status 
Assessment (see Chapter 2, section 2.7), all of them engaged in developmental 
work on Dutch adaptations of foreign questionnaires. 
All 6 instruments are suitable for self-assessment. The number of items differs 
greatly. SIP, NHP (Pat1 I), MOS-20/24 and SF-36 are classical multi-item scales 
(although some scales contain only 2 or 3 items), while COOP/WONCA and 
EuroQol are classification instruments. The rep011ed completion times probably 
relate to relatively well patients. Questionnaires appear to be tested in patient 
groups that can be approached relatively easy (e.g., not too seriously ill, not too old, 
no vision problems, suffering from chronic diseases with a fairly predictable 
course). Data on questionnaire behaviour in 'difficult' popUlations are scarce. 
Different types of response choices (i.e., dichotomous, Likel1) are applied. A 
consequent relatively easy response mode enhances the 'feasibility' of an instru-
ment. The risk of acquiescence bias is the other side of this picture." The occur-
rence of different response choices in one questionnaire probably adds to the degree 
of difficulty experienced by the respondents. 
All 6 questionnaires meet the criteria (see section 3.1) for generic instruments. 
However, some of them were originally designed for groups of patients with rather 
specific diagnoses. The fact that the early research which eventually led into the 
development and testing of the present NHP was conducted in the context of hip 
replacement operations may explain the relative emphasis on walking.6•22 
Applicability of questionnaires in different age groups implies fulfilling two distinct 
criteria. The first relates to the cognitive ability necessary for filling in a question-
naire. The second relates to the validity (including 'face validity', i.e., the appropri-
ateness of the items) in different age groups. 
We originally intended to include a comparison of psychometric testing propel1ies 
of the six instruments (reliability, validity). The attempt to combine literature and 
expert opinions led to the conclusion that a such a comparison is not yet possible. 
This is due to a lack of comparable information, due to incomparability of 
operationalization of testing properties (e.g., test-retest intervals ranging fi'om I 
hour to I year) on the one hand, and employment of the questionnaires with 
incomparable populations on the other hand. 
34 Six generic instruments 
TABLE 3.6 Comparison of characteristics of SIP, NHP, COOPIWONCA, MOS-20/24, SF-36, EuroQol 
SIP NHP COOP/WONCA MOS- SF-36 EuroQol 
20/24 
--
Suitable for yes yes yes yes yes yes 
self-assess-
ment 
Number of 136 38 + 7 6 20 (24) 36 6 
items 
Completion 20 6 5 6 10 2 
lime (min.) 
Response yes/no yes/no 5 categories more than more than 3 
type with one type one type categories 
plclogrammes (3 - 6 (2 - 6 + ther-
categories) categories) mome!er 
Designed adults adults > 14 years adults > 16 years > 12 years 
for age 
group ... 
Designed varied general paUents varied varied varied 
for ... groups population consulting their groups groups groups 
GP 
3.6 Conclusion 
A judgement of the contents of the questionnaires revealed that the concept of 
health status was operationalized somewhat differently in the 6 generic 
questionnaires for health status assessment currently available for use in the 
Netherlands. A comparison of their reliability and validity on the basis of literature 
data was not possible. 
It became clear that none of the presently available instruments is superior to all 
others judged on the basis of 'objective' criteria. This means that none of these 
instruments is eligible as the standard instrument to be used in medical evaluation 
research. Even if a 'superior instnnnent' could be defined, a quick and easy 
acceptance (Le., without pressure) to replace the generic instruments currently in 
use is unlikely. This is due to the investments made by researchers and research 
groups by using instruments in their previous research. 
A general lack of accessible information with respect to the relalive behaviour of 
the available instl1lments in different patient groups was observed. If, for example, 
a researcher wants to know which of the generic instl1lments available best suits the 
purpose of evaluating a new treatment for multiple sclerosis, this information is not 
easy to find. Maybe the Clearing Houses that have recently been established will be 
able to fill this information gap to some extent, preferably at a reasonable cost.2l·24 
More 'parallel research' employing two or more instruments with comparable 
contents in the same patient group is required to provide empirical evidence of the 
relative value of the instl1lments. For comparability of questionnaire properties a 
minimum amount of information should be available in a standard format. 
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4 
NHP or SIP - a comparative study 
Accepted/or publication in Quality a/Life Research as: 
Essink-Bot ML, Krabbe PFM, Agt HME vall, BonselOJ NHP or SIP - a comparative 
study in renal illslif.jiciency associated anemia. Reprinted with the permission 0/ the 
publisher. 
4.1 Abstract 
In this study we compared the feasibility, internal strncture and psychometric 
characteristics (internal consistency, test-retest reliability, construct validity) of two 
widely used generic health status measures, i.e., the Nottingham Health Profile (NHP) 
and the Sickness Impact Profile (SIP) when employed among a sample of patients on 
renal dialysis (n ~ 63). 
The NHP was found to be more feasible, i.e., shOlter and less difficult, than the SIP. 
The NHP scales showed somewhat higher levels of internal consistency (mean a ~ 
.67, range ~ .39 to .80) than the SIP scales (mean a .65, range ~ .14 to .82). Test-
retest reliability with a 24-hour interval was acceptable for most NHP scales (not 
available for the SIP in this study). Intercorrelations between the NHP scales were 
somewhat weaker than those for the SIP, and the expected patterns of scale inter-
correlations were largely confirmed. The overall pattern of cOlTelations between NHP 
scales and SIP scales was consistent with expectations, although the correlations were 
generally rather weak. Correlations between NHP scales and SIP scales and instru-
ments measuring mainly physical functioning (ADL, Karnofsky) were largely as 
expected. Similarly, cOlTelations between NHP scales and SIP scales and instruments 
measuring mainly psychological functioning [STAI (anxiety), SDS-Zung (depres-
sion)] were also as expected, although here the correlations were weaker for the SIP 
when compared with the NHP. The Index of Well-being exhibited intra-class cOlTela-
tions >0.3 with one SIP scale and with 5 out of 6 NHP scales, Common factor 
analysis, yielding a two-factor solution with a physical and a mental factor of equal 
importance, showed the SIP scales to load more on the physical factor, while the NHP 
scales loaded more on the mental factor. 
The NHP generally performed better than the SIP in terms of feasibility and internal 
consistency. Physical functioning is emphasized in the SIP, whereas the emphasis of 
the NHP lies on mental functioning. The analysis also confirms to some extent the 
intentions of the constructors of NHP and SIP respectively, i.e., the NHP to be a 
measure of perceived health and the SIP to be a more functional measure. 
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4.2 Introduction 
The assessment of the consequences of disease and treatment on quality of life has 
gained widespread application. Quality of life in the context of disease and treatment 
is generally limited to 'health-related quality of life', which is commonly referred to 
as 'health status'. Health status can be comprehensively operationalized as physical, 
psychological and social functioning. Examples of applied quantitative health status 
measurement include the National Health Interview Surveys, research in which the 
effectiveness of dl1lgs is evaluated, as well as medical technology assessment (MTA) 
of costly intervention programmes. Data are commonly collected by administering a 
questionnaire to the subject whose health status is to be measured. 
It has become common practice, especially in health status measurement in the 
context of MTA, to employ a combination of generic instruments with disease and/or 
domain specific ones. Generic instruments, being comprehensive and nOll disease 
specific, allow for the comparison of results among disease stages, and among 
different diagnostic categories. 
Each of the currently available generic instruments has its own strengths and weak-
nesses. There is, however, little empirical information available on the relative 
performance of these instruments. We hope that the present paper will contribute to 
the existing knowledge base by addressing an empirical comparison of two generic 
instruments for measuring health status, i.e., the Nottingham Health Profile (NHP) 
and the Sickness Impact Profile (SIP). 
The specific research questions addressed in this study were: 
I. How do the NHP and the SIP compare in terms of feasibility? 
2. How do the NHP and the SIP compare in terms of reliability? 
3. Is there empirical support for the hypothesized structures of the NHP and the SIP 
in terms of the health status domains being addressed (i.e., construct validity)? 
Quantative analyses of patient data were combined with qualitative research of the 
questionnaires and literature research. For this purpose we could make use of an 
existing dataset from a group of patients with renal insufficiency who were treated by 
renal dialysis. The disease and the intervention have variable consequences for 
functioning in the physical, psychological and social domains. 
4.3 Methods 
4.3. J. Instruments 
The NOllingham Health Profile was developed in the 1970s in the United Kingdom as 
a measure of perceived health for use in population surveys. 1 The NHP (part I) 
consists of 38 dichotomous items which are grouped into six scales, labelled respec-
tively Physical Mobility, Energy, Pain, Sleep, Social Isolation and Emotional 
Reaction. Each scale ranges from 0 (~ optimal) to 100. The ultimate score has a 
profile format. The Dutch adaptation of the NHP used in the current study has been 
previously tested in several patient populations. Some NHP items are shown in Table 
4.3.1. 
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TABLE 4.3.1 Examples of Nfif'it~llls(l:lu",nt._1..,9",8,,6)L'I ________________ _ 
I have trouble getting up and down stairs or steps (Physical Mobility) 
I'm tired all the time (Energy) 
I'm in pain when I walk (Pain) 
I'm waking up in the early hours of the morning (Sleep) 
The days seem to drag (Emotional Reactions) 
I feel thai I am a burden to people (Soci.llsolation) 
The Sickness Impact Profile was developed in the US between 1972 and 1981 as an 
instnlluent to assess the consequences of disease and treatment in functional terms. 
The 136 items are grouped into twelve scales: sleep and rest, eating, work, home 
management, recreation and pastime, ambulation, mobility, body care and movement 
(scores of the latter three may be combined as a physical subscore), social interaction, 
alertness behavior, emotional behavior, communication (scores of the latter four may 
be combined as a psychosocial subscore). Apart from a 12-dimensional profile score 
and the physical and psychosocial subscores, the SIP provides the opportunity to 
compute a total score. Each score ranges from 0 (~ optimal) to 100. In the self-
assessment version of the SIP the respondent is requested to tick the statements that 
apply to him/her in relation to his/her health. The SIP was adapted into Dutch by 
researchers of the Utrecht Institute for General Practice.'·) Some examples of SIP 
items are shown in Table 4.3.2. 
Data on 5 additional instlUments were used in the investigation of the construct 
validity of the NHP and the SIP. 
The State-Trait Anxiety Inventol}' (STAI) is an American 20-item questionnaire, of 
which a validated and nonned Dutch version is available (ZBV).4.' We used the 
'state'-pati, which measures situational anxiety.6 The total score ranges from 20 (= no 
anxiety) to 80. 
The Selfrating Depression Scale (SDS-Zung) is an American 20-item instmment for 
measuring depression, with a total score ranging from 25 (~ no depressive state) to 
100.7 We used the Dutch version as recommended by the Dutch Psychiatric Society 
(Vereniging voor Psychiatric).'" 
The Karl/ofsk)' Pelforlllance Scale (or Index) was developed by Karnofsky in 1948 to 
enable quantification of 'objective' quality of life aspects in the evaluation of dl1lgs 
against cancer. to In the original index, the levels are labelled with figures 0 (~ dead), 
10, ..... , 100 (~optimal). Wc translated the original US version and adapted it to make 
it suitable for self-assessment. 
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TABLE 4.3.2 Exam les of SIP items 
I sleep or nap during the day (Sleep and Rest, SR) 
I am eating no food at all, nutrition is taken through tubes or intravenous fluids (Eating, E) 
I often act irritable toward my work associates (Work, W) 
I am not doing any of the maintenance or repair work around the hOllse that I usually do (Home 
managemenl, HM) 
I am going out for entertainment less (Recreation and pastimes, RP) 
I walk shorter dis lances or stop to rest often (Ambulation, A) 
I stay away from home only for brief period of time (Mobllily, M) 
I am very clumsy in body movements (Body care and movement, SCM) 
I Isolate myself as much as I can from the rest of the family (Social interaction, SI) 
I have difficulty reasoning and solving problems, for example, making plans, making decisions, learning 
new things (Alertness behavior, AB) 
I act Irritable and Impatient wilh myself, for example, talk badly about myself, swear at myself, blame 
myself for things that happen (Emotional behavior, EB) 
I am having trouble writing or typing (Communication, C) 
Independency with respect to Activities of Daily Life (ADL) was assessed by a Dutch 
instnllnent asking whether the respondent is able to conduct 9 activities independent-
ly, and if so, at which effort. The 9 activities are listed as: getting in and out of bed, 
going to the lavatory, washing oneself, dressing, eating and drinking, taking a short 
walk, taking steps, cycling, shopping and cooking. The summary score ranges from I 
to 10 (~completely ADL independentj.1' 
The Index of Well-Being (IWB) is a measure for subjective well-being which was 
developed for American population surveys with a score range from 2.1 to 14.7 (~ 
optimal well-being). It was adapted into Dutch." 
4.3.2 Patients 
We used patients' data from a study to evaluate the effectiveness of erythropietin 
(EPO) in the treatment of renal insufficiency associated anemia. Questionnaire 
administration took place around a dialysis session. Before a dialysis session the 
assessment included completion of a comprehensive questionnaire, which included 
the NHP but excluded the SIP. The SIP was completed 24 hours later. This second 
questionnaire also included the NHP in a sample of the patients to investigate test-
retest reliability. We did not collect SIP test-retest data because it was considered too 
burdensome for the patients. 
The optimal test-retest interval has to be short enough to preclude a change in health 
status on the one hand, but long enough to eliminate recollection effects. A change in 
health status is imaginable between Ihe assessments mentioned above, just preceding 
dialysis and 24 hours afterwards, respectively. When asked, patients and clinicians 
generally judged this change as insignificant in relation to the overall health status 
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effects associated with terminal renal insufficiency. Recollection effects can probably 
be ignored, especially because the NHP was part of a comprehensive questionnaire at 
the test-assessment. 
In the present analyses data were available from 63 patients. Although the study 
included administration of questionnaires in a longitudinal design, we used data from 
one administration per patient to prevent introduction of artificial dependence in the 
data. We had 13 assessments preceding EPa treatment and 50 assessments I to 36 
weeks after the start of EPa treatment. The mean age of the respondents was 54 years 
(s.d. 16 years, range 21 - 78 years), 35 (56%) of them were men. 
4.3.3 Statistics 
Featllres o/score distributioll. Mean scores, standard deviations, and the percentages 
of respondents with the best possible score and the worst possible score, respectively, 
were computed. 
The intemal consistency was determined with Cronbach's a-coefficient. An a-
coefficient of 0.70 or higher was considered as sufficient for the purpose of group 
comparisons. J) 
Test-retest reliability was assessed with the intraclass correlation coefficient (ICC). 
The ICC is a statistic comparable with the conventional Pearson's correlation 
coefficient, with level effects between variables being taken additionally into consid-
eration.!'·!S Exact standards for the required magnitude of the reliability coefficient (is 
the instrument reliable enough?) are difficult to give. A test used for individual 
judgement should be more reliable than one used for group decisions. Whether a level 
of test-retest reliability of a test is acceptable for comparisons among groups depends 
on the size of the group under study: a sample of 1000 can tolerate a less reliable 
instrument than a sample of 10.!6 
The intemal stl'llcture of the NHP and the SIP was examined with the use of correla-
tion techniques. Matrices of intraclass correlation coefficients (ICCs) between the 
NHP scales and between the SIP scales, respectively, were computed. For each 
questionnaire scale, the square root of the mean of the squared ICC between that scale 
and each of the other scales was computed to summarize the correlation matrix. This 
statistic was used instead of simply averaging ICCs, in order to retain the interpreta-
tion of the squared ICC as the amount of variance shared. 
Three approaches were taken to investigate the constrllct validity of the NHP and the 
SIP. Firstly, the pattern of ICCs between the scales of the NHP and the SIP were 
examined. It was hypothesized that those scales that are conceptually related would 
be strongly correlated, while those scales with less in common would exhibit weaker 
correlations. Secondly, correlation patterns as observed between the scales of the 
NHP and the SIP and the STAI, the SDS-Zung, the ADL, the Karnofsky and the IWB 
were compared with a priori hypotheses with respect to these correlation patterns. 
Thirdly, common factor analysis with varimax rotation was employed to examine the 
relationships among the elements of the two health status measures and the five 
additional instnnnents. 
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4.4 Results 
4.4.1 Feasibility 
The meaning of the feasibility of questionnaires is not uniformly defined. Some 
aspects of the NHP and the SIP, considered by the authors to be determinants of 
'feasibility' are addressed below. 
Item content: the NHP items refer mainly to 'generic' physical and mental actions, 
including for example walking, standing, bending, sleeping, making contact with 
others, so that the items are applicable to a broad range of age groups, persons in 
different phases of their lives, and to both sexes. The SIP-items refer to a larger extent 
to activities, including for example tying shoe laces, performing household tasks, 
lying in bed, performing paid work, visiting friends, caring for children. 
1nstructions: the SIP instmcts respondents to tick the statements which apply to 
him/her in relation to his/her health. The NHP asks respondents to tick 'yes' if they 
have the problem stated in each item.The addition of 'in relation to his/her health' 
contributes to the complexity of the SIP. 
Routing: routing refers to conditional questions following responses to preceding 
questions. There is no routing in the NHP; all respondents must answer all questions. 
The inclusion of routing in the SIP for Work items adds to the complexity of the 
instnllnent and our data did in fact confirm that the respondents were confused. For 
example, although only 22 respondents indicated that they performed paid work, the 
SIP Work-items were answered by 44 respondents. Because of this, the SIP Work 
dimension was left out offllliher analyses. 
Length: The NHP consists of 38 items. It has been repmied that an average of 10 
minutes is the completion time for self-assessment. The respondents in the present 
study needed on average 8 minutes (s.d. 3'). The SIP consists of 136 items, with 
reports of completion time ranging from 20 to 30 millutes. 
Complexity: the reading burden may be indicated by the number of words per item. 
The NHP-DA consists on average of 8.5 (s.d. 3.9) words per item, the SIP of 11.7 
(s.d. 6.3). The SIP contains 16 questions comprising more than 20 words, compared 
with the NHP where this does not occur. 
4.4.2 Features a/score distribution 
Mean scores, standard deviations, and the percentages of the respondents with the 
maximum possible score and the minimum possible score, respectively, for each 
instmment are shown in Table 4.4.1. The distributions of the scores of the SIP were 
even more skewed in the direction of good functioning than those of the NHP. 
4.4.3 1ntel'l1al consistency and test-retest reliability 
The internal consistency coefficients (Cronbach's a) for NHP and SIP scales respec-
tiveley are shown in Table 4.4.1. 
The scales of the NHP yielded somewhat higher internal consistency estimates (mean 
a ~ .67; range ~ 0.39 to 0.80) than those of the SIP (mean a ~ .65; range ~ 0.14 to 
0.82). The a-coefficients for 3 of the NHP scales [Social Isolation (.39), Sleep (.66) 
and Energy (.69)] and for 5 of the SIP scales [Sleep and rest (.48), Emotional 
behavior (.62), Home management (.68), Recreation and pastimes (.66), Eating 
(0.14!)] fell well below the 0.70 standard recommended for group comparisons. 
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TABLE 4.4.1 Features of score distribution of internal consistency (Cronbach's a) and 24-hours test-
retest reliability (ICC) of NHP and SIP scales; score distributions of STAI, SDS-Zung, 
ADL, IWB and Karnofsky. Renal dialysis patients, n = .63 
mean s.d. % max· % min** 
" 
test-
retest 
NHP (score 0-100) 
Physical Mobility (8)'" 26.3 24.8 29 0 .80 .80 
Energy (3) 33.0 35.8 43 13 .69 .62 
Pain (8) 13.3 20.6 46 0 .76 .73 
Sleep (5) 38.6 34.9 24 10 .66 .75 
Emotional Reactions (9) 17.6 21.8 38 2 .74 .55 
Social Isolation (5) 12.9 19.7 60 0 .39 .57 
SIP (score 0-100) 
Sleep & Rest (7) 16.8 17.1 27 0 .48 
Emotional Behavior (9) 6.5 11.0 67 0 .62 
Bodycare and Movement 6.7 9.9 38 0 .81 
Home management (10) 21.7 20.5 21 0 .68 
Mobility (10) 12.7 14.1 46 0 .70 
Social Interaction (20) 9.3 9.7 25 0 .75 
Ambulation (12) 15.4 14.7 29 0 .73 
Alertness Behavior (10) 11.8 18.5 57 0 .82 
Communication (9) 6.0 12.6 71 0 .77 
Recreation & Pastimes (8) 29.5 22.8 16 0 .66 
Eating (9) 9.4 5.4 13 0 .14 
SIP total score 12.2 9.5 16 0 .95 
SIP physical score 9.8 10.6 19 0 .89 
SIP psychosocial score 8.6 10.2 0 0 .90 
ADL (score 10-1) 8.8 1.4 44 0 
STAI (score 20-80) 38.6 11.3 3 0 
SDS-Zung (score 25-100) 40.1 8.2 0 
Karnofsky (score 100-0) 72.2 16.4 11 0 
IWB (score 14.7-2.1) 10.4 3.2 0 0 
* % max=percentage of respondents with best possible score (ceiling); *'" % mln=percentage of 
respondents with worst possible score (floor); *H number of items 
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Nineteen SIP-items showed zero variance, which was explainable because they 
addressed very serious impairment of functioning. 
Test-retest reliability estimates (ICCs) for the NHP scales are also shown in Table 
4.4.1. The precautions mentioned in the Patients-section are to be borne in mind when 
interpreting these figures. As could be expected from the item content, test-retest 
reliability was highest for Physical Mobility(NHP). Test-retest reliability was rather low 
for Social Isolation (Nl1P) and Emotional Reaction(NlIP). 
4.4.4 Structure 
The ICCs for the NHP scales and the SIP scales, respectively, are summarized in 
Table 4.4.2 (complete data shown in Appendix I). In general, the NHP scales were 
somewhat less highly intercorrelated than were the SIP scales. As was expected, high 
ICCs were observed between Social IsolationlNHP) and Emotional Reaction""IP). The 
SIP scales grouped in the Physical subscore (Bodycare & Movement, Mobility, 
Ambulation) showed high intercorrelations. A similar pattern was observed for the 
SIP scales grouped into the psychosocial subscore (Social Interaction, Alertness 
Behavior, Emotional Behavior, Communication). Eating(SlP) correlated low with the 
other SIP scales. 
4.4.5 Construct validity 
Firstly, the matrix of ICCs between NHP scales and SIP scales is presented in the 
Appendix. We expected higher correlations between 'physical' dimensions (Physical 
Mobility",'HP), Bodycare and Movement(slP), Mobility(SlP), Ambulation(slP)) and between 
'psychosocial' dimensions (Social Isolation(NHP), Emotional Reaction(NHP), Emotional 
Behaviof(slP), Social Interactioll(SIP), Alertness Behavio1'(sIP), and Communication (SIP»); 
and weaker correlations between physical and psychosocial dimensions. 
The correlations observed between the NHP and SIP scales were generally rather low. 
There were some deviations from the expected patterns; for example, low ICCs 
between Social Isolation""IP) and Emotional Behavior(SlP), between Social Interactions 
(NHP) and Communication(sIP), between Emotional Reaction(NHP) and Communication 
(SIP). The latter two observations are understandable as the items of Communication 
(SIP) are ofa rather physical nature (e.g., difficulties in speaking). 
Secondly, correlation patterns as observed between the scales of NHP and SIP and 5 
instruments with proved validity (STAI, SOS-Zung, AOL, Karnofsky, IWB) were 
compared to a priori hypotheses with respect to these correlation patterns. For 
example, we expected the highest correlations with AOL and Karnofsky for Physical 
MobilitY(NHP) and for Pain""IP). and we expected the highest correlations with STAI 
and SOS-Zung for Social IsolationlNllP) and Emotional Reaction(NHP). We similarly 
expected the highest correlations with STAI and SOS-Zung for the components of the 
psychosocial subscore of the SIP (Social Interaction, Alerhless behavior, Emotional 
behavior and Communication), and the highest correlations with ADL and Karnofsky 
for the components of the physical subscore of the SIP (Bodycare and movement, 
Mobility, Ambulation). 
The association patterns observed between the NHP and the SIP, respectively, and the 
other five instruments were largely as expected (see Table 4.4.3). Exceptions were 
Communication(sIP) which correlated weakly with STAI and SOS-Zung, understand-
able in view of the from the reasoning described above, and Social interactions(NHP) 
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which also correlated weakly with STAI. The IWB (as a measure for experienced 
well-being) showed the highest correlations (ICC >.3) with Recreation & pastimes 
(SIP), Household management(SIP), and all NHP dimensions except Pain(NHP). 
TABLE 4.4.2 Internal structure of NHP and SIP: summary' of ICCs for each scale with the other scales of NHP and 
f------ SIP respectively (re,~al dlalysis·JP",a",lie",n",,(s,.. n,,=,,63"'-_______________ -1 
NHP Phys. Pain Energy Sleep Soc Ernot Total 
Mob 
041 .38 .33 .32 .35 .43 .37 
SIP SR ES SCM HM M SI A As C RP E Total 
.39 .39 .43 043 048 045 043 .39 .38 .32 .22 040 
----_ ... _-_ .. _-----------
• For example: the figure of .41 for NHP Physical Mobility represents the square root of (((.4W+(.48)2+(.40)2+(,31)'+ 
(.33)')15) (Appendix 1) 
Common factor analysis with varimax rotation of the combined data of NHP (6 
scales), SIP (physical subscore, psychosocial subscore, Sleep & rest, Recreation & 
pastimes, Household management), ADL, Karnofsky, STAI, SDS-Zung and IWB 
yielded two factors with eigenvalues> 1.0; see Figure 4.4. The first factor explained 
26.3% of common variance and was interpreted as a physical dimension, the second 
factor explained 25.7% of common variance and was interpreted as a mental dimen-
sion. Scales with high loadings on the physical factor were the Physical subscore of 
the SIP; Physical Mobility(NHP); ADL; Household management(SIP); and Karnofsky. 
Scales with high loadings on the mental factor were SDS-Zung; STAI; IWB; Emo-
tional reaction(NIlP); Social Isolation(NlIP); and the SIP psychosocial subscore. The 
physical scales ofNHP and SIP (Physical Mobility(NllP) and the physical subscore(sIP») 
are closer to each other in Figure 4.4 than the mental scales (Emotional reaction (NlIP), 
Social Isolation(NHP), psychosocial subscore(SIP»). This means that there is more 
Similarity between NHP and SIP in the physical domain than in the mental domain. 
The IWB loaded very high on the second factor, indicating that well-being as 
measured with the IWB is largely detelll1ined by mental factors in this population. 
NHPorSIP 47 
TABLE 4,4,3 Correlation (ICCs) of NHP and SIP scales, respectively, wilh STAI, SOS, AOL Kamof-
sky and IWB (renal dialysis patients, n = 63) 
AOL' Karnofsky· STAI' SOS-Zung' IWS' 
NHP 
Physical mobility ,58 ,55 ,35 ,37 ,37 
Pain .41 ,32 ,25 ,35 ,23 
Energy ,20 ,34 .48 ,28 ,36 
Sleep ,25 ,30 ,32 ,24 ,39 
SociallsolaUon ,32 .22 ,28 .46 ,34 
Emotional reaction ,27 ,35 .48 .48 ,37 
SIP 
Sleep and rest ,25 ,27 ,31 ,35 .21 
Emotional behavior ,16 ,15 ,22 ,27 ,14 
Bodycare & movement ,55 ,20 ,13 ,28 ,12 
Home management .42 .40 ,34 ,37 ,32 
Mobility ,57 ,34 ,22 ,29 ,10 
Social interaction ,20 ,16 ,23 ,34 ,17 
Ambulation ,51 ,32 ,20 ,37 ,20 
Alertness behavior ,19 ,27 ,30 .41 ,24 
Communication ,18 ,18 ,08 ,17 ,04 
Recreation & pastimes ,16 ,35 ,35 ,22 ,33 
Eating ,05 ,07 ,04 ,06 ,02 
* Rescaled to a 0-100 scale (0 = optimal score) in accordance with NHP and SIP scales. 
,---, 
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FIGURE 4.4 Factor analysis with varimax rotation of NHP, SIP, ADL, Karnofsky, STAl, SOSwZung and 
IWB (renal dialysis palients, n=63) 
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4,5 Conclusion and discussion 
In this study we have compared the feasibility, structure and psychometric character-
istics of 2 well-known generic health status measures - the NHP and the SIP - when 
employed in a group of renal dialysis patients. The results are summarized in Table 
4.5. 
TABLE 4.5 Summary of the empirical comparison of NHP and SIP 
Feasibility 
Internal consistency 
Test·retest reliability 
Structure 
Construct validity 
NHP OI'S!P 
NHP 
generally better 
acceptable for 5 out of 6 scales 
acceptable 
confirmed 
more emphasis on mental health, 
perceived health 
SIP 
acceptable for 8 out of 11 scales 
not available 
confirmed 
more emphasis on physical 
health, functional health 
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The NHP can be considered to be generally more feasible than the SIP. The NHP is 
shorter and less difficult. The observed difference in item contents (relating to actions 
in the NHP, to activities in the SIP) might cause the SIP to be less universally 
applicable and more culture-bound than the NHP. For example, the Work items of the 
SIP have often been observed to be omitted from the questionnaire in elderly popula-
tions. It is interesting to note that Part 2 of the NHP, which was not used in the 
empirical part of our study and is thus not addressed in this paper, refers to activities 
as well. 
The results for internal consistency were better for the NHP than for the SIP. The 
internal consistency is (almost) acceptable for 5 out of 6 NHP scales, and for 8 out of 
II SIP scales. Published data on internal consistency of the NHP scales for the UK 
version appeared to be unavailable. The study by Erdman et al among 276 Dutch 
general practice patients showed a mean a of 0.78, all as 0.70 or higher." The lower 
internal consistency estimates in our study especially for the Social Isolation Scale 
(0.39), may be due to the different nature of the study population. It supports the fact 
that psychometric characteristics are population-specific. 
Internal consistency estimates for 10 out of 12 US SIP scales are available for a 
stratified sample of members ofa US prepaid group practice [n ~ 495; mean a ~ .61, 
range ~ 0.29 (Eating) to 0.82 (Social interaction); 8 out of 10 as below 0.70] and a 
group of 168 noncognitively impaired nursing home patients [mean a ~ 0.72, range ~ 
0.60 (Eating, Sleep and rest) to 0.84 (Body care and movement); 3 out of 10 as below 
0.70].18 These results and the results of the present study are indicative of a borderline 
acceptable level of internal consistency of several SIP scales. Internal consistency 
estimates for the SIP as a whole (136 items) exceed .90 for the US, the Swedish, Ule 
Spanish and the Dutch version, but this is pm11y attributable to the large number of 
items. 19 
With respect to test-retest reliability, results (4-week intervals) for the UK NHP 
among 58 m1hrosis patients were in the range of 0.77 to 0.85 (Spearman rank 
correlation coefficients)"·'1 and among 93 patients with peripheral vascular disease in 
the range of 0.75 to 0.881. Test-retest reliability of the Dutch NHP in cardiac patients 
showed Spearman rank correlations of 0.69 - 0.84. 17 The somewhat lower test-retest 
reliability estimates in the present study may be partly attributed to the fact that it is 
not quite sure that patients health status remained unchanged between the two 
assessments: preceding dialysis and 24 hours later. For the US SIP, 24 hours test-
retest reliability coefficient was 0.92 for the total score over 136 items." 
Examination of the inter-scale correlations for the NHP and the SIP showed these 
correlations to be of moderate magnitude, suggesting little redundancy of information 
generated by the scales of the instruments. For the Dutch NHP, these results replicate 
the findings of Erdman et al. 17 
The ICCs observed belween NHP scales and SIP scales were rather low, suggesting 
that the NHP and SIP to some extent measure different aspects of health status. ICCs 
observed between the NHP scales and the SIP scales, respectively, and instruments 
indicating mainly physical functioning (ADL, Karnofsky) and mainly psychological 
functioning (STAI, SDS-Zung) were largely as expected. However, the psychosocial 
scales of the SIP correlated more weakly with STAI and SDS-Zung than the psycho-
social scales of the NHP. The IWB exhibited ICCs >0.3 with one SIP scale and with 5 
out of 6 NHP scales. Factor analysis yielded a two-factor solution with a physical and 
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a mental factor of equal importance and showed the SIP scales to load more on the 
physical factor (with the psychosocial subscore as the only exception). A similar 
result was obtained by Bmin et ai, who performed principal components analysis on 
835 SIPs completed by subjects from different diagnostic categories." 
The NHP scales loaded more on the mental factor (exceptions: Physical Mobility, 
Pain). This may be interpreted as the SIP emphasizing physical functioning, whereas 
the NHP emphasizes mental functioning. The analysis also confirms to some extent 
the intentions of the constl'llctors of the NHP and the SIP respectively, i.e., that the 
NHP was intended to be a measure of perceived health while the SIP was intended to 
be a more functional measure. 
The results of the present study add to the developing body of knowledge with 
respect to performance characteristics of Dutch adaptations of the NHP and the SIP. 
A cross-culturally adapted health status measure is essentially a new instrument, and 
investigation of its characteristics is required.!6 Cross-cultural adaptation of health 
status measures requires more than 'conceptually equivalent' translation, because of 
expected cultural differences with respect to health beliefs and response to question-
naires. This is required even among residents of industrialized societies. Jacobs 
showed that the US item weights for the SIP items can be validly applied for Dutch 
SIP data." The French NHP item weights showed some differences if compared with 
the British ones.2S 
The NHP generally performed better than the SIP in this study. This does 1101 imply 
that the NHP is generally to be preferred to the SIP in medical evaluation research. 
Firstly, responsiveness to change over time was not a subject of comparison in the 
present study. Secondly, performance characteristics of generic instruments for health 
status are probably population specific. For an instrument to perform well it must do 
so in terms of feasibility, internal consistency, test-retest reliability, and validity 
including responsiveness to change over time. An instrument which performs well 
according to the aforementioned criteria in a population of elderly, rather seriously ill 
patients with renal insufficiency will not necessarily perform equally well when 
employed for example among young patients with lung problems. The possibility that 
an instrument perfonns equally well in all types of patient groups with varying 
degrees of illness can be seriously doubted. The case might eventually be that NHP 
and SIP are each superior in different groups. 
Notes 
I. An exception to the broad applicability of the NHP was observed when the NHP 
was employed in another study among patients with spinal cord injury. As these 
patients were not able to walk at all, most of the items belonging to the dimen-
sions Physical Mobility aud Pain were 'not applicable' for them. 
2. Eating!s!,) was left out of the ultimate factor analysis that is presented here, 
because it was so different from the other variables (see low correlations with the 
other variables) that it emerged as a separate 'factor' and interfered too much with 
the factor analysis. 
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APPENDIX 1 ICCs of NHP scales and SIP scales (n=63). 
PHYSMOB PAlN ENERGY SLEEP SOCIAl EMOTION SR ES SCM HM M Sl A AS C RP 
PAIN .49 
ENERGY .48 .25 
SLEEP .40 .23 .33 
SOCIAL .31 .38 .12 .24 
EMOTION .33 .48 .38 .38 I .56 1 
SR .27 .20 ! .09 .22 .23 .23 
ES .10 .31 .11 .09 .22 .38 .35 
SCM 32 .42 .10 I .11 .34 .24 .29 .50 
HM .56 .28 .29 .26 .35 .35 .46 .24 .34 
M .40 .31 .18 .15 I .32 .33 .51 .47 .60 .61 
$1 .17 .14 .14 .11 .38 .31 .51 .56 .48 .38 I .50 
A .43 .36 .23 .13 .21 27 .40 .38 .54 .58 .61 .36 
AS .25 .34 .19 .11 .59 .41 .2S .42 .41 .43 .41 .50 .38 
C .16 .15 .05 .05 .27 .25 .22 .42 .51 .30 .42 .44 .26 .57 
RP .37 .OS .33 .23 .17 .26 .46 .20 .14 .54 .34 .26 .42 .29 .17 
E .02 .05 .02 .02 .02 .07 .21 .23 .21 .14 .20 .40 .22 .16 .14 .12 
PHY$MOB=NHP Physical MObility; PAIN=NHP Pain; ENERGY=NHP Energy; SLEEP=NHP Sleep; $OCIAL-NHP Social Isolation; EMOTION:::::NHP Emotional Reaction; SR=SIP Sleep & rest; 
EB=SIP Emotional behavior; BCM=SIP Bodycare & movement; HM=SIP Home management; MOB=SIP MObility; $I=$IP Social interaction; A=SlP Ambulation; AB=$lP Alertness behavior; C=$IP 
Communication; RP=SIP Recreation & pastimes; E=$IP Eating. 
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5 
An empirical comparison of 4 generic health status 
measures: the Nottingham Health Profile, the MOS 36-
Item Short-Form Health Survey, the COOP/WONCA 
Charts, and the EuroQol Instrument 
Submitted as: 
Essillk-Bol ML, Krabbe PFM, BOllsel GJ, Aarollsoll NK. All empirical comparisoll of 4 
generic heallh slalus measures: Ihe NOllillgham Heallh Profile, Ihe MOS 36-lIem 
Shorl-Form Heallh SUlWY, Ihe COOPIWONCA Charls, alld Ihe EuroQol illslrumenl. 
5.1 Abstract 
In this study we compared the feasibility, internal structure and psychometric charac-
teristics (internal consistency, construct validity, 'known groups' validity) of 4 generic 
health status measures - the NHP, the SF-36, the COOP/WONCA chalis and the 
EuroQol - when employed in a sample of migraine sufferers and a control group (total 
IFI,OII). 
In terms of feasibility, the NHP had the lowest missing value rate. The SF-36 exhibited 
high levels ofiilternal consistency (as between .76 and .91) as compared with the NHP 
(.62 - .82). The NHP scales were somewhat less highly intercorrelated than those of the 
SF-36. The COOP/WONCA items were found to be relatively highly correlated with 
one another, as were the EuroQol items. The overall patterns of correlations between 
the scales of the NHP and the SF-36, and belween the COOP/WONCA chalis and the 
EuroQol items, respectively, were consistent with expectations. Two combined factor 
analyses (i.e., the SF-36 scales, the COOP/WONCA items and the EuroQol items; the 
SF-36 and NHP scales, and the EuroQol items) resulted in similar solutions, with two 
higher-order factors being identified - one reflecting physical health, the other mental 
health. A qualitative comparison of the measures indicated that each addresses these 
two basic health domains from a somewhat different perspective. The SF-36 was best 
able to discriminate between groups formed on the basis of self-reported chronic 
conditions and work disability days, respectively. In general, all four instruments 
exhibited a good performance profile. However, both instruments with a multi-item 
structure (i.e., the SF-36 and the NHP) outperformed the COOP/WONCA charis aud 
the EuroQol. Future research is needed to investigate the relative performance of these 
measures when employed in more seriously ill patient populations, and to extend the 
comparison to test-retest reliability and responsiveness to change in health over time. 
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5.2 Introduction 
Generic health status assessment was applied first in population surveys measuring the 
state of health of communities, irrespective of diagnosis. More recently, researchers 
have recognized the potential value of incorporating generic health status outcomes in 
the evaluation of medical interventions, in addition to more traditional biologic (e.g., 
survival) and symptom-oriented measures. Although every disease is associated with 
specific health effects, these effects are also reflected in patterns of impairment at the 
broader level of physical, psychological and social functioning captured by the more 
generic class of health status measures. Because generic outcome measures can be used 
to evaluate the functional health of individuals without regard to cause', they offer the 
oppOltunity of comparing levels of functioning across patient populations, and between 
patient populations and the general population. In this way, rank ordering of diseases 
according to their relative effects on functioning (Le., burden of disease') and of health 
care interventions in terms of their impact on functioning levels (Le.) treatment 
effectiveness) becomes possible. 
A range of generic health status measures are currently available, including the 
Sickness Impact Profile (SIP), the Nottingham Health Profile (NHP), and the more 
recently developed COOP/WONCA charts, EuroQol and MOS 36-Item ShOl1 Form 
Health Survey (SF_36).'·4.,.6.7.8.9 Each of these measures has its pal1icular strengths and 
weaknesses. The decision to use anyone of these measures in a particular survey 01' 
clinical trial is often based on diverse scientific and extrascientific considerations, 
including the nature of the research questions to be addressed, the characteristics of the 
study population, the tradition of the research group, and intellectual investments made 
in a given instrument in previous research. 
Relatively little attention has been paid to the fact that the perfonnance characteristics 
of an instl1lment, including feasibility, reliability and validity, may, to a greater or 
lesser degree, be population dependent. If, for example, an instrument performs well in 
a population of seriously ill cardiac patients, this does not guarantee that it will work 
equally well when employed among patients with low backpain. Given the increasing 
use of formal health status assessment in medical research, there is a pressing need for 
empirical data on the relative performance of the available generic measures among 
distinct patient populations. 
In an effort to contribute to this process, we conducted a study of the health status of 
migraine sufferers and a matched control group in which a head-to-head comparison 
was made between the NHP, the SF-36, the COOP/WONCA charts and the EuroQol 
instrument. Although the study had primarily a substantive research focus, these 4 
generic health status instnnnents were purposively included in the research design to 
enable these comparisons to be made. 
The specific research questions addressed in this study were: 
1. How do these 4 instruments compare in terms offeasibility and reliability? 
2. Is there empirical support for the hypothesized structure of the questionnaires in 
terms of health status domains being addressed (Le., construct validity)? 
3. How do the instruments compare in their ability to discriminate between groups 
known to differ on other indicators of health (e.g., presence of chronic health 
conditions, disability days) ('known groups' validity)?" 
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5.3 Methods 
5.3.1 Stlldy sample and data collection procedllres 
Migraine sufferers and a matched control group were surveyed to assess the societal 
impact (costs and health status effects) of migraine in the Netherlands. Details of the 
study design and substantive results are described elsewhere."· 12 The following 
provides a brief description of the sampling strategy and data collection procedures. 
To establish the prevalence of migraine in the Netherlands, face-to-face interviews 
were conducted with a representative sample of the Dutch general population 
(n~10,480). Subjects were included as migraine patients if they met the International 
Headache Society criteria II alld had experienced at least one attack of migraine during 
the 12 months prior to the interview. 992 migraine sufferers met these criteria (I-year 
prevalence ~ 9.5%). Of these 992 cases, 846 (85%) expressed an initial willingness to 
take part in a subsequent study investigating the impact of migraine on health status 
and direct/indirect costs. 
The control group WaS selected from among those subjects in the original prevalence 
survey who did not meet the criteria for migraine. Frequency matching was used to 
generate a control group reflecting the age (in 5-year intervals), gender and employ-
ment status characteristics of the migraine sample. 
Questionnaires were mailed in June, 1993, followed by reminders after 2 and 5 weeks. 
Half of the addressees received a packet containing the NHP, the SF-36 and the 
EuroQol. For the other half of the sample, the NHP was replaced by the COOPI 
WONCA charts. This was done to reduce the total respondent bnrden (i.c., a total of 3 
rather than 4 questionnaires were administered per respondent). The sequencing of the 
questionnaires was varied systematically in order to avoid an ordering effect. 
The useable response rate was 58% (n~436) in the migraine group and 71% (n~575) in 
the control group. Non-response analyses failed to reveal any statistically significant 
differences between addressees and respondents with regard to age, gender, social class 
or degree of urbanization in either the migraine group or the control group, 
The number of questionnaires available from the migraine group and the control group, 
respectively, was; the SF-36 ~ 436 and 575; the EuroQol ~ 436 and 575; the COOPI 
WONCA charts ~ 210 and 286; and the NHP ~ 226 and 289. 
5.3.2 Health Statlls Measllres 
The Nottingham Health Profile was developed in the 1970s in the United Kingdom as 
a measure of perceived health for use in population surveys.' The NHP consists of 38 
dichotomous items which are grouped into the scales described in Table 5.4.1. Each 
scale ranges from 100 to 0 (~ optimal). The Dutch adaptation of the NHP used in the 
current study has been previously tested in several patient populations,l4,l5 
The MOS 36-ltem Short-Form Health SIII1'eY, developed in the United States, is 
derived from the larger battery of health statns instruments employed in the Medical 
Outcomes Study.8.9.10.16 It consists of 36 items, organized into 8 scales (see Table 5.4.1). 
The number of response choices per item ranges from 2 to 6. The SF-36 yields an 8-
dimensional profile, with each scale having a range from 0 to I 00 (~optimal). The 
Dutch version of the SF-36 employed in the current study was developed as a part of 
the International Quality of Life Assessment (IQOLA) Project, whose objective is to 
translate, validate and norm the SF-36 in a wide range of languages and cultural 
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settings. 17 
The COOPlIVONCA charls were developed to assess the fimctional status of patients in 
primary care settings.' Subjects are requested to score their fimctioning on each of the 
6 items descdbed in Table 5.4.1 during the 2 weeks pdor to assessment on 5-point 
scales (I =optimal). The levels on the scales are illustrated with pictograms. The 
standard Dutch version of the revised charts was used. 18 
The ElIl'oQol illsll'lIlIIenl was developed by the international EuroQol Group as a 
standardized generic measure for description of health status, with the additional 
possibility of converting the descriptive data into values for economic (cost-effective-
ness) analysis by linking patients' health state descriptions to empirical valuations of 
health states obtained from the general population.6 The standard Dutch 5D-version of 
the EuroQol was used. 7 The descriptive part of the instnnnents consists of 5 items (see 
Table 5.4.1), each following the general form: I = no problems, 2 = some problems, 3 
= extreme problems. The 6th item is a global health evaluation using a visual analogue 
scale ranging from 0 (worst imaginable health state) to 100 (best imaginable health 
state). Only data from the first 5 items are included in the current analyses. 
5.3.3 Addiliollall'al'iabies 
A standard set of sociodemographic questions were asked to obtain information on age, 
sex, education and employment status. 
Comorbidity was assessed by the standard list of chronic conditions of the Central 
Bureau for Statistics (CBS). This list enumerates 28 conditions in lay terms (e.g., 
'asthma, chronic bronchitis or COPD', 'diabetes'). For each chronic condition, respon-
dents were asked to repOlt if they currently had the condition, or if they had had it in 
the previous year. 
5.3.4 Analysis Plan 
Qualitative analysis of questiol1naire content 
A qualitative comparison was carried out of the item-content of the multi-item scales of 
the NHP and the SF-36, and of the individual items of the COOP/WONCA and the 
EuroQol. Scales/items were considered 'comparable' if their content was judged to 
refer to the same general health domain. 
Quantitative analyses 
All of the following analyses were performed for the migraine group and the control 
group separately, as well as for the pooled data. The results of the analyses based on 
the pooled data will be presented, except in those cases where the separate analyses 
yielded significant differences. 
Feasibility. The number of missing cases per item was employed as an empirical 
indicator of feasibility. Missing values were defined as those cases where no answer 
was provided, and those where multiple responses were given when only one was 
required. As the number of respondents with complete records was large enough for 
further analyses, we did not impute constl1lcted values for missing values. For the 
purpose of comparability, an index was constructed accounting for the number of 
respondents and the number of items per questionnaire. 
Features of score distribution. Mean scores, standard deviations, and the percentages 
of respondents with the maximum possible score and the minimum possible score, 
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respectively, were computed per scale (NHP, SF-36) or item (COOP/WONCA, 
EuroQol), respectively. 
Reliability. The internal consistency of the NHP and SF-36 multi-item scales was 
determined with Cronbach's a-coefficient. 19 An a-coefficient of 0.70 or higher was 
considered as sufficient for the purpose of group comparisons. 19.20 Internal consistency 
estimates could not be calculated for the COOP/WONCA charts or the EuroQol, as 
these instruments consist of I item with an ordered response choice per 'scale'. Due to 
the cross-sectional nature of the study, data on test-retest reliability were not available. 
Internal scale structure. The internal structure of the 4 instnuuents was examined with 
the use of correlation techniques. For the NHP and the SF-36 scales, intraclass correla-
tion coefficients (ICCs) were employed. The ICC is a statistic comparable with the 
conventional Pearson's correlation coefficient, with level effects between variables 
being taken into consideration. 21 ,22 For each questionnaire scale, the square root of the 
mean of the squared ICCs between that scale and each of the other scales was com-
puted to summarize the ICC-matrix. This statistic was used instead of averaging ICCs, 
in order to retain the interpretation of the squared ICC as the amount of variance 
shared. ICCs are not appropriate for the ordinal EuroQol and COOP/WONCA data. As 
an alternative, polychoric correlation coefficients (PCCs) were used. The PCC has 
certain statistical advarHages over alternative indicators such as the Spearman rank 
correlation coefficient. First, the PCC provides a reliable estimate of the correlation 
between ordinal variables even when the number of categories is limited. Second, the 
PCC does not appear to be sensitive to the shape of the marginal distributions. Finally, 
the PCC uses the attractive premise of a continuous bivariate normal distribution 
underlying the categories. 23,24 The PCC correlation matrices were summarized in a 
manner similar to the ICC matrices, 
Construcl validity. Two approaches were taken to examining the construct validity of 
the 4 health status instruments. First, the pattern of correlations between the scales of 
the NHP and the SF-36 (ICCs), and between the items of the COOP/WONCA and the 
EuroQol (PCCs) were examined. It was hypothesized that those scales/items that are 
conceptually related would be relatively strongly correlated, while those scales/items 
with less in common would exhibit weaker correlations. 
Second, common factor analysis with va rima x rotation was employed to examine the 
relationships among the elements of the 4 health status measures, and to look for 
possible higher order factors. Because any given respondent completed only 3 of the 4 
instruments (see section 5.3.1), 2 factor analyses were performed: (I) with data from 
the NHP (scales), the SF-36 (scales), and the EuroQol (items); and (2) with data from 
the SF-36 (scales), COOP/WONCA (items) and EuroQol (items) (see Note I). 
'KnolVn groups J validity. A series of statistical tests was carried out to evaluate the 
ability of the 4 health status measures to discriminate between subgroups of respon-
dents known to differ on several relevant variables. For these group comparisons, the 
Mann-Whitney U test was employed due to the non-normal distribution of the data. 
The grouping variables included: (I) the number ofself-rep0l1ed chronic conditions « 
I versus> I; IF I ,0 II); and (2) for the respondents with paid employment (n~46I), the 
number of days absent from work due to illness in the 2 weeks prior to assessment (0 
versus, 0.5 days). 
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Given a large enough sample size, statistical significance can be somewhat misleading. 
That is, relatively small mean group differences may reach conventional levels of 
statistical significance without representing meaningful differences in functioning. For 
this reason, an effect size estimation was calculated which relates the difference in 
mean scores to the dispersion of the scores. The formula employed to calculate the 
effect size (d) was: Mean(a) - Mean(b) / standard deviation (see Note 2). Following 
Cohen's suggested guidelines, d ~ 0.2 was taken to indicate a small effect size, d ~ 0.5 
a moderate effect size, and d~ 0.8 a large effect size." 
5.4 Results 
The respondents in the migraine group and in the control group were comparable in 
terms of gender distribution (84% versus 80% female), mean age (40 versus 41 years), 
employment status (47% versus 44% in paid employment), and educational level (38% 
versus 38% with an intermediate educational level; 28% versus 31 % with a higher 
educational level). 
5.4.1 Qualitative comparison of questionnaire content 
A comparison of the health domains covered by the 4 health status instruments is 
presented in Table 5.4.1. The psychological domain is similarly represented in all 4 
instruments. The physical domain is operationalized with an emphasis on mobility 
(NHP, EuroQol) or on overall physical functioning (SF-36, COOP/WONCA). The 
social (role) domain is underrepresented in the NHP. Social Isolation(NHP) relates to the 
ability to make contact with other people, and was thus considered to belong to a 
psychological rather than a socialmle domain. The SF-36, the NHP and the EuroQol 
all contain pain measures. A pain assessment is not included in the standard set of 
COOP/WONCA chalis used in the current study (although a pain chart is optionally 
available). The EumQol is the only instnnnent to address other somatic sensations than 
pain by combining both 'pain' and 'discomfort' in a single item. The SF-36 is the only 
instrument to address the concept of positive health (e.g., an item of the Vitality scale 
referring to feeling 'full of pep'). Despite it's label, the NHP(E""gy) scale contains only 
negatively worded items (e.g., 'tired all the time', 'everything is an effort'). The NHP 
is the only measure to assess sleep problems. Both the EuroQol and the SF-36 (the 
Physical Functioning scale) contain items relating to self-care (e.g., washing, dressing). 
Both the SF-36 and the COOP/WONCA contain a health transition item (Le., change in 
perceived health). All instruments, with the exception of the NHP, provide an assess-
ment of overall health, although this is operationalized in slightly different ways: 
general health perceptions (SF-36); overall health (COOP/WONCA); or valuation of 
health (EuroQol). 
5.4.2 Feasibility 
An overview of missing values is presented in Table 5.4.2. The NHP produced the 
lowest number of missing values. The COOP/WONCA chalis, the SF-36 and the 
EuroQol showed somewhat higher, though acceptable, missing value rates. 
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Despite the use of appealing pictograms, completing the COOPIWONCA chaIts was 
more problematic than expected, with the items Physical Fitness(cooP) (6.3% missing) 
and Change in Health(cooP) (5.8%) yielding the most missing data. For the EuroQol, the 
item on Valuation of Own Health had the highest rate of missing data (6.7%). 
TABLE 5.:~ualitaUve comparison of content ofNHP, SF-36,COOPIWONCA charts,EuroQol 
NHP ___ ... __ SF-"'36 ______ C--.O-:.OPIWONCA'--__ EUROQOL_---1 
Emotional Reactions 
Social Isolation 
Physical Mobility 
Pain 
Energy 
Sleep 
Mental Health (MH) 
Physical Functioning 
(PF) 
Role Physical (RP), 
+ 
Role Emottonal(RE)** 
+ Social functioning 
(SF) 
Bodily Pain (BP) 
General Health 
PercepUons (GH) 
Vitality (VT) 
Reported Health 
Transition 
(1 year) 
Feelings 
Physical Fitness 
Daily Activities + 
Social activities 
Overall Health 
Change in Health 
(2 weeks) 
Anxiety/Depression 
Mobility 
Usual activities 
PainlDiscomfort 
Valuation own health 
... 
self-car"e ___ ~ 
... --. __ ._-
" Role limitations due to physical health problems 
** Role limitations due to emotional problems 
**" ~hysical ~unctioni"~g(SF.36) co~tains ite~s relating _to self car~_. __ . ___ .. __ _ 
--_. __ .. _- -_ .. __ .. _- ---
TABLE 5.4.2 Missing values (pooled data:'.) ____________ _ 
.-_ ... __ .. _---
NHP (n=515) 
SF-36 (n=1011) 
COOPIWONCA (n=496) 
EuroQol (n=1011) __ _ 
range', ____ ._____ Index2 ___ ... __ _ 
0.4·1.3 
1.1·5.4 
0.6·6.3 
3.0·6.7 
0.8 
3.1 
2.7 
4.3 __ _ 
-_.-
1 range = range in percentage missing values per item 
2 index = (mean nu~ber of missing valu"es per reseondent I ~ items)· !"O,,-O __ .. ______ _ 
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5.4.3 Features a/score distribution 
Mean scores, standard deviations, and the percentages of respondents with the maxi-
mum possible score and the minimum possible score, respectively, for each instrument 
are shown in Table 5.4.3. The distributions of the scores for all 4 instmments were 
skewed in the direction of positive health/functioning, as could be expected given the 
nature of the population under investigation. The EuroQol and the NHP data, with 
approximately 70-80% of the respondents scoring at the ceiling, were more skewed 
than the COOP/WONCA and the SF-36 data. The distributions of the EuroQol and the 
SF-36 compare similarly with those observed in a UK general practice sample (note: 
the 60-version of EuroQol)." 
5.4.4 Reliability 
The internal consistency coefficients for the SF-36 and NHP scales, based on those 
respondents who completed both instnnnents, are shown in Table 5.4.3. The scales of 
the SF-36 yielded consistently higher internal consistency estimates (mean ,,~ 0.84; 
range ~ 0.76 to 0.91) than those of the NHP (mean"~ 0.72; range ~ 0.62 to 0.82). The 
a-coefficient for 2 of the NHP scales (Energy and Social Isolation) fell below the 0.70 
standard recommended for group comparisons. Six of the 8 SF-36 had a-coefficients 
greater than 0.80. 
5.4.5 Internal structure 
The ICCs for the NHP scales and the SF-36 scales, respectively, are summarized in 
Table 5.4.5.1 (complete data are shown in Appendix I). In general, the NHP scales 
were less highly correlated than were the SF-36 scales. For both instruments, the 
interscale correlations tended to be higher in the control group than in the migraine 
group (data not shown). The ICCs between Pain(NHP) and Physical Mobility",1/P) in both 
the migraine and control groups were remarkably high. Though less pronounced, the 
same effect was reported for the UK NHP in a general population sample.17 High ICCs 
were also observed for Emotional Reaction(NHP) and Social Isolatiol1(l\1JfP), and for 
Mental Health(sFJ6) and Social FUllctioning(SFJ6). 
PCCs between COOP/WONCA items and EuroQol-items, respectively, are summari-
zed in Table 5.4.5.2 (complete data shown in Appendix 2). For both the EuroQol and 
the COOP/WONCA charts, inter-item correlations were relatively high (summary 
PCC~0.65 and 0.57 for the EuroQol and COOP/WONCA, respectively). The only 
exception to this general pattern was the Physical Fitness item of the COOP/WONCA, 
which exhibited a low correlation with all other items (summaoy PCC~0.15). 
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TABLE 5.4.3 Features of score distributions of the NHP (n=515), SF-36 (n=1 ,011), COOPiWONCA 
mean S.D. % max! %min.,u Cronbach's a 
NHP (score 0-100) 
Physical mobility (8)'" 7.2 14.2 70 0 .71 
Sleep (5) 11.9 23.1 71 2 .77 
Emotional Reactions (9) 10.1 17.3 62 0 .78 
Energy (3) 15.6 26.5 70 3 .62 
Social Isolation (5) 6.6 15.7 80 0 .63 
Pain (8) 7.2 18.7 73 0 .82 
SF-36 (score 100-0) 
Physical Functioning (10) 85.5 20.4 38 0 .91 
Role physical (4) 70.9 38.7 57 16 .87 
Role emotional (3) 78.5 35.8 69 12 .83 
Vitality (4) 65.2 18.6 2 0 .79 
Mental Health (5) 74.8 18.4 5 0 .87 
Social Functioning (2) 81.0 21.1 41 0 .81 
Bodily Pain (2) 76.2 22.1 29 0 .88 
General Health Perc. (5) 69.6 18.9 4 0 .76 
COOPiWONCA (score 1-5) 
Physical Filness (1) 1.72 1.04 60 3 
Feelings (1) 1.88 .92 40 2 
Daily Activities (1) 1.74 .86 46 
Social Activities (1) 1.54 .79 60 
Change in Health (1) 2.62 .79 12 
Overall Health (1) 2.65 .99 15 2 
EuroQol (score 1-3) 
Mobility (1) 1.15 .38 86 0 
Self care (1) 1.02 .15 98 0 
Usual Activities (1) 1.23 .46 79 2 
PainlDiscomfort (1) 1.43 .54 60 3 
Anxiety/Depression (1) 1.22 .45 80 2 
* % max = percentage of respondents with maximum possible score (ceiling) 
H % min = percentage of respondents with minimum possible score (floor) 
*** number of items 
------_. 
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TABLE 5.4.5.1 Summary'" of ICCs for each subsea Ie with the other subscales of NHP resp. SF-36 
(pooled data; n=515) 
NHP Energy Pain Emot.R Sleep Social Phys.Mob Overall 
.35 .39 .41 .28 .35 .40 .37 
SF-36 PF RP RE VT MH SF BP GH Overall 
.38 .41 .37 .46 .47 .52 .48 .47 .45 
• For example: the figure of .35 for NHP Energy represents the square root of «(.33)'+(.46)'+(.27)'+ 
(.35)'+(.33)')15) (Appendix 1) 
TABLE 5.4.5.2 Summary* of polychoric correlation coefficients of COOPIVVONCA-charts and EuroQol 
(pooled data; n=496). 
COOPIWONCA Phys Feel Daily Social Change Heallh Overall 
.15 .58 .78 .64 .51 .57 
EuroQol Mob Self Usual Pain Anxiety Overall 
.71 .64 .67 .70 .48 .65 
• For example: The figure of .58 for CooplWONCA Feelings represents Ihe square rool of «(.08)'+ 
(.73)'+(.72)'+(.56)')14) (Ap"pe"'n:c:d:c:ixcc2)'--____ _ 
5.4.6 Construct validity 
The ICC matrices for NHP scales with SF-36 scales, and the PCC matrices of COOPI 
WONCA items with EuroQol items are presented in Appendices I and 2. The associa-
tions observed between the NHP and the SF-36 scales were largely as expected. 
Role emotionalcsF-36) correlated best with Emotional Reactions(J'.'HP); Vitality(sF-36) with 
Energy(NHP); and Mental Health(sF-36) with Emotional Reactions(J'.'HP). EnergY(NHP) 
correlated relatively highly with all SF-36 scales, while the only NHP scale with which 
Vitality(sF-36) exhibited a moderate correlation was Energy(J'.'HP). This latter pattern 
suggests that Vitality(sF-36) is a more conceptually distinct scale, while Energy(J'.'HP) is a 
more general scale. Physical Functioning(sF-36) correlated best with Physical Mobi-
lity(NHP) and Pain(NIIP)_ Role physicaltsF-36) had no counterpaIi in the NHP. 
Feelings(cooP) correlated best with AnxietylDepression(EUfoQol), and Usual Activities 
(EuroQol) correlated well with Daily Activities(cooP) and Social Activities{cooP), Physical 
Fitness(cooP) did not correlate well with Mobility(EoroQol), reflecting the differences in 
item content. The general nature of Overall Health(cooP) is evidenced in the fact Ihat it 
correlated about equally with all of the EuroQol domains. 
Common factor analysis of the combined data of the SF-36 (scales), COOP/WONCA 
(items) and EuroQol (items) yielded two factors with an eigenvalue> 1.0, together 
explaining 52% of the common variance. The factor loadings after varimax rotation are 
shown on the left-side of Table 5.4.6. The first factor extracted appears to reflect a 
mental health dimension; the second factor a physical health dimension. 
66 NHP, SF-36. COOP 01' EUl'oQol 
Common factor analysis of the combined data of the NHP (scales), SF -36 (scales) and 
EuroQol (items) yielded two similar factors, together explaining 54% of the COl11mon 
variance (see Table 5.4.6, right-hand side). 
5.4.7 Known Groups Validity 
Table 5.4.7 repOlts the data relating to the ability of the 4 health status measures to 
discriminate between 'known groups' characterized by differences in: (I) the number 
of self-reported chronic conditions in the previous year; and (2) the number of days 
absent fi'om work due to illness in the 2 weeks prior to assessment. The SF-36 scales 
discriminated best between the groups reporting one or less versus more than one 
chronic condition. All p-values were beyond <.01, with effect sizes being in the 
moderate to high range (.49 to .92). The NHP scales also discriminated clearly between 
these groups, with the effect sizes being in the moderate range (d around .50). 
Five of the 6 COOPfWONCA charts yielded significant group differences (with the 
exception of Physical Fihless), with effect sizes ranging from .12 to .74. Statistically 
significant group differences were also observed for all of the EuroQol items, although 
the effect sizes were more variable (ranging from .13 for Self-Care to .84 for PainlDis-
comfort). 
The parallel analyses employing absence from work as the grouping variable yielded 
similar results. The SF-36 performed best, with all scales yielding statistically signifi-
cant group differences, and 7 of the 8 scales exhibiting large effect sizes (d > .80). The 
very high effect size estimate for Role physical(SF.J6) is probably at least in part an 
artifact of the conceptual overlap between the criterion 'absence from work' and the 
content of Role physical (SF-J6). This makes the high effect size estimates of the other 
SF-36 scales, which do not have a high degree of conceptual overlap with the criterion 
(Bodily Pain(sF-J6), Social Functioning(sF-36), Vitality(sF-J6), Physical Functioning(sF-36») all 
the more striking. The NHP yielded consistently significant results, although the effect 
sizes tended to be lower than in the analysis of chronic disease groups (d ranging fi-om 
.47 to .74)_ Only 4 of the 6 COOP/WONCA charts yielded statistically significant 
group differences, with effect sizes ranging from. 71 to 1.02. All of the EuroQol items 
discriminated clearly between the two groups, with effect sizes ranging frol11 .54 to 
1.16. 
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TABLE 5.4.6 Common factor analyses of the SF-36 (scales), EuroQol (items), and COOPiWONCA 
(items) [left; n=4961; and of SF-36 (scales), EuroQol (items) and NHP (scales) [right; 
n=515}; fact?f loadings> 0.3 after varimax rotation, 
----
Factor 1 Factor 2 Factor 1 Factor 2 
% of common variance explained 29 23 28 26 
COOPiWONCA 
Physical Fitness -- --
Feelings .85 --
Daily Activities .69 .51 
Social Activities .71 --
Change in Health -- --
Overall Health .54 .53 
SF-36 
Physical Functioning -- .83 .87 --
Role physical .41 .59 .53 .42 
Role emotional .69 -- -- .70 
Vitality .70 -- -- .71 
Mental Health .88 -- -- .86 
Social Functioning .69 .42 .42 .64 
Bodily pain -- .66 .66 --
General health perceptions .46 .56 .53 .49 
EuroQol 
Mobility -- .64 .66 --
Self care -- .41 .46 --
Usual Activities -- .68 .66 --
PainlDiscomfort -- .62 .62 --
AnxietylDepression .70 -- -- .71 
NHP 
Energy .45 .51 
Pain .81 --
Emotional Reactions -- .83 
Sleep -- --
Social Isolation -- .65 
Physical Mobility .86 --
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TABLE 5.4.7 Discriminallve ability of NHP, SF~36, COOPfWONCA and EuroQol between groups 
differing in the number of self~reported chronic conditions; and the number of days of 
absence due to illness in the two weeks prior to assessment, respectively, 
~
Salf-reported chronic conditions Absence from work due to illness 
< 1 > 1 p-va- Effect o days >.5 days p-valua Effect size 
n=40e' n=603' ,,, size n=39S' n=66' (MWU) (d)' 
X(s,d.) X(s.d,) (MW (d)' X(s,d) X (s.d) 
U) 
--.-_. 
-- --
NHP 
(range 0-100) 
Energy 5.1 (14.9) 22.4 (29.9) <0,01 .69' 11.2(21.2) 22.2 (30.6) <0,01 .4B 
Pain 1.9 (l.7l 13.2 (22.0) < 0.01 .63' 4.6(11.1) 11.4 (19.5) .03 .54' 
Emotional Reac!:ons 3.5 (8.6) 14.3 (20.0) < 0.01 65" 8.4 (13.9) 15.2 (17.2) < 0.01 .47 
Sleep 5.3 (14.3) 16.1 (26.4) < 0.01 .47 6,3(15.0) 17.6(26,6) < 0.01 .66' 
Social Isolation 2.4 (8 2) 9,2 (18,5) < 0.01 .44 3,5 (11.6) 9.1 (132) < 0.01 .47 
Physical mobility 2.3(7.8) 10,4 (16.4) < 0,01 .59' 3.3 (7.5) 102 (16.S) < 0.0\ .74' 
SF·36 
(range 100-0) 
Physical functioning 92,8(13.2) 80.4 (22,8) < 0.01 ,64' 92,5 (12.1) 78.1 (24.2) < 0.01 .99" 
Role physical 85.4 (29.7) 60.8 (41,0) < 0.01 .67' 80,2 (32,5) 36.0 (38,5) < 0.01 1.35" 
Role emotional 88,7 (26.8) 71.6 (39.4) < 0.01 .49 82.5 (32 2) 66,7 (40.5) < 0.01 .47 
Vitality 72.1 (15,7) 60,5 (19.0j < 0.01 .65' 68.9 (15,4) 53,2(21.4) < 0,01 .96" 
MenIal health 81.3(14.1) 70,4 (19.7) < 0,01 .62' 782(14,9) 65.7 (19.6) < 0,01 .80" 
Social functionin9 89.2 (17.1) 75.4(21.8) < 0,01 .64' 85,7 (16.4) 64.6 (23.8) <0,01 1.19" 
Bcdily pain 87.2 (16.9) 68.6(22.1) < 0.01 ,92" 81,2 (18.1) 582(24,6) < 0.0\ 1.20" 
General health per- 77.1 (14.7) 64,4 (19.8) < 0.01 .71' 75.0 (15.3) 59,2 (21.4) < 0.0\ .91" 
ceptions 
COOPI'NONCA 
(range 1-5) 
Physical Fitness 1,68 (.97) 1.75 (1.09) .73 .06 1.59(.91) 1,91 (1,29) 26 .33 
Feelings 1.63 (.68) 2,05 (1.02) < 0.01 .47 1.77(.77) 2.45 (1.21) < 0.0\ .80" 
Daily Activities 1.46 (.69) 1,94 (.89) < 0.01 .59' 1.56 (.63) 2.24 (1.11) < 0.01 .94" 
Social Activities 1.33 (,63) 1.70(.86) < 0.0\ .49 1.40 (.61) 1.85(.75) < 0.01 .71' 
Change in health 2,68 (,70) 2.57 (,83) < 0,01 .12 2.57 (.76) 2,73 (1.03) .15 .20 
Overall health 2,25 (.95) 2,94 (,91) < 0.01 .74' 2,36 (,87) 3,27 (1.00) <0,01 1.02" 
EuroQol 
(range 1-3) 
Mobility 1.05 (,23) 1,22 (.43) <0.01 .50' 1.06 (.24) 1.24 (,53) < 0.01 .60' 
Self-care 1.01 (.10) 1.03(,18) .03 .13 1.00 (0,00) 1,08 (.28) <0,01 ,80" 
Usual activities 1.10 (.36) 1.32 (,50) <0.01 50" 1.11 (,32) 1.55 (.61) < 0.01 1.16" 
Pain/discomfort 1.18 (.40) 1.60 (.56) < 0.01 84" 1,31 (.47) 1.62 (.58) < 0.01 .63' 
Anxietyldepresslon ___ 1.0~~. 1.31 (.51) < 0.01 ,50' 1.15 (.36) 1.36 (.54) < 0.01 .54' 
--- -- ----
I Due to the study design we had different numbers of cases available for NHP, COOP/wONCA and 
SF~36 + EuroQol, respectively. The numbers of NHP· and COOPIVVONCA cases were weighted up to 
the sample size of SF~36 and EuroQol. 
2 Interpretation: d = .2: small effect; d = .5: medium effect; d = .8: large effect. 
~ .5 < d < .8 
** d > .8 
~~--- .. ------.-
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5.5 Discussion 
In this study we have compared the feasibility. stmcture and psychometric characteris-
tics of 4 well-known generic health status measures - the NHP. the SF-36. the COOPI 
WONCA Charts. and the EuroQol - when employed in a large sample of migraine 
sufferers and a matched control group ITom the general population. 
Despite inherent differences in their design (e.g., multi-item scales versus single-item 
measures; dichotomous versus categorical response choices). broadly speaking. all 4 of 
these measures address two basic health domains: physical and mental health and 
functioning. The qualitative comparison of these measures, however, indicates that 
each approaches the topic areas covered from a somewhat different perspective. For 
example. despite the similarity in labels. the NHP 'Energy' scale and the SF-36 
'Vitality' scale differ in the type and range of subjective health experiences elicited 
from respondents. While the NHP focuses on symptoms of fatigue, the SF-36 includes 
a mix of both positive and negative items. Similarly, while the EuroQol mental health 
item focuses on anxiety and depression, the SF-36 'Mental Health' scale includes 
positive emotions as well (e.g., feeling 'calm and peaceful'). 
The feasibility of the measures (i.e., the ease with which they can be completed by 
respondents) was examined indirectly by calculating rates of missing values. Impor-
tantly, the length of an instrument does not appear to have any direct bearing on the 
frequency of missing responses. For example, the highest rate of missing values was 
observed for the EuroQol, one of the shortest of the instnunents investigated. The NHP 
had the lowest missing value rate; lower than the proportions of missing data reported 
for the UK version of the instrument.21 This reflects the simple, dichotomous response 
choices used consistently throughout the questionnaire, as well as the low demands 
placed on the respondents' reading skills via the use of short, uncomplicated sentences. 
Although not examined in the current study, the simplicity of the item wording and 
response choices of the NHP, combined with its negative question valence, may also 
make it susceptible to acquiescence response sets,I9 
Interestingly, the use of visual aids (i.e., pictograms) in the COOP/WONCA charts 
does not necessarily guard against respondent errors. In fact, one of the charts (Physi-
cal Fitness) yielded the second highest missing value rate across measures. The missing 
value rates for the SF-36 observed in the current study were comparable to those 
reported for the UK and the US versions of the instrument."·21 It should be noted that, 
because the sequencing of the 4 questionnaires was varied, an ordering effect cannot 
account for the observed differences between the instruments in rates of missing 
values. 
The SF-36 scales exhibited high levels of internal consistency, which are comparable 
to those rep0l1ed for the US version of the questionnaire when employed in a sample of 
patients with chronic health conditions (as ranging from 0.78 to 0.93)", and in a 
sample of migraine sufferers (as ranging between 0.80 and .88).28 Lower, though 
generally acceptable reliability estimates were found for the NHP scales. The differ-
ences in scale reliabilities noted between the SF-36 and the NHP may be due, in part, 
to the type of data generated by the two instruments (i.e., the SF-36 yields polytomous 
data, the NHP dichotomous data). It might be argued that the NHP sacrifices some 
internal consistency for the sake of simplicity. 
Examination of the inter-scale correlations (ICCs) for the NHP and for the SF-36 
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indicated that the NHP scales are somewhat less highly correlated with one another 
than are those of the SF-36. In general, however, the inter-scale correlations for both 
the NHP and the SF-36 were of a low to moderate magnitude, suggesting little redun-
dancy in the type of infonnation generated by the various scales with these two 
instruments. 
In contrast, the COOP/WONCA chatis were found to be relatively highly correlated 
with one another (overall PCC~0.57) as were the items of the EuroQol (overall 
PCC~0.65). This suggests that there is a higher degree of conceptual overlap among 
the items in these two instmmellts than is the case with the multi-item scales of the 
NHP and SF-36, respectively. 
The pattern of ICCs observed between the scales of the NHP and the SF-36 was 
generally consistent with expectations, with conceptually similar scales yielding the 
highest correlations. One exception was the relatively low correlation observed 
between the Pain(sF.J6) and Pain(NJIP) scales in the migraine group (ICC ~ .46; compara-
ble ICC in the control group .65). This may be explained by the fact that the SF-36 
pain items refer to bodily pain, in general, whereas the corresponding NHP items focus 
on pain as it relates specifically to physical movement. Thus, while migraine sufferers 
might repmi more pain on the Bodily Pain(sF.J6) scale, this would not necessarily be the 
case for the Pain(NHP) scale. 
The overall pattern of correlations between the COOP/WONCA chatis and the Euro-
Qol items was also consistent with expectations. Patiicularly striking was the generally 
high correlation between the Overall Health(eooP) and all of the EuroQol items (all 
PCCs >0.60), suggesting that this COOP/WONCA chart is indeed tapping a general 
health construct. 
The two combined factor analyses (Le., the SF-36 scales, the COOP/WONCA and the 
EuroQol items; the SF-36 and NHP scales, and the EuroQol items) yielded remarkably 
similar results. Both analyses resulted in an intuitively appealing solution, with two 
higher-order factors being identified - one reflecting physical health; the other mental 
health. A similar 2-dimensional model has been proposed for the Sickness Impact 
Profile (SIP») and the Rosser-Kind Matrix,' In the SIP, scores for 3 (out of 12) scales 
are combined to describe physical dysfunction, scores for 4 other scales are combined 
to describe psychosocial dysfunction, while the remaining 5 scales are named 
'independent'. The Rosser-Kind Matrix consists of a classification of illness along two 
dimensions 'disability' and 'distress\ respectively. The results of OUI' study are similar 
to those obtained in other factor analytic studies of the MOS measures and of the 
SIP.IO,lO If these results are replicated in future studies, it may be possible to efficiently 
summarize health status data by physical and mental health component scores. This 
could increase the precision of such scores, and could facilitate certain types of studies 
(e.g., cost-effectiveness) which require the use of summary health status indicators. 
The tests of 'known groups' validity indicated that, of the 4 instruments examined, the 
SF-36 was best able to discriminate between groups formed on the basis of chronic 
disease status, and work disability days. Of the 3 remaining instruments, the NHP and 
the EuroQol also performed well, while 4 out of the 6 COOP/WONCA charts evi-
denced good discriminative ability. These results confirm earlier repOlis of the ability 
of the SF-36 to discriminate between patients with minor versus major medical 
conditions, and between patients with physical health versus psychiatric conditions.' It 
should be noted that evidence of discriminative power based on cross-sectional 
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analyses does not necessarily imply that an instrument will also be responsive to 
changes in health status over time. Although this may well be the case, this needs to be 
confirmed empirically with the use of longitudinal study designs. 
An overall summary of the results of this study is reported in Table 5.5. All 4 of the 
health status instruments examined yielded low levels of missing data. This finding 
adds to the already substantial body of evidence supporting the feasibility of collecting 
subjective health status data in relatively large scale survey research setlings. The 
question of whether similar assessments can be successfully incorporated into more 
clinically-oriented, longitudinal studies of seriously ill patient populations is the subject 
of current study. 
In general, all 4 instruments exhibited a good performance profile, including reliability 
(where assessed), construct validity, and 'known groups' validity. Of the two health 
profiles investigated, the SF-36 performed best psychometrically, exhibiting highest 
scale internal consistency and discriminative ability. Both health profiles outperformed 
the COOP/WONCA chalts and the EuroQol, reflecting the psychometric advantages 
often associated with instruments having a multi-item scale structure. 
TABLE 5.5 Summary of empirical comparison of NHP, SF-36, COOPIWONCA charts and EuroQol 
NHP SF-36 COOPIWONCA EuroQol 
-- -- --".--.--
---- --'---
Missing value rate best acceptable acceptable acceptable 
Internal consistency acceptable best not applicable not applicable 
Construct validity confirmed confirmed confirmed confirmed 
Discriminative ability good best good good 
--' .. --' .. -- -- .-- --.-- --'.--
Additional research is needed to provide a head-to-head comparison of the test-retest 
reliability of these instruments, as well as of other aspects of their validity, including 
patticularly their responsiveness to change in health status over time. Additionally, 
more formal, confirmatory tesls are needed (e.g., using structural equation models) to 
explore further the underlying, higher-order physical and mental health score compo-
nents identified in the current study. Finally, the relative performance of these measu-
res when employed with more seriously ill patient populations needs to be further 
investigated, 
Ultimately, choosing among available generic health status instruments requires not 
only a careful consideration of their formal psychometric properties, but also of the 
match between their substantive content (e.g" the breadth and depth with which they 
address relevant health domains) and the specific research question at hand. Addition-
ally, practical considerations such as respondent burden, and the availability of 
culturally- and language-adapted versions can be important in identifying the most 
appropriate measure for use in a given study. Finally, it may be imprudent to approach 
such decisions from an I either-or' perspective. The use of several generic measures, or 
combining generic with disease-specific measures in a single study, may yield the 
greatest return on our investment in health status assessment. Particularly given that 
72 NHP, SF-36, COOP 01" EUI"oQol 
many of the available generic instl1lments are quite brief, such n strategy should be 
possible without resulting in excessive respondent burden. 
Notes 
I. Separate factor analyses for each of the 4 health status measures were also carried 
out. The results were similar to those derived from the two analyses in which 3 of 
the 4 instnllnents were examined simultaneously. Results of these additional 
analyses are available upon request. 
2. Given unequal score variance between groups, the denominator used in calculating 
the d statistic was the square root of: 
[CN, -I)S,' + (Nb -1)Sb'] / [CN,-I) + (Nb-I)] 
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L.t~PENmX 1 Intrac1ass correlation coefficients of NHp-scales and SF-36 scales' (pooled data, 0:515) 
-
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• As NH? and SF-36 scales run in the oppos~a direction, we used (100, (SF-3S scale score)) In the delermlnatlon of ICes, 
ENERGY" NHP Energy; PAIN = NHP Paln; EMOTION" NHP EfMtiClll!1 Reaction; SLEEP = NHP S~ep: SOCIAL" NHP Soclallsolalion; PHYSMOa = NHP 
Physical Mobn~y 
PF = SF-3$ Physkal functioning; RP '" SF·36 Role physical; RE .. SF·3a Role emotional; vr" SF·36 Vrtalify; MH = SF·3a Menial health; Sf = SF-3a Social 
~I?g: BP" SF·36 Bodily paIn; I3H = Sf-36 Ge~,eral heahh perceptions. 
--
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~ENDIX2 Polychorlc tXlrre!aliol13 of COOPNJONCA'Hem~ Md EUfoQol-~em$ (pooled dala, n=4%). 
-
EQ·Mob EO-Self EO-Usual EQ- EQ-Mood Co-Phys CO- CO_Daily CO-Soc CO-Change 
Pain Feel 
EQ.Se!f .70 
----
--
~~ual .71 . 
-----
EO-Pain _._ r--='-.- .77 . 
EQ.-Mood .' AO .51 .52,._ 
-
~Cl-Phys .26 .56 .33 .19 .' 
--
CO-Feel ~. ~- A' .39 ." .08 ._----
~t?~ L:?~ -.~ .75 64 .71 .' .73 
--
-----
CO-Social .42 .62 .61 .5~_ ~~ .10 .72 0,82 ._---
CO-Cha~e . .10 . . . . . 
-----
CO-Overall .61 .69 .79 .66 .56 .22 56 . .66 
----
-' polychorte correlation coefficient Is unreliable, because the assumption of a btvariate nOffllel distributIon of data Is not fulfilled. 
EQ-MOB" EureQol Mobility; EO-SELF" EuroQol self-care; EO-USUAL = EureQol Usual Activities; EO-Pain" EurcQol Pa!nfdiscomror1; EO-MOOD = EuroQo! 
Anxiety/depression. 
Co-PHYS = COOPM'ONCA Physical FMess; CO-FEEL'" COOPN.'ONCA Feelings: CO-DAILY = COOPM'ONCA Dally actri~res: CO-SOCIAL" COQPM'ONCA 
~~! Activities; CO-CHANGE" COOPIWONCA Chang6in heatth; C(),·OVERALL" ~,OOP/WONCp;,()verell health . 
----
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6.1 Abstract 
Problems. What is the effect of migraine on health status, defined as the subject's 
physical, psychological and social functioning? And, suppose that the health status of 
migraine sufferers appears to be impaired, to what extent is this a consequence of 
migraine-associated comorbidity rather than of migraine itself'! 
Methods. A group of 846 migraineurs, selected from the general population following 
IHS criteria, and a control group were surveyed with the Short Form-36, the Notting-
ham Health Profile, the EuroQol instnnnent and the COOPfWONCA charts. Questions 
on demographic characteristics and comorbidity were included. 
Results. The health status of migraineurs appeared to be significantly impaired in 
comparison to the cono'ol group. Because statistical significance is distinct from 
relevance, effect size estimators were employed. Although the direction of the differen-
ces indicated consistently a worse health status of the migraineurs, regardless of the 
instrument used, the sizes of the differences were small to medium. Self-reported 
comorbidity, especially depression, was more prevalent in the migraine group. 
However, this offered only a partial explanation for the impaired health status of the 
migraine group. 
Conclusions. Migraine has an independent, moderately deteriorating effect on the daily 
functioning of individuals. 
6.2 Introduction 
The burden of migraine, a chronic, attack-wise and presumably disabling disease, 
should not be underestimated. The reported one-year prevalence in adults exceeds 
10%, with a male to female ratio of about I to 2-3.' People in the age range 15-55 
years are predominantly afflicted, i.e., those in the work force. Long term consequen-
ces of migraine may result from interference of frequent attacks with daily life, thus 
precluding optimal functioning. We designed a study to quantify the burden of 
migraine both in terms of its economic consequences and in terms of its impact on 
health status. 
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The economic part of the study, that was published in detail elsewhere, showed that 
direct costs of migraine in the Netherlands accounted for 0.3% of the total health care 
costs in 1988, 80% of which could be attributed to 'alternative' medical practice. 
rndirect costs, due to absence from work and reduced productivity, were estimated to 
amount to at least 542 million Dutch guilders per year (1988 1$ ~ 1.9 fl.' 
Health status, the focus of the present paper, is defined as physical, psychological and 
social functioning. Osterhaus concluded from a survey of 845 migraineurs (meeting 
lHS criteria') with the Medical Outcomes Study 36-item Short-Form Health Survey 
(SF-36) that 'although migraineurs may be physically able to function, they function 
behaviorally at a level well below their physical capabilities, and for some domains 
even worse than patients suffering from arthritis, gastrointestinal disorders or 
diabetes','1 Solomon assessed the health status of 208 patients attending a Headache 
Center with the Medical Outcomes Study 20-item instrument (MOS-20). The authors 
conclude 'that chronic headache disorders are associated with significant limitations in 
all measured dimensions of patient well-being and functioning when compared to 
patients with no chronic condition; and that patients with chronic headaches have a 
level of fUllction worse than that of patients suffering from diabetes, arthritis, depressi-
on and back problems'.5 Jenkinson rep01ied the results of interviewing 80 women 
attending a migraine out-patient clinic (diagnosed as suffering from migraine by a 
neurologist) with the Nottingham Health Profile and the General Health Questionnaire 
(OHQ; a screening instrument for non-psychotic psychiatric disturbance).6 GHQ-scores 
were indicative of mood disturbance in no less than 41 % of the subjects. In a Dutch 
study among elderly patients (age range 55 - 79 years) only 9% of those who stated 
they suffered from 'migraine or severe headache' repOIied physical limitations, and 
10% gave a negative evaluation of their general health. However, 45% regarded their 
psychological well-being as being impaired by their headache complaints.' Overall, 
these studies are indicative of a worse functioning of migraine sufferers. However, 
controlled studies, enabling a comparison between migraine sufferers and non-afflicted 
subjects and an estimation of the size of the effect of migraine on health status, are not 
known to us. 
1 t has been recognized that III igraine often occurs in association with other conditions, 
like mood dishlrbances (depression, anxiety)8.9.IO, allergic phenomena (atopy, asthma, 
food aliergy)JI,'2 and vasospastic disorders (Raynaud's phenomenon).JJ·I4·15 This higher 
prevalence of comorbidity was confirmed in a recent Dutch survey on socio~econolllic 
health inequalities in a representative sample of the general population (11= 15,973; age 
range 15-64). The prevalence of self-reported migraine (no chcck on IHS criteria) was 
12% for women and 5% for men. Women with migraine repOlied no other chronic 
condition in 39% of cases, while 15% reported 2 or more; for women without migraine 
these figures are 60% and 5%. The largest difference in prevalence of a specified 
chronic condition was for 'depression/nervous exhaustion' (22% for women with 
migraine, 6% for women without migraine). Similar figures held for men with and 
without migraine in this study. (K Stronks, Departement of Public Health, Erasmus 
University Rotterdam; personal communication, 1994). 
With regard to the causal relationship between migraine and comorbid conditions 
several authors have proposed a cOlllmon disposition or a common pathogenetic 
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defecL '2 ,'6 Information about the consequences of the higher prevalence of comorbidity 
in migraine sufferers is scarce. In particular, the relative contribution of migraine and 
other conditions to the lower level of functioning by migraine patients has not been 
investigated previously. 
In the present study the health status of migraine patients is compared with that of a 
control group. We intend to answer the following questions: 
I. What is the health status of migraine sufferers compared with a control group that is 
comparable on age, gender and employment status? 
2. Are the differences between migraineurs and controls consistent if measured with 
different generic instnnnents? 
3. What is the relative contribution of migraine and associated comorbidity, especially 
self-reported depressive disorders, to the impaired health status of migraine 
sufferers? 
6.3 Methods 
6.3.1 Somples 
Migraine patients were selected from a series of face-to-face interviews with a repre-
sentative sample of the Dutch general population (n~ I 0,480), avoiding the selection of 
only severe cases who seek medical care, during the period October 1992 to February 
1993. Subjects were included as migraine patients if they met the IHS criteria' and had 
experienced at least one attack of migraine during the 12 months prior to the interview. 
992 migraine sufferers met these criteria (I-year prevalence 9.5%). Of these sufferers, 
who were all invited to participate in a second study, i.e., the actual investigation on 
health status and (in)direct costs, 85% (n~846) actually agreed to cooperate. 
The control group was selected from the subjects in the survey who did not meet the 
criteria for migraine by frequency matching to the migraine group on 5-year age class, 
gender and employment status. 
6.3.2 fllstruments 
Generic instruments for health status assessment measure basic values (physical, 
psychological and social functioning) which are relevant for everyone's health status. 17 
There is general agreement that the primary source for such information is to be found 
in the subjects themselves. Generic questionnaires are non-disease specific, enabling 
comparison of health status data across the borders of specified diagnoses. 
A combination of four generic questionnaires, the MOS Short Form-36, the Notting-
ham Health Profile (Dutch Adaptation), the EuroQol descriptive instrument and the 
COOP/WONCA charts, was applied to investigate whether differences between 
migraineurs and controls were consistent if measured with different instruments. Data 
were also analysed to compare testing properties of these questionnaires. 
The Medical Oulcollles Sludy 36-ilem Shorl-Forlll Health SlIIwy (SF-36) was devel-
oped in the US from the Medical Outcome Study General Health Survey Instru-
ment. 18,19,20 It consists of 36 items, assigned to the domains of Physical Functioning (10 
items), Social functioning (2), Role limitations (physical problems) (4), Role limita-
tions (emotional problems) (3), Mental Health (5), Vitality (4), Pain (2), General 
Migmine 81 
Health Perceptions (5) and Health Change (I). The numbers of response categories per 
item range /i·om 2 to 6. The end score is an eight-dimensional profile. The Dutch 
version we used was developed as a part of the IQOLA project, which aims to transla-
te, validate and norm the SF-36 in a range of languages and cultural settings." 
The Nottingham Health Profile (NHP) was developed during the seventies in the UK 
as a measure for perceived health, to be used in population surveys." Part I of the NHP 
consists of 38 dichotomous items, covering the domains of Physical Mobility (8 items), 
Pain (8), Energy (3), Sleep (5), Social Isolation (5) and Emotional Reaction (9). Part 2 
consists of seven items on problems because of health in seven specified areas of life. 
The Dutch version we used has been tested in several patient populations. 21.24 
The EuroQol classification consists of five items (Mobility, Self-care, Usual activities, 
Pain/discomfort and Anxiety/depression), each following the general form: no prob-
lems - some problems - extreme problems." Additionally, evaluation of own health is 
assessed with a visual analogue scale ranging from 0 (worst imaginable health state) to 
100 (best imaginable health state). The EuroQol instIlunent was developed by the 
international EuroQol Group as a standardised, non-disease-specific measure for 
description of health status. EuroQol health state descriptions can be linked directly to 
empirical valuations of health states by the general population, a feature which makes 
it especially interesting for the economic assessment of medical interventions. 
The COOP/WONCA charts were developed to assess health status of patients in 
primary care. 26 There are six charts, covering the domains of Physical Fitness, Feel-
ings, Daily Activities, Social Activities, Change in Health and Overall Health. The 
levels on the scales are illustrated with pictograms. 
COll1orbidity was assessed by the list of chronic conditions, as included in the Dutch 
Health Interview Survey of the Dutch Central Bureau of Statistics. This list counts 28 
conditions in lay terms (like 'asthma, chronic bronchitis or COPD', 'diabetes', 
'varicose veins'). Respondents are asked to indicate for each condition whether they 
have it nolV or if they have had it in the year prior to assessment. 
6.3.3 Questionnaire lay-out and mailing scheme 
We used four different questionnaires, two for the migraine group and two for the 
control group. All versions contained the SF-36, EuroQol and questions relating to 
comorbidity and demography. The two migraine versions differed from each other, one 
containing the COOP/wONCA charts, the other the NHP. The two control group 
versions differed in the same way. Both migraine versions contained additional 
questions on the number of attacks during the year prior to assessment and on medical 
consumption. 
Questionnaires were sent by mail in June, 1993, with reminders two weeks (a postcard) 
and five weeks (a complete questionnaire) later. 
6.3.4 Analysis 
To investigate any selectivity of response, non-response analyses were conducted by 
comparing and testing (Chi-square test) the distributions of age, gender, social class 
and degree of urbanization of addressees and respondents. 
Scores were declared as missing values if nothing was filled in or if ambiguous 
information was provided. Because of generally low missing value rates we did not 
impute constructed values for missings. Scale scores for the SF-36 and NHP were 
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based on complete records only. 
The Mann-Whitney U test was applied for testing differences in scores of continuous 
non-normally distributed variables between the migraine group and controls. To avoid 
the effect of multiple testing, p < 0.01 was regarded as statistically significant. Given 
the large sample size, statistical significance may be misleading: relatively small mean 
differences will achieve conventional levels of statistical significance without represen-
ting meaningful differences in fimctioning. We employed an estimator of effect size d 
for continuous variables, which relates the differences in mean scores to the dispersion 
of the scores. A d = .2 indicates a small effect, ad = .5 a medium effect and ad = .8 a 
large effect.27 
The Chi-square test was used to test for proportional differences in contingency tables. 
Again, p < 0.0 I was regarded as statistically significant. The effect size estimator IV for 
contingency tables has a different interpretation: IV = .1 indicates a small effect, IV = .3 
a medium effect, IV = .5 a large effect. 27 
Multiple classification analysis (MCA) was applied to explore the relative effects on 
health status of migraine and associated comorbidity."·29 Essentially, MCA is multiple 
regression analysis using dichotomous predictor (or explanatolY) variables. We used 
'migraine yes/no\ 'depression yeslno' and 'diseases of the skin yeslno' as predictor 
variables. The choice of the latter two conditions was based on significant differences 
of their prevalences in the migraine group and the control group. The scale scores of 
the SF-36, NHP and EuroQol (valuation of own health) that showed the largest 
differences between the migraine group and the control group were used as dependent 
(or explained) variables in separate MCAs. 
It can be argued that loglinear analysis would be more appropriate, because for MCA a 
continous and normal distribution of the dependent variable is required. Application of 
loglinear analysis did not change the conclusions. We have chosen to present MCA 
results as they are easier to interpret. 
6.4 Results 
6.4.1 Response 
The questionnaire was mailed to 846 migraine sufferers as identified by the diagnostic 
interview. 65 of them returned it, remarking they did not have migraine. A number of 
migraineurs as classified by the diagnostic interview probably did not label their 
headaches as migraine themselves. After exclusion of these 65 and after correction for 
wrong addresses, the cmde response-rate was 63%. Of these, 90% were usable 
(n=436). There were no significant differences in response rates between the two 
migraine groups (questionnaire with COOP/WONCA charts or NHP respectively). 843 
questionnaires were mailed to the control group. After correction for wrong addresses, 
the crude response rate was 72%. All but ten were usable (n=575). As in the migraine 
group, there were no significant differences in response rates between the two control 
groups. 
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Due to the different composition of the questionnaires, the following numbers per 
instrument were available for analysis: for SF-36 and EuroQol, n~436 in the migraine 
group and n~575 in the control group; for NHP, IF226 and n~289; for COOPI 
WONCA IF210 and n~286. 
The non-response analyses did not show significant differences between addressees 
and respondents in either the migraine group or the control group, suggesting no 
selective non-response. 
6.4.2 Respondents' characteristics 
Demographic characteristics and data relating to the prevalence of self-reported 
comorbidity are presented in Table 6.4.2. The differences between the respondents in 
the migraine group and the controls were not significant for sex distribution, age, 
employment status or educational level. However, after exclusion of 'migraine' and 
'severe headache', the respondents in the migraine group reported significantly more 
chronic conditions now or in the past year. Especially 'diseases of the skin/eczema' 
and I depression/ nervous exhaustion' were more prevalent in the migraine population 
(14% and 29% in the migraine group, 9% and 16% in the control group respectively). 
The migraine patients rep0l1ed an average number of 13 attacks of migraine during the 
past twelve months (41%, 4 or fewer; 18%,5-9; 23%,10-19; 18%,20 or more). About 
70% of the migraine patients consulted a general practitioner for their headaches. Only 
half of them did so during the past year and only 6% of them consulted a neurologist 
during that year. 
TABLE 6.4.2 _Hespondenls' characlerislics in Ihernigraine group (n=436) and conlrol group (n=575) 
Migraine Controls 
Sex (% female) 84 80 
Age [X, (sd)] 40 (13) 41 (14) 
Employment status 47 44 
(% wilh paid job) 
Education 
Low 34% 31% 
Medium 38% 38% 
High 28% 31% 
Comorbidity (excl. migraine and 
headache) 
o conditions 29% 43% 
1 conditions 31% 27% 
2 conditions 22% 14% 
> 2 conditions 19% 16% 
Number of conditionsJX (sd)] 1.50 (1.54) 1.15 (1.40) 
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6.4.3 Heallh slalus 
The results of the SF-36 (see Table 6.4.3.1 and Figure 6.4.3.1) show statistically 
significant worse functioning for the migraine group in all eight domains. 
The differences are small to medium-sized. The differences between migraine patients 
and controls are the largest for Pain, Social Functioning, Vitality and Role Limitations 
due to physical problems. 
The NHP-I results (see Table 6.4.3.2 and Figure 6.4.3.2) show significant results only 
for the scales Energy and Emotional reactions. The effect sizes arc small. The results 
for the NHP-2 (see Table 6.4.3.3) show that migraine causes significant problems for 
household work, social life, home life and sex life; the largest effects are medium-sized 
(household work and home life). 
The scores of the migraine group and the control group for the COOP/WONCA chaIts 
are shown in Table 6.4.3.4. The lower level of functioning of the migraine group is 
significant for two out of six items, viz. Daily Activities (small effect) and Overall 
Health (medium effect). 
Table 6.4.3.5 shows the EuroQol classification scores. The scores of the migraine 
group are indicative of significantly worse health status of the migraine group for the 
Hems Usual Activities, Pain/Discomfort and Anxiety/Depression as well as for the 
valuation of own health. The effect sizes of these differences are small to medium. 
TABLE 6.4.3.1 SF-36. Migraine·group (n=436) and control group (n=575) 
Migraine Controls 
X (sd) X (sd) MWU Effect size 
(p-values) (d)" 
Physical Functioning" 85 (19) 86 (21) .006 .07 
Social Functioning 76 (21) 85 (21) <.001 .39*** 
Role limitations (physical) 63 (40) 77 (36) <.001 .34*"'-
Role limitations (emot.) 75 (38) 81 (34) .007 ,17"** 
Mental Health 72(19) 77(18) <.001 .25 
Vitality 62 (19) 68 (18) <.001 .35 
Pain 65 (22) 78 (22) <.001 .57 
General Health Perceptio!ls 68 (20) 73 (18) <.001 .29 
* all scales: 0 = bad functioning, 100 = optimal functioning 
** d = ,2 : small effect; d = ,5: medium effect; d = .8 : large effect 
*** Because of non-normal or non-continuous distribution of the data of these scales, use of effect size 
W is gener~Jly mor~ appropriate, Howev~!, computatio!1 of Ws did not ctlan.ge the conclusions, 
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FIGURE 6.4.3.1 SF-36 scores. Migraine group (n=436) and conlrol group (n=575) 
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TABLE 6.4.3.2 Nottingham Heallh Profile(part 1). Migraine group (n=226) and conlrol group (n=289) 
-
Migraine Controls 
X (sd) X (sd) MWU Effect size 
p·values (W) .. 
Mobility· 9 (15) 6 (13) .013 .12 
Energy 20 (29) 12 (24) .001 .15 
Pain 11 (21) 7 (16) .029 .12 
Sleep 13 (24) 11 (22) .221 .07 
Social Isolation 8 (18) 5 (14) .031 .10 
Emotional Reaction 12 (18) 8 (17) <.001 .21 
• all scales: 0 = optimal level, 100 = worst level. 
u W= .1 : small effect; W= .3: medium effect; W= .5 : large effect. Wwas used here instead of d 
because of non"normally or non-continuously distributed data. 
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FIGURE 6.4.3.2 NHP scores. Migraine group (n=226) and control group (n=289) 
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TABLE 6.4.3.3 Nottingham Health Profile (part 2). Migralne·group (n=226) and conlrol group (n=289) 
Migraine Controls 
----
-----. 
-----
.----- .-----
Chi2 Effect size 
j%yes) (%yes) ( ·values) (W)' 
Health causes problems for ... 
... paid job 22 11 .34 .14 
... household work 33 15 <.001 .21 
... sociallife 25 11 <.001 .18 
".home life 29 8 <.001 .27 
... sex life 21 10 <.001 .15 
... hobbies 22 14 .025 .10 
... holidays 7 5 .335 .04 
,,----_. 
, W = .1 : small effect; W = .3: medium effect; W= .5 : large effect 
6.4.4 Consequences of comorb;dity on jUllctioning of migraine patients 
The results of the study as described above showed worse functioning of the migraine 
group alld a higher prevalence of self-repOlied comorbid conditions, especially 
'depression/nervous exhaustion' and 'diseases of the skin/eczema'. We examined the 
extent to which the impaired health status of the migraine sufferers could be attributed 
to migraine and to the Illost relevant comorbid conditions respectively. We did seven 
consecutive MeAs with Pain{sF.J6), Role limitations (physical){sF.J6), Vitality{sF-J6), Social 
Functioning{sF.J6), General Health Perceptions{sF.)6), EnergY{NJlP) and Valuation of own 
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health(EufOQOI) as dependent variables respectively. 
Each of these MCAs showed significant coefficients for the explanatolY variables 
'migraine' and for 'depression' (p's<O.OOl), but insignificant coefficients for 'diseases 
of the skin'. The effect of 'depression' was larger than the effect of 'migraine', except 
for Pain(sF·J6I. For some of Ihe dependent variables (Social Functioning(s"·J6I, Valuation 
of own heallh(E""QoI), Role limitations - physical(sF.'6») the interaction effect (migraine* 
depression) was significant (p's<.O I, .0 I and .02 respectively), which indicates that the 
detrimental effect of the presence of both conditions on the dependent variable is larger 
than the additive effect of each of them. 
Migraine Controls 
X (sd) x (sd) MWU Effect size (d)" 
f--- _________ .. ___ .. ___ . ___ . ___ ---.i£l:value) ._-
Physical fitness* 1.7 (1.0) 1.7 (1.1) .981 .00 
Feelings 2.0 (1.0) 1.8 (0.9) .031 .22 
Daily activities 1.9 (0.9) 1.6 (0.8) <.001 .29 
Social activities 1.6 (0.8) 1.5 (0.8) .210 .19 
Change in health 2.6 (0.8) 2.7 (0.8) .098 .10 
Overall health 2.9 (0.9) __ ~O_) __ <.001 .39 
--_ .. _-
* all charts: 1 = optimal/evel, 5 = worst level 
•• d = .2 : small effect; d = .5:mediumeffect; d = .8 : largee~ ___ . _________ ~ 
6.5 Conclusion and discussion 
Our study shows that the health status of migraineurs is significantly impaired in 
comparison with a control group. The direction of the differences consistently indi-
cated a worse health status of the migraineurs, regardless of the instrument used, 
The fact that these differences were found with generic instruments, which are in-
tended for assessment of health status ranging from 'velY bad' to 'velY good' is an 
indication that they are real differences. Because statistical significance is distinct from 
relevance, the differences between migraine and control group were placed in perspec-
tive by effect size estimators. The sizes of the differences were small to medium. 
This finding has face-validity; despite the impaired functioning of migraineurs, 
migraine is generally not a severely incapacitating condition like, for example, end-
stage cancer. Comparison of the results of the health status assessments of the migraine 
sufferers with published results for other patient groups are likely to be fiawed to some 
extent because of different composition of the groups regarding, for example, age and 
sex. With this precaution in mind, the NHP scores of the migraine group in our study 
are in the same range as those of a group of Dutch patients with mild ai .. Oow obstl1lc-
tion ,30 
The largest differences between migraine sufferers and controls were observed in the 
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domains Pain{sF-J6), and to a lesser extent Pain/discomfort{EllwQo1); Role limitations 
(physical)(s'.)6), Household worke""P.2); Social Functioning(s'.)6), Homelife("1P.2); Vitality 
(SF·36) and Energy(NHP), Overall health(coo?) and Valuation of own health(I',mQoI). The 
unexpected lack of a difference on Pain(NHP) can be attributed to the fact that many of 
the items of this scale relate to pain when walking or standing; Pain(sF-J6) refers more 
generally to the amount of bodily pain experienced in the past four weeks and its 
interference with normal work. 
--'--'--'--.-- ---_._--- .--. 
TABLE 6.4.3.,5 EuroQol classification.Migrainewoup (n=436) and control group (n=575) 
. __ ... _____ Migraine, Controls 
Chi? 
__ . __ .. __ . __ . ___ (%_) __ .. __ (o/~ _",(Pc...-v..-a.,.lu",e"s),--_ 
Mobility': 
no problems 83.0 87.4 .051 
some problems 16.3 12.4 
confined to bed 0.7 0.2 
Self-care: 
no problems 97.2 98.0 .386 
some problems 2.8 2.0 
unable to 0 0 
Usual activities: 
no problems 72.4 83.3 <.001 
some problems 26.4 14.8 
unable to 1.2 1.9 
Pain/Discomfort: 
none 49.5 67.4 <.001 
some 46.6 31.2 
extreme 3.9 1.4 
Anxiety/Depression: 
none 73.0 85.3 <.001 
some 24.6 13.7 
extreme 2.5 1.1 
Valuation of own health 
Effect size 
ryv)" 
.06 
.03 
.15 
.19 
.15 
(0-100): X (sd_) _ 77 (17) 83(15) <.001 . __ .38 (eI''') 
• 1 =optimallevel, 3=worst level 
"W=.1 : small effect; W= .3: medium effecl; W=.5: large effect 
~u d = .2 : small_ effect; d _= .5: me,d_ium effect; d = .8 _:,Iarge eff~ . __ .. ______ . 
Additionally we explored whether (self-rep0I1ed) depressive disorders and diseases of 
the skin, which have a higher prevalence among migraineurs, could explain their health 
status impairment. The effect of migraine on health status remained significant after 
correction for these two conditions, which means that migraine has a consistent 
independent, though moderate, impact on health status. 
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The relevance of the presented results is twofold. Firstly. the impairment of the overall 
functioning of migraine patients has been quantitatively documented. Secondly, we 
showed the effect of migraine on health status to be independent of two relevant 
comorbid conditions, viz. self-reported depression alld diseases of the skin. The impact 
of migraine on health status justifies the continuing search for cost-effective remedies 
for this condition. Treating migraine wiII probably improve the sufferer's functioning. 
However, migraineurs are at a greater risk of depression and other comorbid conditi-
ons, some of which have all additional detrimental effect on health status. Clinical 
awareness may result in a higher 0ppOliunity of treating these associated conditions, 
with probably additional positive effects on the daily functioning of migraine sufferers. 
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7.1 Abstract 
Analysis of the quality-of-life effects was part of the technology assessment of the 
Dutch orthotopic liver transplant program. 
Data were collected by means of computer-assisted interviewing, including one 
interview before transplantation and allnllal follow-up interviews. Data on psychiatric 
morbidity were obtained from medical records. 
This article shows preliminaJY results of a cross-sectional analysis of data collected 
from 1987 to 1989. Eighty-eight measurements were obtained from 46 adult patients 
(response rate 82%). Pre-transplant scores suggest major restrictions on all domains 
of life, especially a low amount of energy, After transplantation all indicators show 
improvement, although the level of the general popUlation is not always attained. 
Improvement of subjective quality of life is more marked, probably due to euphoria at 
surviving the hazardous procedure. Psychiatric events occurred only infrequently, 
We conclude that orthotopic liver transplantation contributes positively to the quality 
of life of surviving patients. Additionally, empirical health status assessment in these 
sometimes very ill patients appeared to be feasible. 
7.2 Introduction 
Though never assessed in a randomized clinical trial, orthotopic liver transplantation 
has been accepted as an effective therapy for patients with elldRstage liver disease. l 
The considerable claim on financial resources and uncel1ainty about the balance of 
harm and benefit have given rise to many investigations of its overall effectiveness. 
Results on the gain in length of survival of patients treated with liver transplantation 
have recently become available. 2,3,4 However, studies assessing the gain in quality of 
life as a result of liver transplantation are few. 5,6 Most shldies on the effect of liver 
transplantation on the quality of life have studied a few noncomprehensive indicators 
of quality of life, - e.g., days spent in hospital, work, activity status, and growth in 
height (children).'···,·lO.Jl.I2.lJ In addition several reports are available on psychiatric 
morbidity, focusing primarily on neuropsychiatric symptoms of end-stage liver 
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disease (hepatic encephalopathy).I4·l5·l6 
A more comprehensive assessment of qnality of life. in liver transplantation patients 
was repOlied for liver transplant recipients only after the procedure, probably due to 
considerable difficulties in obtaining measurements from pretransplant patients. 
17.18.19." The study by Lowe is of pmiicular relevance since it applied a quality of life 
instl'llment (the Nottingham Health Profile) that was also used in our study." Only the 
study published by Talier in 1988 has a longitudinal design; preliminary results 
indicated a sharp improvement in quality of life after liver transplantation, although 
the premorbid level of quality of life usually was not attained.2l The present article 
describes the design and the first results of a study on the changes in health-related 
quality of life in adult Dutch liver transplant patients. The study was part of a medical 
technology assessment of the liver transplant program in the Academisch Ziekenhuis 
Groningen in the Netherlands that analyzed effects of liver transplantation on 
survival, quality of life, and various resources. 3,n 
7.3 Materials and methods 
7.3.1 Paliellls 
The protocol of patient selection, timing of transplantation and support during follow-
up has been described before.')·2l·25 The nationally accepted protocol states overt 
psychiatric morbidity, including active alcoholism, to be a contraindication. Intensive 
support by a specialized social worker is a regular part of the clinical program. 
A longitudinal study design for the quality of life study with pre- and posttransplant 
measurements was aimed at. Until the stmi of data collection for the quality of life 
study in June 1987,63 patients received a transplant; 38 of these were still alive from 
I month to 8 years posttransplantation. These 38 patients constituted the group that 
was only eligible for posttransplant measurements (the cross-sectional group), for 
obtaining information on the long-term quality of life. Eight patients under 18 were 
not elegible for the quality of life study; additionally 4 adults were left out for 
practical reasons as they lived abroad. 
The remaining 26 Dutch adults living with a transplant in June 1987 were included in 
our study and completed a questionnaire once a year. 
The longitudinal group consisted of all adult Dutch-speaking liver transplantation 
candidates who have entered the program since June 1987, as defined by the formal 
request for a donor liver from Eurotransplant. Collection of data for the present report 
was terminated on July 1st, 1989. By then the longitudinal group consisted of 26 
patients, 6 of them still awaiting transplantation. 
7.3.2 Questionnaire 
It is generally recognized that health-related quality of life (or 'health status') 
constitutes a complex, multidimensional constl1lct. 26 According to present standards 
objective and subjective components are discerned." Objective quality of life usually 
refers to observable phenomena that can be compared with external standards (e.g., 
walking distance). Subjective quality of life refers to experienced well-being. We 
selected a set of general and specific questionnaires that addressed objective and 
subjective quality of life. If possible validated Dutch questionnaires were used. The 
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left-hand columns of Table 7.3.2 show the questionnaires used as well as their ranges 
of scores and reference scores for the general population, if available. 
The Nottingham Health Profile (NHP, pmt I) is a comprehensive measure designed 
to measure perceived health on 6 specific domains of life, as shown in Table 7.3.2.28 
The NHP consists of 38 items with a yes/no answering format and was used by Lowe 
in his assessment of post-transplant status of liver transplantation patients." The 
Karnofsky index is a global one-item measure for health status, often used in onco-
logic research.29 It covers domains like intensity of treatment and ability to take care 
of oneself. The Index of Well-being is a global measure for experienced well-being, 
consisting of II items." 
The other questionnaires mentioned in Table 7.3.2 concern more specific indicators. 
The State-Trait Anxiety InventolY (STAI) and Self-rating Depression Scale (SDS or 
Zung), are 20-item questionnaires to measure anxiety and depression respec-
tively.lO.lI.n.3J The questions on Activities of Daily Life were derived from a Dutch 
national survey on health related problems. For nine activities, ranging from dressing 
to shopping, patients were asked whether they performed these activities independ-
ently - and, if they did, at what effort. The questions on physical complaints and 
working capacity were designed for this study. Inquiries were made about the 
following complaints by means of a three-point scale (absent/sometimes present! 
always present): lack of appetite, abdominal cramps, swollen belly, itching, jaundice, 
bone pain, backache, hematomas, drowsiness. The questions on satisfaction with 
aspects of life originate from the Dutch health survey mentioned above. 
The resulting questionnaire consisted of about 250 items. Stand-alone computer 
assisted interviewing was used as method of presentation of the questions and 
registration of the response. J4 This technique was succesfully applied earlier with 
ambulatory as well as bedridden patients in a similar study of heart transplantation 
patients.J5 
In addition to the self-reported quality of life, medical records of all patients were 
abstracted for the presence of psychiatric events. A psychiatric event was defined as 
clinical or outpatient treatment by a psychiatrist andlor the prescription of psychiatric 
drugs (excluding temporary prescription of benzodiazepine-derivatives). 
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TABLE 7.3.2 Quality of life before and after liver transplantation (reference values, mean patient values 
r-____ --'a"nccd-'s"la"'n~da!~~d~~i,~uons; 1987-1989, n=46, cross-sectional analysIs) 
-~ 
_____ ---'R"e"'fe:cre=nc:c"e-'v:cal"ue=s'---___ .. _R.-'~~ults In liver transplantation-population 
Questionnaire 
General Indicators: 
Nottingham Health 
Profile - 1 
Mobilily 
Pain 
Energy 
Sleep 
Social isolation 
Emotional reaction 
Range*" General 
popula-
tion 
Wailing 
Llsi 
(n=22) 
3 months 
post LTx 
(n=18) 
1 year 
post LTx 
(n=13) 
2-5 yrs 6-10 yrs 
post L Tx post L Tx 
. (n=.1~) ~_-'( n,,-=-,1 ",0),--
100~0 <15 34 (29) 24 (26) 13 (27) 15 (24) 9 (14) 
100~0 <15 19 (25) 9 (18) 2 (5) 8 (17) 2 (4) 
100~0 <15 63 (42) 18 (29) 3 (10) 11 (29) 9 (20) 
100~0 <15 42 (35) 14 (20) 9 (18) 5 (7) 10 (6) 
100~0 <15 18 (23) 7 (16) 2 (5) 7 (13) 2 (6) 
100~0 <15 14 (21) 7 (17) 3 (7) 5 (8) 5 (9) 
Karnofsky~lndex 0~100 > 90 64 (18) 71 (15) 87(13) 85 (16) 90 (5) 
~ln~d~ex~o~f-'W~e~II~~B~el~ng~~2~.1~-~14~.7~--'>-1~2----~9.~5~(2~.9~)_-'1~3.~5(~1-'.1L) __ 1,~3.2Q".0~)_1~3~.4~(2~.~3)~_1~3~.4~(2~.0) 
__ ~pecific Indicators: 
State-Trail Anxiety 
Inventory 
Self-rating Depres-
sion Scale (lung) 
Activities of dally 
life 
Physical 
complaints 
Working· activity 
(hoursfday) 
Median value 
Satisfaction with 
... hearth 
... Ieisure lime 
... dailyactivities 
... tife as a whole 
80-20 
100-25 
1-10 
10~ 1 
0-12 
5~1 
5-1 
5-1 
5-1 
~~~~~-
--------
<37 
,33 
±8 
<2.6 
<2.6 
<2.6 
<2.6 
41(11) 
50(11) 
8.7(1.7) 
5.6(2.0) 
1.9(3.0) 
0.0 
34(10) 
43(8) 
9.2(1.4) 
3.4(1.9) 
1.7(1.8) 
1.0 
29(7) 
39(5) 
9.3(1.9) 
2.6(1.9) 
3.3(2.3) 
4.0 
30(7) 
44(7) 
9.4(1.4) 
3.4(1.8) 
4.1(2.6) 
4.0 
32(5) 
43(6) 
9.8(0.6) 
2.8(1.9) 
5.0(2.5) 
5.0 
4.1(1.0) 2.2(1.1) 1.6(0.8) 1.6(1.0) 1.4(0.7) 
3.2(1.6) 2.3(1.3) 1.7(0.8) 1. 7(0.9) 1.5(0.7) 
3.1(1.5) 2.3(1.0) 1.7(0.9) 1.8(1.1) 2.0(1.0) 
3. O( 1 .1) --=2",.2,,( 1",. 2"-) _--,1",.5"(0,,,.7,-) __ .1.5(0,,,,. 8ce) _---"1.-"4 (cO 'cc5)'--1 
* paid and unpaid work (e.g., housework, study); U worst possible score on the left, best possible score on 
Ihe right 
~~~~~~~ ~~~~ 
7.4 Results 
7.4.1 Response 
Of 57 theoretically possible measurements among the 26 cross-sectional patients, 42 
(75%) were actually realized. From all of them at least one measurement was 
obtained. Fourteen measurements were missed (including 2 refusals) from 12 patients 
due to initial organizational reasons unrelated to the physical condition of the patient. 
In the longitudinal group, 22 of 26 possible pretransplant measurements (85%) were 
obtained. Impaired physical condition of three patients prevented them from patiiei-
pation. Among the 20 patients meanwhile transplanted, five died. From the survivors, 
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all 24 possible posttransplant measurements were obtained. 
A total of 88 (42+22+24) measurements was obtained from 46 patients (overall 
response rate: 82%). The number of measurements related to the time of completion 
is presented in Table 7.4.1. As for paired observations (Le., measurements obtained 
from the same patients before and after liver transplantation), 14 pre-3 months pairs 
could be obtained. 
TABLE 7.4. 1 Number of questionnair~,~~c~o~m~p~le~te~d~ ______ ~. 
2yr 
22 _-,1c:8 __ 1c:3 __ 8 
pre 3m 1yr 3yr 
5 
4yr 
3 
5yr 
4 
6yr 7yr 8yr 9yr 10yr Total 
5 __ 4'--_-'4'--_-'-_ 88 
7.4.2 Patient characteristics 
Sociodemographic and medical characteristics at the time of transplantation are 
summarized in Table 7.4.2. Only one of the interviewed patients showed clear signs 
of hepatic encephalopathy preceding liver transplantation. She completed half of the 
questionnaire with considerable as'sistallce. There was no significant difference in 
severity of disease, diagnosis, or other patient characteristics between earlier or later 
transplanted patients in the study-group; liver function of those alive at I-year follow-
up or more was good (data not shown). 
7.4.3 Quality of Li/e 
The interview results are summarized in Tables 7.3.2 and 7.4.3. The results shown in 
Table 7.3.2 represent a cross-sectional analys!s. This implies that average results of 
measurements relate to groups of partially different composition. For reasons of 
presentation the results for the cross-sectional group of patients from 2 years after 
liver transplantation onward were combined into two groups: 2-5 years after liver 
transplantation and 6 years or more after liver transplantation (including only one 
measurement per patient per follow-up group). The results of the longitudinal 
analysis are shown in Table 7.4.3. Next we addressed the question of whether 
physical complaints were related to restrictions on particular domains of quality of 
life. The severity of the self-repOlied complaints were correlated with the dimension 
scores of the Nottingham Health Profile and with the Index of Well-being. Only 
Pearson correlations (r) exceeding 0.55 are mentioned. Restrictions on the mobility 
dimension of the Nottingham Health Profile correlate most with the presence of bone 
pain (t=0.57), on the pain dimension with the presence of bone pain (t=0.61) and 
backache (t=0.67), on the energy dimension with the presence of a swollen belly 
(r~0.60), on the sleep dimension with itching (t=0.57), on the emotional reaction 
dimension with drowsiness (1~0.59). None of the complaints cOlrelated sufficiently 
witlHhe score on the social isolation dimension of the Nottingham Health Profile. A 
low Index of Well-being correlated most with the presence of drowsiness (1~0.59). 
Only three patients needed psychiatric treatment. One patient undenvent psychiatric 
consultation preoperatively because of a suicide attempt in the past. One patient 
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needed antipsychotic medication during the postoperative period. The third patient, 
who was actually transplanted for primary biliary cirrhosis, had a histOlY of alcohol 
abuse. As anxiety to move hampered her remobilization, she was prescribed anxio-
lytic medication postoperatively. 
TABLE 7.4.2 Sociodemographlc characleristics of the study population (n=46) 
Sex 
female 
male 
Educational/evel 
mInimal education 
Intermediate education 
high edUcation 
Diagnosis 
cirrhosis exel. pac 
primary billairy cirrhosis 
primary sclerosing cholangitis 
retransplantation 
other 
Chlld·Pugh classification at transplantation 
A 
B 
C 
Age (years) at transplantatlon* 
X (sd) 
~ minus 5 patients not yet transplanted 
98 
n 
31 
15 
10 
30 
6 
12 
17 
6 
2 
8 
12 
24 
10 
42.S 
% 
67 
33 
22 
65 
13 
8 
37 
13 
4 
17 
26 
52 
22 
(11.1) 
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TABLE 7.4.3 Quality of life before and 3 months after liver transplantation (n=14, longitudinal 
analysis, t-test) 
Questionnaire Waiting list 3 Months after L Tx p-value 
General Indicators: 
Nottingham Health Profile-1 
Mobility 42 27 > 0.1 
Pain 24 12 > 0.1 
Energy 73 19 0.00 
Sleep 47 16 0.D1 
Social isolation 17 8 > 0.1 
Emotional reaction 23 8 0.07 
Kamofsky Index 57 71 0.02 
Index of Well-Being 8.9 13.3 0.00 
S eeifle Indicators: 
State-Trait Anxiety Inventory 39 34 > 0.1 
Self-rating Depression Scale 51 43 0.04 
Activities of daily life 8.4 9.1 > 0.1 
Physical complaints 6.0 3.4 0.D1 
Satisfaction with 
... health 4.4 2.3 0.00 
... Ieisure time 3.7 2.4 0.02 
... daily activities 3.4 2.3 0.04 
... life as whole 3.4 2.1 0.D1 
7.5 Conclusions and discussion 
In this article preliminary results of a study assessing the influence of liver transplan-
tation on the quality of life are shown. The pretransplant state can be characterized by 
a rather low Karnofsky index, psychological distress, many physical disturbances and 
a low level of experienced well-being. Three months after transplantation patients 
show a considerable rise of the quality of life level. Further improvement in the first 
postoperative year results in a quality of life level similar to or slightly below the 
level of the general population. This level appears to stabilize in the following years. 
Evidently the very low frequency of long-term complications added to this favorable 
picture. 
Experienced well-being shows an impressive favorable change following liver 
transplantation - to a level exceeding that of the general population. A comparison 
with the NHP-scores as reported by Lowe shows close similarity of the post trans-
plant results, though comparison should be made with caution as the latter study 
combines data from patients shOltly after transplantation (43% < I year) with data of 
patients at Illore than 2 years of follow-up. 20 
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We are aware that our conclusions depend on some assumptions, especially with 
regard to the absence of a control group of nontransplanted patients and the effect of 
selective nonresponse. In this study, liver transplantation patients were used as their 
own controls. As gradual deterioriation of quality of life in the nontransplantation 
case is likely", a comparison of quality of life-values before and after liver transplan-
tation may give a conservative estimate of the positive effect of liver transplantation. 
Selective (non-) response is another threat to validity. High severity of disease 
precluded three patients, who can be expected to benefit most /i'om liver transplanta-
tion, from completing the pretransplant questionnaire. Measurements fi'om 5 post-
transplant patients were missed as a result of mortality. The overall result of this 
selective nonresponse might be a slight overestimation of average pre- and posth'ans-
plant quality of life. 
Some results deserve special attention. Firstly, the fairly good activities of daily life 
score preceding liver transplantation seems to contrast with the limited scores on 
work status and the Karnofsky index. Liver transplantation candidates are able to 
perform most daily activities independently only with great effort. Following liver 
transplantation these activities can be performed with little if any effort. 
Secondly, the scores after liver transplantation on the SDS-Zung scale for depression 
seem rather high, - i.e., in the range of Dutch nondepressive psychian'ic patients. J7 As 
reported by Smith, a high score does not necessarily mean the presence of a clinical 
depression following DSM-IlI standards." Although the SDS-Zung scale is an 
accepted and validated questionnaire for depression, its interpretation for somatic 
patients remains to be established. 
Thirdly, psychiatric morbidity occurred apparently only infrequently. The supp0l1 by 
a specialized social worker probably contributes to this favourable outcome. Surman 
reported tl'equent episodes of pre- and postoperative anxiety and depressive disorders, 
and considered psychiatric consultation an essential supp0l1 to the transplant 
program. I' 
All together these results suggest that at present liver transplantation not only 
improves survival but also brings about significant improvement in quality of life. 
These findings should be validated by a longitudinal study, for which data are being 
collected now. 
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8 
Evaluative health status measurement: an overview 
8.1 Introduction 
As explained in chapter 2, application of health status data in assessing the burden of 
illness within populations, in public health models and in the comparative (economic) 
evaluation of medical interventions implies going one step beyond mere description of 
health status.
'
.2.3 Descriptive instnnnents yield profile scores. If we are to judge 
whether one profile represents a better health status than another, i.e., if it is to be 
preferred over another, and if so, how much, a summary measure for score profiles is 
needed. Such sunllnmy figures ('values') may be obtained by means of a valuation 
procedure for health states. Once the values are available, they can be combined with 
survival data into a comprehensive outcome measure: for example, into quality 
adjusted life-years (QAL Ys) or disability adjusted life-years (DALYs).' 
The present chapter provides an overview of the current scientific state of affairs in 
evaluative health status measurement. It concerns the valuation of health states. Many 
other important issues, such as the aggregation of individual outcomes to group 
outcomes and' ethical' implications of QAL Y s are not addressed here. 
In section 8.2 the empirical three-stage procedure that is currently followed in 
evaluative health status measurement will be explained. Important choices to be made 
at each stage will be elaborated in section 8.3. In section 8.4 we will explain some of 
the consequences of this three-stage approach, which is in fact an artificial 
disaggregation of the evaluation of composite outcomes characterized by quality and 
duration of survival. In section 8.5 we will demonstrate a tentative application of health 
status values in the evaluation of liver transplantation. Conclusions and recommen-
dations for future research will be addressed in section 8.6. 
8.2 Empirical evaluative health status measurement 
The current three-stage approach to evaluative health status measurement will be 
introduced by an example. 
Assume patient X suffers from a disease that causes physical and psychosocial 
dysfunction both to a moderate degree. Assume further that without treahnent, patient 
X will live the following 2 years in the same health state. However, patient X might 
undergo an intervention that promises favourable effects with respect to both length 
and quality of life. 
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FIGURE 8.2 CUrrent empirical three-stage approach to evaluative HSM 
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The effects of the intended intervention on the outcome of patient X will be evaluated. 
Figure 8.2 shows a diagram of the three-stage approach. In stage I, the descriptive 
stage, the health status of patient X is described, for example with a two-dimensional 
system consisting of a physical dimension A with three levels (I ~best, 2~intennediate, 
3~worst) and a psychosocial dimension B with three analogous levels. Let us assume 
that patient X's health status was assessed once before the intervention and twice 
afterwards, and that these assessments resulted in the following summarized health 
state descriptions: 
before the intervention: A,B, (i.e., moderate physical and psychosocial 
functioning); 
I month after the intervention: A,B) (i.e., moderate physical and bad psychosocial 
functioning); 
6 months after the intervention: AlB, (i.e., good physical, moderate psychosocial 
functioning). 
So, the result of stage I is sunllllarized information about the health status of patient X 
before and after the intervention. In the subsequent valuation stage (II), states A,B" 
A,B) and AlB, should be valued. The health state descriptions should be in a type of 
format that enables their valuation. The subjects who perform the valuation task are 
requested to indicate, for example by means of a method called time trade-off (TTO), 
how good or how bad these three health states are, and to indicate their degree of 
undesirability. Assume the following values result from the value procedure: A,B, 
0.70, A,B, 0.40, AlB, 0.80, where 1.00 ~ 'optimal death' (,most desirable') and 0.00 ~ 
'death' ('most undesirable'). 
The values resulting from stage II are combined with life-years in stage III. If we 
asslime that health status as measured at one month after the intervention is 
representative for the first period of three months after the intervention, and that the 
third assessment is representative for the remaining 21 months of the first two years 
after the intervention, we can compute the combined outcome of health status and life-
years by simple linear weighting: 
without intervention: 2 years * . 70 ~ 1.4 QAL Y; 
with intervention: (0.25 * .40) + (1.75 * .80) ~ 1.5 QAL Y. 
The (hypothetical) intervention yields patient X a 0.1 QAL Y gain in the first two years 
after the intervention. 
The above example is a simplification of the reality. Only one patient is evaluated. No 
mortality or other lasting undesirable effects are observed. To evaluate the 
effectiveness of an intervention, a well-designed randomized clinical trial evaluating 
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groups of patients should be condncted. Both survival time and health status (until 
death) should be measured in the groups in both anns of the trial. 
With respect to empirical health status assessment there are important issues to be 
decided on in stage I, Le., the descriptive stage. These are: 
a. the domains of health status to be described and their operationalization, i.e., the 
choice of the dimensions; 
h. methods 10 summarize the health stale descriptions, so that they can be valued in 
stage II. 
Choices tQ be made in the design of the valuation study (stage II) relate to: 
c. the valuation met/we{; 
d. characteristics of presentation of the valualion task (stimulus presentation); 
e. the subjects who pel/arm the valuation task (the 'panel '); 
f analysis and modelling of the panel data, leading to a comprehensive set of values 
for all health states than can possibly be described with the descriptive system 
chosen in h. 
After the assignment of panel-based values to each individual patient's health status 
descriptions in stage II, the final process which combines patients' data on health status 
and length of life into one figure involves one more choice, Le.: 
g. whether 01' not to discount life-years 01' quality adjusted life years. 
Points a.-g. will be addressed in the next section. 
8.3 Choices to be made in the current three-stage approach of outcome 
evaluation 
a. First issue of choice: the dimensions 
It was argued in Chapter 2 that the level of decision making at which information is to 
be used, or the perspective of the research question, determines the type of measure for 
descriptive health status assessment. If a societal viewpoint is adopted, the descriptive 
measure should be generic, i.e., comprehensive and non-disease specific, Generally, 
the choice of one of the 6 generic instruments addressed in Chapter 3 is equally 
defendable from a purely descriptive viewpoint. The subsequent valuation stage, 
however, has implications for the preceding descriptive stage, as will be explained in 
the next section. 
h. Second issue of choice: methods to summarize the health slate descriptions 
Currently, health state values are often elicited by presenting a respondent with a 
description of a health state and asking him or her to rate how good or how bad that 
health state is according to his/her opinion. Health state descriptions are often 
presented as 'vignettes', see below. 
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TABLE 8.3.~xample of a heallh state description (vig"elle): EuroQol state 21221 _' __ ,_ 
Some problems in walking about (2) 
No problems with self-care (1) 
Some problems in performing usual activities (2) 
Moderate pain or discomfort (2) 
Not ,anxious or ~epressed ~ __ , ____ , ____ ,_ , ____ ,, __ '_ , ___ _ 
Descriptive measures for health status are available that provide a direct link to the 
valuation stage, e.g., the Quality of Well-being Scale (QWB), the Rosser-Kind Index 
and the EuroQol instnunent.'·6.7 A Dutch version is, as far as we know, only available 
for the latter instrument. These instnllneuts either include a formalized procedure to 
translate health state descriptions into 'judgeable' vignettes (QWB, Rosser-Kind), or 
'vignettes' are the direct result of the descriptive stage (EuroQol). 
There are two options available if a descriptive measure is used that is not directly 
linked to health state valuations (for example: SF-36, MOS20124, NHP, SIP, COOPI 
WONCA charts). The first option is to use the existing link to values of other 
instruments: the researcher 'converts' a patient's SF-36 data (or from any of the other 
measures mentioned) into the dimensions of an instrument directly linked to health 
state valuations (e.g., EuroQol). This procedure was applied in the Dutch medical 
technology assessments of heart transplantation and liver transplantation.'" The 
reliability and validity of the translation itself should be established. 
The second option involves creating a direct link to health state valuations, i.e., the 
empirical valuation of health state descriptions resulting from the SF-36 or one of the 
other instruments. To allow for this option two conditions should be satisfied. Firstly, it 
must be possible to describe the scores on a scale by a system of mutually exclusive 
levels (in other words, a - probably ordinal - classification). Secondly, the number of 
dimension statements in the health state description should not exceed, say, 6 to 
preveut cognitive overloading of the respondents. Clearly, the creation of a direct link 
to health state valuations for the 5 generic instnllHents mentioned above is a relatively 
straightforward procedure only in the case of the COOP/WONCA charts (being a 
classification instrument itself). 
c. Third issue of choice: the valualion method 
Essentially tlVO types of valnation methods are available. Direct valuation methods, 
e.g., a rating scale (RS), involve respondents being requested to attach a value to a 
given health state directly, i.e., to indicate the relative position of the state to be valued 
on a scale. Indirect methods, as represented by the standard gamble (SG) and time 
trade-off (TTO), involve deriving the value for a given health state from the amount of 
risk a subject is willing to take, or the number of life-years (s)he is willing to trade-off, 
respectively, to avoid being in the state to be valued. SG, TTO, and RS will be 
explained in more detail below. Altel11ative direct valuation methods, including 
magnitude estimation, and alternative indirect ones, including willingness-ta-pay, will 
not be addressed here. 
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The standard gamble method essentially comprises an iterative paired comparison. The 
respondent is asked to select one alternative (s)he prefers from the two offered. His/her 
choice determines which alternatives will be offered in the iteration. SG is commonly 
operationalized as the choice between being in a specified lifelong stationalY state (the 
state to be valued) on the one hand, and an intervention, for example a surgical 
procedure, with two possible outcomes, i.e., instantaneous and lasting improvement to 
perfect health (probability: p), or immediate death [probability (l-p)]. By varying p, 
the point of indifference between the two alternatives is determined. The more risk of 
immediate death the respondent is willing to take, the worse (s)he values the stationary 
state. SG is based on Von Neumann and Morgenstern's Theory of Expected Utility for 
decision-making under unceliainty." SG includes two basic characteristics, i.e., choice 
and uncertainty. 
Time trade-off was developed by Torrance as a less complicated but equally sound 
alternative for SG. The respondent is asked to trade-off length of survival and quality 
under conditions of certainty. The first alternative offers the respondent life in a 
(suboptimal) state for a fixed duration. The competing alternative offers a better health 
state (commonly optimal health) at a shorter duration. The indifference point is arrived 
at by varying the duration of optimal health. The shorter the period of optimal health 
the respoudent is willing to accept, the lower (s)he values the alternative. 
In methods which apply a rating scale, the respondent is offered a scale with labeled 
endpoints, for example 'death' and 'healthy', and asked to locate the state(s) to be 
valued on the scale. The EuroQol visual analogue scale, a thermometer with endpoints 
'0' (~ the worst imaginable health state) and' 100' (~the best imaginable health state) 
is an example ofa rating scale (see Figure 10.3.3). 
Several empirical studies aiming at comparing the results of different valuation 
methods have been reported; (see ref. 12, p.80 for a summarizing overview).11,12,J3,14,15 
An important observation is that the ordinal ranking is generally not sensitive to the 
specific valuation method. A simple transformation from values obtained by oue 
method into another is therefore theoretically possible. 
With respect to numerical comparisons of valuations resulting from different valuation 
methods, there is empirical evidence suggesting that valuations resulting from SG and 
TTO procedures are to a large extent equivalent, whereas RS valuations are not 
equivalent to SGITTO values. The relatively good health states especially are assigned 
lower values on a RS than in SGITTO. This difference can intuitively be understood 
from the differences in the tasks. In SG and TTO respondents have to face a choice 
with important (hypothetic) consequences, while rating health states directly on a RS 
requires ranking without having to consider the consequences. 
Although the results from the indirect methods are rather similar, empirical SG values 
are generally somewhat higher than ITO values. This observation is commonly 
explained by the fact that in SG risk-attitude plays a role. SG as a method to elicit 
values for health states is derived from game theOlY.'o The behaviour of subjects in 
game-theoretical studies of individuals' preferences for goods such as money may be 
explained by a general risk-attitude and time-preference. 
With respect to risk-attitude, a subject shows (by definition) risk-neutral behaviour if 
he is indifferent between a 50-50 gamble of obtaining 5 guilders or 15 guilders 
(expected utility of the gamble: 10 guilders) and a certainty of obtaining 10 guilders. If 
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the subject prefers the gamble, (s)he is risk-seeking. If (s)he prefers the certain 
outcome, (s)he is risk-averse. 
Time-preference refers to the timing of an outcome. A positive time preference 
indicates that an individual values goods higher if they are received now instead of 
later. Assume that the above example now offers a 50-50 gamble between obtaining 5 
guilders or 15 guilders now, or a certainty of obtaining 10 guilders in one week's time. 
A subject with a positive time preference will prefer the gamble, a subject with a 
negative time preference prefers the ce11ain outcome, whereas a subject without a time 
preference is indifferent. In this example, a positive time preference causes the subject 
to behave in a risk-seeking manner. Empirical evidence suggests that the risk attitude 
in SG is dependent on the context, i.e., the nature of the outcome (money or health)."'" 
When applied to preference measurement for health states, Gafni and Torrance argued 
that preference behaviour in gambles involving outcomes consisting of combinations 
of duration (L Y) and quality (Q) of survival can actually be dis aggregated into three 
effects, i.e., a quantity effect, a time-effect and a gambling effect." A gambling effect 
stands for a general fear of (or a liking for) gambles themselves. The effect may be 
dependent of the subject of the gamble. The qnantity effect refers to the diminishing 
marginal value of additional L Y*Q,. The time effect represents a preference stmcture 
determined by the timing of the health gains. In SG the health states to be valued are 
presented for a given amount of life years, so that the quantity effect and the time 
effect are reduced to a single time preference effect." This implies that a subject is 
risk-neutral in gambles with life-years if (s)he values each year of life equally and is 
neutral towards gambles. " 
Miyamoto and Eraker operationalized a parameter r which is 'interpretable as a 
representation of a patient's risk attitude with respect to survival duration'." They 
further state that: 
'An individual is risk seeking if he always prefers a gamble with e.\pectation Y to a 
certain sUI1'ival 0/ Y years. (..) For example, if/aced with a choice between a certain 
survival 0/6 years and a 50-50 gamble that yields either a 2-year survival 01' 10-yeal' 
survival, a risk-averse individual would prefer the certain sUJ11ival of 6 years, a risk-
seeking individual would pre/el' the 50-50 gamble, and a risk-neutral individual would 
regard the certain option and the gamble to be equally desirable (01' undesirable)' (ref 
19, p. 193). 
Following this operationalization, a risk-averse (r < 1.0) individual values years in the 
near future higher than years that are further away in the future, while a risk-seeking 
individual (r > 1.0) values later years more highly than years in the near future (ref. 19, 
fig I). In other words, an individual that is risk-averse with respect to sUl'vival duration 
shows a positive time preference. Clearly, Miyamoto & Eraker's parameter r does not 
disentangle the gambling effect and the time preference effect, as was recognized by 
Stiggelbout et al." 
Miyamoto & Eraker proposed the method of certainty equivalents to estimate 
parameter r. If r < 1.0, indicating risk aversion with respect to gambles with life years, 
values elicited by SG are higher than those elicited by TTO. Adjustment ofTTO values 
by r decreased the differences with SG both when the evaluators were students and 
patients. 12 ,1J,19 
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The observation that individuals may exhibit risk-averse or risk-seeking behaviour 
shows that they do not behave according to the axioms of expected utility theory. 
Kahneman & Tversky's Prospect theory may offer an explanation for the attitude 
towards risk in general; it argues that relative to a (hypothetical) individual reference 
point, outcomes are viewed as gains or losses, and risk attitudes vary depending on 
whether the outcome is seen as a gain or a 10ss.20 A study by Verhoefet al. showed that 
the subjects were not risk-neutral with regard to life years.,,·n Regret theory, 
suggesting that people may regret in the decisions they make, thus losing more utility 
than predicted by the expected utility approach, may offer an alternative explanation 
for general risk-attitude." 
d. Fourth issue of choice: stlinu/us presentation 
Valuations of health states may be affected by the way the valuation task is presented 
to the raters, irrespective of the valuation method. The following heterogenous group 
of issues will be treated under this heading: 
Attributes of the 'vignettes': e.g., disease-labels, duration, prognosis. 
Alternatives to the 'vignette' mode of presentation of health states; for example, a 
multimedia presentation. 
Method of assessment: interview, paper-and-pencil, etc. 
Contextual effects: influence of presence of other states ('setting'). 
'Framing' effects. 
Empirical evidence suggests that the addition of a disease !abel to the health state to be 
valued alters preferences."'" We agree with the argument of Froberg & Kane that the 
addition of a disease label has the effect of providing more information for the subjects 
carrying out the valuation task." Moreover, any labeling might convey negative 
connotations, e.g., about the duration and prognosis of a state, which might have an 
impact on the values. For example, it was shown that the use of the word 'cancer' 
negatively influenced subjects' valuations." 
Implicit or explicit statements about the duration of health states may be assumed to 
affect the values attached, even without taking into account the preceding state 
(his/O/y) and the state to follow (prognosi,). 'Health is unlike the usual outcomes 
studied in economics or decision theory. One reason is that the health of an individual 
has a time aspect inextricably bound to it.'" Sutherland et al. postulated the concept of 
'maximal endurable time'." They reported empirical evidence that attitudes of health 
professionals towards survival strongly depended both on the amount of time to be 
spent in a hypothetical health state and on the quality of the state. Subjects appeared to 
identify a personal variable, the maximal endurable time in a given state. When this 
time was exceeded, attitudes toward additional increments of survival changed 
dramatically. Recent data fi'om YorkJO sUPPOlted this hypothesis: the longer a bad state 
lasts, the more intolerable it becomes and the lower the valuation assigned to that state. 
Duration and prognosis interact conceptually: a long duration of a bad state implies a 
bad prognosis, while a long duration of a good state implies a good prognosis. Kaplan 
et al. argued that prognosis of a state consists of the probabilities of transitions across 
function levels over time - in effect, the expected duration of a function level." 
However, the authors treat the state to be valued, its duration and the following state as 
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independent factors, i.e., without taking the possible interaction effects with respect to 
the valuation into account.3Z 
Several studies have examined whether preferences shift due to the mode of 
presentation of the health states, for example written scenarios referring to laryngeal 
cancer patients compared with written scenarios plus a voice recording (Boyd 1982; 
cited in ref. 26); written outlines of scenarios compared with narrative style"; and a 
multimedia (computer screen + voice) presentation compared with narrative text." In 
the latter study, the mean ratings for the two presentation modes were similar, but 
subjects who were presented with the multimedia description showed better processing 
of the information (indicated by better recall and better recognition). We consider that 
in general alternatives of 'vignette' presentation may inform the subjects performing 
the valuation task about the reality of the health state. Careful design of the 
presentation should prevent unintended subjective connotations similar to the situation 
as described above in relation to 'disease labels'. 
Froberg and Kane cite one study showing that preferences were not significantly 
influenced by two assessment methods, i.e., the lise of a computer compared with paper 
and pencil techniques." There is some experience with methods other than inter-
viewing in the context of the valuation of health states. One of the first studies with the 
EuroQol instrument [using a visual analogue scale (VAS)] dealt with the feasibility of 
collecting values elicited from a rating scale without outside assistance in a postal 
survey (see Chapter 9). The complexity of SO and TTO may preclude reliable and 
valid application without assistance. Collective evaluation of health states with SO and 
TTO with the help of slide presentation and a presenter in front of the floor appeared to 
be feasible in a group of students." 
Direct valuation methods commonly present the subject who performs the valuation 
task with a number of states simultaneously. For example, the EuroQol V AS presents 8 
health states on one page of the valuation questionnaire, of which 4 are located on the 
left of a vel1ical VAS and the other 4 on the right, see Figll1'e 10.3.3. We define 
contextllal effects as the effects that the group of states as a part of which a state is 
presented (e.g., predominantly rather bad states, or predominantly rather good ones) 
might have on the rating assigned to that state. Such effects could not be shown in two 
experiments using categOlY rating by Kaplan & Ernst (provided the endpoints of the 
scale are clearly defined)" nor in EuroQol V AS-data." 
Inconsistencies in valuations for health states which arise when the same objective 
alternatives are viewed in relation to different points of reference are called 'ji'Glning 
effects'.38 For example, respondents appear to show different preferences, depending 
on whether the celiain outcome alternative in a gambling situation is presented as a 
gain or as a loss. In evaluative health status measurement, framing effects may occur 
(along with others) from differences in outcome descriptions and from a change in the 
anchoring (or reference) points. 
With respect to outcome descriptions, McNeil et al. found that the attractiveness of 
surgelY for lung cancer, relative to radiation therapy, was substantially greater when 
the information consisted of life expectancy rather than information regarding 
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cumulative probability of survival, and when the problem was framed in terms of 
probability of living rather than in terms of the probability of dying." 
Empirical evidence suggests that both values elicited from rating scales" and values 
obtained with a standard gamble" alter with a change of the reference points. In the 
study by Sutherland, the ordinal ranking of the states was insensitive of different 
anchoring points. However, only a limited number (5) of states was valued. Values 
obtained by SOs in which one or both endpoints are replaced by any other health state 
can be rescaled so that they become comparable to values obtained with conventional 
SOs provided that the ranking of states remains unaffected, and provided that values 
for the alternative anchoring states are available. 14 
Froberg and Kane advocate helping the rater as much as possible and thus correcting 
the inconsistencies that occur as a result of limitations in human judgment, such as 
when the framing of a decision problem influences the rater's reference pain!." 
e. Fijlh issue of choice: the subjects who pelf arm the valualion task 
It was argued in chapter 2 that the perspective from which a study is conducted 
determines conceptually whose values are the most appropriate to use. In studies from 
the patient group perspective the values of representatives of those patients are 
appropriate. If the health care policy perspective is adopted in a study, the values 
should represent the societal view. The latter is commonly operationalized by using the 
values of a representative sample (including patients and persons who have experience 
of bad health states) of the general population. If different groups in the general 
population, for example patients and healthy subjects, could be shown to hold different 
value patterns with respect to health states, the consequential question is how to 
aggregate those values to values reflecting the viewpoint of society. 
With respect to the degree to which health status values are being affected by personal 
characteristics of the subjects who perform the valuation task Froberg & Kane 
conclude in their 1989 review" that the generally observed large inter-subject variation 
can only to a minor extent be explained by demographic characteristics (e.g., gender, 
age, education). The literature on rater differences suggests that only the rater's age 
and hislher experience of the health state being rated, respectively, may influence 
raters' valuations although even the evidence with respect to these variables is patchy." 
For example, close agreement was found between weights for rating states as defined 
by the Quality of Well-being Scale obtained from the general population and from 
rheumatoid arthritic patients. 4J 
It may be the case that that an effect of age on valuations of health states is in fact 
partly an effect of experience of suboptimal health states, because the probability of 
experience of states of illness increases with age. Previous experience of illness 
(affecting oneself, close relatives 01' friends, or subjects encountered professionally) 
probably makes the rater more aware of what bad states are actuaily like. Additionally, 
actuaily being in a state should be distinguished fi'om past experience. Often patients in 
a state rate their own health state higher than healthy controls" or their proxies." An 
interesting question is how such patients rate other states, both those that are better and 
worse than their own.46 
We are not aware of any studies on the influence of personality characteristics, 
including, for example, neuroticism or coping style, on values of health states. 
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f Sixth issue of choice: analysis and modelling of the value data elicited Fom a panel 
The issue of aggregation of health state values from different respondents for one 
particular health state has been tOllched lipan already in the preceding section. For 
'common' data the choice of a measure of central tendency (mode, median, mean) 
depends on the level of measurement (nominal, ordinal, interval/ratio), aud, to a lesser 
extent, the distribution of the data. In skewed distributions, the mean is sensitive for 
outliers, whereas the median is not. When aggregating the values attached to a health 
state by the members of a panel performing the valuation task the choice of a measure 
of central tendency is also a political one. I f it is desirable to take values that deviate 
strongly from the majority into account, the mean is the appropriate measure of central 
tendency. If the majority mle of a voting procedure is applied, the median or even the 
mode would be more appropriate. 
Ideally, empirical values should be available for all health state descriptions that can be 
constmcted with a particular set of dimensions and categories. For example, the 5-
dimensional, 3-level EuroQol allows for 243 (3') possible states. Due to the complexity 
and the cost of the task of obtaining empirical valuations, often only a limited number 
of these can be valued empirically. For example, the standard EuroQol valuation 
questionnaire, of which one page is shown in Figure 10.3.3, contains 13 states. This 
implies that a valid predictive model for the values for the empirically untouched states 
should be developed. Of course valid modelling needs empirical values for more than 
131243 = 5% of the states. 
Often, empirical values are collected by using rating scales for reasons of feasibility 
(e.g., a rating scale being easier to understand and less time consuming than the 
indirect methods, thus allowing for a larger number of states to be valued per subject). 
Results from an as yet unpublished study by Krabbe et al also showed a V AS to be 
more reliable than either SO or TTO, at least among students. Several authors argue 
that TTO values are more valid than V AS values for use in econom ic outcome 
evaluation."·47.48,49 We think that in studies conducted from a societal viewpoint, the 
use of TTO values is more valid than the use of SO values, because at the aggregate 
level no unce11ainty exists about the occurrence of different possible outcomes. 
V AS values may be simply transformed into TTO values, provided that the ranking of 
the states is identical. Several authors suggest an exponential relation between VAS 
and TTO."·J2 
TTO = I-(I-VAS)'. 
The value of the exponent x is 1.61 in Torrance's model, 2.12 in Busschbach's model 
and 2.32 in Krabbe's model (unpublished). The fact that Torrance's subjects 
performing the valuation task were selected from the general population, while 
Busschbach and Krabbe used students, may offer an explanation for the different 
values ofx. 
Theoretically, TTO values can be transformed to SO values, for example by empirical 
determination and application of Miyamoto & Eraker's exponent l' (see section c.). If it 
is agreed that for decision-making at the aggregate level TTO values are more valid 
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than SO values, transformation ofTIO values to SO values may only be considered in 
supporting the decision-making process at an individual patient's level. 
g. Seventh issue of choice: to discount or nol to discount? 
The steps described in the preceding sections result in a set of values for different 
health states. In the processing into QALYs, these values are combined with the 
durations of the states by simple linear weighting. 
There is general agreement that in cost-effectiveness analysis costs should be 
discounted (i.e., future costs are valued as less important than costs to be made now). 
The rationale for discounting costs can be explained from the concept of time 
preference (see section c.) or from the concept of opportunity cost (if we have to spend 
money on a health care programme now we cannot spend the money on alternative 
activities). The discount rate is subject to debate. For reasons of comparability it is 
recommended to use a discount rate (r) of 5%, to perform sensitivity analysis and to 
always present results from the r ~ 0% variant. A detailed account on the discounting 
of future costs goes beyond the subjects of this thesis. 
There has been considerable debate as to whether health effects should also be 
discounted. It has been argued that if costs are discounted, not discounting health 
benefits may lead to irrational or absurd consequences." The time paradox of Cretin 
and Keeler implies that under the application of a lower (or zero) discount rate for 
health benefits than costs, every health programme can appear more cost-effective 
simply by delaying it." 
Discounting QALYs may result in double (dis)counting." That is because, as 
addressed above in section c. (and see also section 8.4 below), in current methods of 
eliciting health state values (SO, TIO) time preference of individuals already plays a 
role. The magnitude of the error introduced by double discounting will depend on 
numerous factors, including the time frame used in utility assessment (the effect will be 
small if a short time frame is used)." The removal of the time preference effects from 
current valuation methods is not simple. Lipscomb suggested a method (called scenario 
strategy) enabling estimation of the magnitude of several effects (including time 
preference) on SO values, thus theoretically providing the opportunity to remove time 
preference effects from the quality weights preceding QAL Y calculations." We are not 
aware of any application of this complicated method other than the study presented by 
Lipscomb that included valuation by 'undergraduate students taking a course in 
decision analysis'. Oafni argued recently that individuals' responses to time preference 
questions regarding health states are inevitably compounded by other effects that 
cannot be easily isolated, one of those being the sequence effect (see section 8.4)." 
Redelmeier et al. showed in a descriptive study that time preferences towards 
hypothetical health states vary widely among individuals, and that within individuals 
the discount rate is not constant over time and also depends on the type of health 
state. 53 
Despite the evidence that time preferences in individual choice behaviour cannot be 
described by a uniform discount rate, there are arguments to adhere to the current 
practice of discounting health benefits in cost-effectiveness analyses. 4.54.55 It is 
important to keep the perspective of a study in mind. If the study is conducted from a 
societal perspective, the use of average individual discount rates for health states (often 
estimated to lie between 2% and 10%) is appropriate and sensitivity analysis should 
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determine how important the disconnt rate is to the results. In estimating the Global 
Burden of Disease a low positive discount rate of 3% was chosen for the calculation of 
Disability Adjusted Life Years.' A study from a patient's perspective requires an 
explicit elucidation of time preferences of the patients involved. 56 
8.4 The consequences of disaggregation of the outcome tree 
In the preceding sections the current three-stage approach to evaluating outcomes has 
been explained. Outcomes are considered to be characterizable by duration and quality 
of survival, operationalized as life years and health status. In the current 
operationalization of the QAL Y 01' QAL Y type concept, health states are separated 
from their duration in the valuation stage. This procedure is actually a disaggregation 
of reality, as will be illustrated below. After that, some of the consequences of the 
disaggregation will be addressed. 
Comprehensive outcome measurement implies description and evaluation of the 
complete 'outcome space'. The outcome-space of a disease or of an intervention 
consists of mUltiple branches, each of them in the most complicated (often occurring) 
case consisting of a different number of life-years characterized by different health 
states occurring in different sequences, see Figure 8.4.!. Each branch is further 
characterized by a probability, which is on the aggregate level reflected by a frequency 
of occurrence. 
When comparing the effects of diseases or interventions, essentially the complete 
outcome tree of each treatment option should be valued. If data scarcity did not prevent 
us from doing so, cognitive overloading of respondents would. 
Consequentially, in the current operationalization of the QAL Y concept the outcome 
space was dis aggregated for practical reasons. Health status is regarded separately from 
its duration in the valuation stage. Games such as SG and TIO are played in an attempt 
to obtain 'timeless' health status values. Subsequently these health status values meet 
their duration again in a procedure of combining life years and health status effects in 
each separate branch of the outcome tree. Then, quality adjusted life-years are 
discounted. The value of the outcome space is a weighted average of the number of 
discounted QALYs per branch. Some of the problems arising from this disaggregated 
approach are discussed below. 
Firstly, a procedure where the quality of survival is valued without taking the duration 
into account assumes mlltualutility independence oj life-years and health statlls. This 
implies among other things that the duration of a health state should not affect the 
value of the health state, which assumption is generally not satisfied, for example if the 
existence ofa 'maximal endurable time' concept is replicated (see section 8.3.d). 
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FIGURE 8.4.1 Example of an outcome-tree 
Treatment AI 
Disease X 
Treatment B\ 
A3 ====== 
length of branch", duration 
height", health status 
best health state 
moderate health state 
1+:»<>1 worst health state 
Secondly, implicit lillie preferences continue to affect the values resulting from TIO 
and SO in spite of attempts to obtain timeless values. The TIO approach seems 
attractive, because quality is traded-off against duration and the resulting value is 
dimensionless. However, the time-unit used to elicit TIO values can be expected to 
affect the results. Ifa subject is requested, for example, to choose between 10 days in a 
state (followed by death) and less than 10 days in perfect health, (s)he will be likely to 
choose the ten days unless the state to be valued is so bad that a length of 10 days 
exceeds its 'maximal endurable time'. TTO in days leads to an unwillingness to trade-
off any length of remaining life. This situation is similar to SO if the gamble includes a 
risk of immediate death, and subjects are thus asked to risk the loss of life-years in the 
very near future. 
TTO tasks are often phrased in terms of an age-adjusted life expectancy; e.g., subjects 
in their thiliies are presented with a life expectancy of, e.g., 40 years, whereas subjects 
aged 60 are confronted with, e.g., 15 years. The problem with this approach is that the 
younger subjects can be expected to trade-off more readily those far-away years at the 
expected end of their lives in order to avoid less-than-optimal health now. This 
problem is not solved by offering younger and older subjects similar time periods of, 
say, 10 years, as in that case younger subjects may be expected to be unwilling to 
trade-off any of those ten years because they want to live at least 10 years (to a large 
extent irrespective of the quality of those years), because, for example, they have 
young children to raise. Stiggelbout et al suggested obtaining information about the 
effect of time preference on TTO scores by repeating the TTO for various periods of 
time. JJ Johanneson et al. suggested deriving the QAL Y weights from TIO by dividing 
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the number of discounted life years in full health by the number of discounted life 
years in the assessed health states." In any case, the validity of the assumption of 
constant proportional trade-off (Le., the loss of I year to a 5-year life span is equivalent 
to a loss of 10 years from a 50-years lifespan) may be doubted, as was also indicated 
by Kiebert et al. 16 
Direct rating by means of a rating scale also requires a statement of length. In the 
EuroQol V AS valuation questionnaire, respondents are instlUcted to imagine that the 
duration of each state to be valued is one year, while what happens afterwards is not 
known and should not be taken into account. Empirical evidence suggested that a 
majority of a group of 100 students performing the valuation task did not use this 
information in the subsequent valuation task. 12." However, the values resulting from 
the EuroQol questionnaire essentially hold for a duration of one year. 
Thirdly, preferences for sequences of outcomes are not taken into account by the 
disaggregated operationalization of the QAL Y concept. A health state is valued in 
isolation. The validity of the assumption that the value of a state is independent of 
history and prognosis may be doubted. For example, a bad state may be tolerable for 
one day with the expectation of complete recovery and a better health state afterwards, 
whereas the same state lasting two months and a prognosis of gradual deterioration 
may be valued as worse than death. 
The type of problems expected to occur when separate health states are valued instead 
of sequences will be illustrated by an example (see Figure 8.4.2). 
Assume patient Y with health status AIB2 and patient Z with health status A2B, (the 
two-dimensional instrument is the same as in the example in section 8.2). The 
preference can be established easily: Y's health status is dominant over Z's. 
Assume Y's and Z's health status to develop over time. At a second assessment, Y's 
health status is still AIB2, but Z's is AIBI. At the second assessment, Z's health status is 
dominant over Y's. However, if we look at the course of health status, Y is in a 
stationary state, while Z has improved. Although it is easy to choose whose health 
status is better at each point of assessment, a preference for one of the scenarios is not 
straightforward. Evidently, more assessments over time may complicate the compa-
rison even further. 
Apart from the fact that sequences of outcomes are disregarded, the (dis)utility of a 
change is not valued either: changes are assullled to occur instantaneously and without 
burden. 
The solution proposed by Mehrez & Gafni to overcome some of the problems 
addressed in this section (Le., the Healthy Years Equivalents) has recently been shown 
to suffer from similar deficits as the conventional QAL Y approach."·"·60 
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FIGURE 8.4.2 Different sequences of outcomes 
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8.5 A tentative application of health status values III the MTA of liver 
transplantation 
The health status effects of liver transplantation can be demonstrated by the application 
of health status values. The data presented result from the study as described in chapter 
7, supplemented with data from the extension of the project until 1991.9•61 
In the first stage actual patients' health states, occurring before and at regular intervals 
after liver transplantation, were described using, among other instruments, the 
Nottingham Health Profile, see Table 8.5.1 [NHP scores range from 0 (= best possible 
score) to 100; general population norms < 15 for all dimensions]. 
TABLE 8.5.1 Nottingham Health Profile scores (mean (s.d.)) before and after liver transplantation 
(LTx) 
NHP Waiting list 3 months post L Tx 1 year post L TX 
n = 43 n = 31 n = 25 
Mobility 36 (29) 27 (25) 15 (27) 
Pain 19 (27) 12(19) 5 (20) 
Energy 68 (40) 21 (30) 5 (15) 
Sleep 43 (36) 17 (23) 14 (22) 
Social Isolation 19 (23) 8 (16) 9 (21) 
Emotional Reaction 
L .. 
21 (23) 8 (17) 4 (9) 
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After LTx, the health status of patients as measured by the NHP showed an 
improvement. The question is how much improvement? A second problem is that 
these 6-dimensional profile scores cannot easily be combined with life years into one 
outcome measure. Therefore, a measure is needed that summarizes each profile score 
into one figure. These summary figures should rellect the values of the respective 
health states from a societal viewpoint, as the liver transplantation study was a 
comprehensive MTA. 
In the liver transplantation case, the procedure consisted of the foll.owing steps: 
I. Recoding of the patients' NHP-scores at relevant assessl)1ent points into 
descriptions according to the dimensions of the EuroQol operationalization of 
health status. 
2. Linking these health state descriptions to health state valuations Ii-om a sample of 
the general population, as collected using the standard EuroQol visual analogue 
scale (V AS). 
3. Transformation of V AS values to TTO values: TTO ~ 1-(1 -VAS)'. 
4. Sensitivity analysis for values ofx. 
5. Combination with life years gained into QAL Ys. 
Steps I. to 5. are illustrated below. 
I. Recoding NHP into ElIroQol. The recoding of NHP-scores into descriptive 
EuroQol scores was necessary here because the patients did not complete the 
EuroQol descriptive instillment themselves. The prototype of the EuroQol 
instrument became available only after the start of the datacollection in the liver 
transplantation study. In present studies, this recoding step is not required. The 
EuroQol system of dimensions of health status (see Table 10.3.2) consists of 5 
dimensions (labeled Mobility, Self-care, Usual Activities, Pain/discomfort and 
Mood, respectively) with 3 ordered categories (I ~no problems, 2~some problems, 
3~extreme problems/unable to) each. Theoretically, 3' (~243) health state descrip-
tions are possible. 
The patients' responses to the NHP were used to recode each patient's health state 
at the relevant assessment points into the EuroQol dimensions. 
2. Linking descriptions to VAS vollies. Empirical values from a general population 
sample are available for 25 of the 243 EuroQol health states. These values were 
obtained by using the standard EuroQol Visual Analogue Scale (VAS) in a postal 
survey, (see Chapter 10). The endpoints of this VAS are 0 (~ the worst imaginable 
health state) and 100 (~the best imaginable health state). Values for the remaining 
states were tentatively modelled." 
3. Trans/orlllation 0/ VAS values to TTO values. V AS values are relatively easy to 
obtain. Time trade-off (TIO) is more difficult to operationalize, but several authors 
argue that TTO values are more valid for use in QALY calculations."·47.48." 
4. Sensitivity analysis /01' vollies a/the exponent x. Varying the exponent x may be 
regarded as a sensitivity analysis of the results for the valuation method employed. 
It is also necessary because the 'right' value of x has not been established (see 
section 8.3.1). 
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Table 8.5.2 shows the median values before (in the column x ~ 1.00) and after the 
exponential transformation (for a number of levels of x) of the health states 
observed before and at three moments after LTx. 
TABLE 8.5.2 Median transformed (TIO = 1-(1-VAS)'j values for health states observed before and 
________ ~a~ft=erLTx 
Waiting list 
3 months post L Tx 
1 year post L Tx 
x=.80 
.43 
.56 
.69 
x=1.00 
.51 
.64 
.77 
x=1.25 
.59 
.72 
.84 
x=1.50 
.66 
.78 
.89 
x=2.00 x=2.25 x=2.50 
.76 .80 .83 
.87 .90 .92 
.95 __ ... 9"'6 __ --'.97 
From the results presented in Table 8.5.2 we may conclude that there is an 
important health status improvement after L Tx (from waiting list to I year after 
L Tx), the size of which may be estimated in a range between 0.14 - 0.26 on a O-to-I 
scale. 
5. Combination of health status vailles with life years. Values for health states can be 
combined with the duration of those states. In the MTA of liver transplantation, the 
mean number of life years gained was estimated to be 3.8 (study horizon 10 years, 
5% discount rate) and 7.6 (study horizon 25 years, 5% discount rate). When these 
life years gained were combined with estimates for the values for the health states 
by using VAS values after an exponential transformation as described above (using 
Torrance's value of the exponent), the mean numbers of QAL Y s gained were 3.5 
and 6.9, respectively,9,61 
8.6 Conclusions and recommendations 
In this chapter we explained the current three-stage operationalization of the QAL Y 
concept, consisting of descriptive health status assessment, followed by a second stage 
in which health states are valued and a third stage consisting of combining life years 
with these quality estimates. We also showed SOllle of the consequences of the 
disaggregation of the outcome tree, in which length and quality of survival are 
regarded separately during the valuation stage. However, despite its limitations, a 
demonstrable superior alternative to the existing operationalization of the QAL Y 
concept has still to be developed. 
'But please do not be discouraged. Our experience is that ill practice these 
measurements are not as onerous as they may at first appear. And our conviction is 
that for quality economic appraisals these measurements are often essential - for it is 
far better to have an approximate measure a/the right/aclors than a precise measure 
of the wrong alles, '3 
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Further research is urgently needed especially on the following topics: 
I. The role of 'time' in evaluative health status assessment. The problems occurring in 
the current approach of eliciting 'timeless' values of health states and the 
subsequent recombination with life-years can not easily be solved. In the valuation 
of outcome, length of survival,' its quality, and the sequence of states are essentially 
inseparable. Ceasing to attempt to obtain timeless values, as they are essentially 
non-existent, might be a step in the right direction. 
2. Population subgroups showing systematically different valuation patterns. If such 
subgroups cannot be shown to exist, the aggregation problem mentioned above in 
section 8.3.e. does not exist. We think that 'experience of bad health states' (past 
and/or present; in self, in close relatives/friends or professionally) is the only factor 
which might have a relevant effect on health state values. If population subgroups 
are shown to hold different value patterns with respect to health states, the 
consequential question is how to aggregate these values. 
3. Modelling the valuation space. The claim of a 'direct' link of EuroQol health state 
descriptions to values should be interpreted with caution. Only a limited number of 
the theoretically possible states have been valued empirically, while adequate 
modelling of values of the remaining states is still a technical challenge. 
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Valuation of health states by the general public: feasibility 
of a standardized measurement procedure (the Bergen op 
Zoom survey) 
Originally published as: 
Essink-Bot ML, Bonsei GJ, Van del' Maas PJ. Valuation of health states by the 
general pUblic: feasibility of a standardized measurement procedure. Soc Sci Med 
J 990; 3 J (J J): J 201-1206. Reprinted with permission from Elsevier Science Ltd. 
9.1 Abstract 
In the context of an international collaborative study (the EuroQol enterprise) we 
tested the feasibility of a procedure to measure valuations of health states in the Dutch 
general population. A postal questionnaire was sent to a random sample of 200 
households in a town in the Netherlands (± 50,000 inh.). Respondents were requested 
to value 14 six-dimensional health states by means of visual analogue scaling (VAS). 
The response was considered as satisfactOlY (57%) given the demanding task and the 
response-rates to postal questionnaires generally observed in the Netherlands. 
However, about a fifth of those willing to complete the questionnaire did not manage 
to use a VAS to express their opinion. Inconsistent answers were relatively rare. 
Generally consensus existed with regard to relative (ranking) and absolute values of 
different health states. These first results have encouraged us continue with the 
development of this international instrument for the valuation of health states. 
9,2 Introduction 
Cost-effectiveness analysis and cost-utility analysis have currently been recognized as 
sources of information for decisions about the incorporation of new medical technolo-
gies in health insurance schemes,l,2 For example, governmental decisions about the 
reimbursement of heart transplantation in the United States, the United Kingdom and 
the Netherlands were taken using the resuits of national studies on the costs and 
effects of this intervention,J,4,5 Despite a growing interest in the measurement of costs 
and effects of health care intervention programmes, published studies continue to 
display large disparities with respect to concepts and operational design, especially in 
the measurement of effectiveness. 1,6 
In cost-utility analysis, effects on length of life and on health status are represented in 
a composite measure, e.g., quality adjusted life years (QAL Ys). One of the strategies 
to obtain values that can be used to combine life years and quality is empirical 
measurement of valuations of health states.' The operational designs of various 
empirical techniques to determine the quality adjustment index show many differen-
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ces. This is to some extent undesirable. The application of different descriptive 
systems and different operationalizations of valuation methods limit the possibility to 
benefit from methodological studies conducted by others elsewhere, especially in the 
judgement of aspects of validity.' This hampers the progress and development of the 
resal'ch field. Furthermore, it leads to incomparability of results of cost-utility 
analyses of different intervention programmes, thus precluding the intended use of 
this information in setting priorities among interventions by governments, health 
insurance companies and others. 
Following an initiative by Professor Alan Williams (York) in 1987, several European 
research groups combined their research efforts to form the EuroQol Group, with two 
principal aims: firstly, the development of a 'common core' of methods and practical 
devices to measure health state valuations, and secondly, the establishment of a 
common set of data collected with this 'common core' instrument in different 
European countries. Details on the aims and the development of this research group 
were published elsewhere.' Based on the shared experience and on the results of pilot 
studies, consensus was reached about a prototype of a common instrument to measure 
valuations on health states in 1988. An international pilot study using this measuring 
instrument has been conducted since. 
This article describes the results of the Dutch contribution of the international pilot 
study and addresses the following questions: 
1. Is the proposed procedure for measuring valuations on health states feasible for 
large scale surveys? Feasibility in this context should include the following 
aspects: 
The feasibility of valuing complex multi-dimensional health-state descriptions. 
The feasibility of the valuation of health states by the general public, as 
opposed to students or well-educated convenience samples.'·lO 
The feasibility of the valuation of health states by means of a postal question-
naire, as opposed to the more commonly used interviewer~sllpported designs,10 
2. What are the actual values of health states, that range from the health state of, for 
example, heati transplantation candidates to that of the healthy popUlation? 
3 Is there sufficient consensus among respondents with respect to valuations of 
health states to justify future research to be directed at application of the results in 
cost-utility analysis? 
Questions relating to the influence of background variables (including nationality) on 
the valuations of health states, validity of the measurement procedure and use of the 
results in cost-utility analYSis will be addressed more extensively in later papers, 
combining the results of several national studies. 
9.3 Methods 
9,3. J Evaluative health status measurement 
A procedure to empirical evaluative health status measurement consists of three 
consecutive steps: 
I. descriptive health status measurement of the target population, usually patients; 
2. valuation of the resulting health state descriptions by subjects who represent, for 
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example, the general public, experts or patients; 
3. combination of the health state valuations with survival data, for example into 
QALYs. 
9.3.2 The concepl o/heallh used 
In the operationalization of health status, a multidimensional approach was adopted in 
order to take the complexity of the concept of health into account. A 6-dimensional 
(6D) concept of health status was agreed. This is opposite to, for example, the 
approach of Rosser and Kind who used a two-dimensional operationalization of 
health status, i.e., disability and distress." The choice of dimensions was guided by a 
careful review of existing descriptive health status measures such as the Nottingham 
Health Profile and the Sickness Impact Profile, and of the operationalizations of 
health status used by Patrick and Bush and by Rosser & Kind respectively.'·lO.l2.]) 
Each dimension was divided into levels or categories. Each level represents a 
different degree of difficulty with respect to that specific dimension. Three dimen-
sions were divided into three categories, the other three into two categories, see Table 
9.3.2.1. Thus a complete health-state description or 'vignette' consists of six state-
ments ('items'). Theoretically this set of dimensions and items allows for 216 (23 x 
33) permutations. Each possible vignette can be characterized by a string representing 
the item-levels per dimension, '1' representing the optimal categOlY, '2' and '3' 
representing the intermediate and worst categories, respectively, in the case of a 
dimension divided in 3 categories. The Figure '2' represents the worst category in the 
case of a dimension divided in 2 categories. An example of vignette is shown in Table 
9.3.2.2. 
9.3.3 The EuroQol valuation questionnaire 
A questionnaire was developed for the valuation of health-state descriptions (step 2 of 
the procedure mentioned above) by members of the general public. 
The EUl'OQol Group selected a standard set of thirteen health state descriptions to be 
valued in the questionnaire. The state of 'being dead' was added,I4 Two states were 
presented twice. This resulted in sixteen vignettes. . 
The vignettes were presented in boxes on 2 pages of the questionnaire. Four boxes 
were placed on either side of a Vetiically placed visual analogue scale (V AS) in a 
random sequence. The endpoints of the VAS were marked with the words 'worst 
imaginable health state' (0) and 'best imaginable health state' (100). No additional 
information about the interpretation of the scale was added. Respondents were asked 
to indicate how good or how bad each state was to them by drawing a line from each 
box to the thermometer. The duration of each state was stated to be I year; what 
happens afterwards was stated not to be known. A detailed instl1lction paragraph was 
added, including an illustration of the valuation method using a non health-related 
example. The lay-out of the questionnaire was carefully designed. 
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TABLE9,3.2.1 Dimensions of the Euroqol health concept (60) 
Mobility (3 levels) 
Daily activities and self care (3 levels) 
Working performance (2 levels) 
Family and leisure performance (2 levels) 
Pain/discomfort (3 levels) 
Mood (2 levels) 
TABLE 9.3.2.2Example of a vignette:~EuroQol state 112.2",3,"2~ ___ _ 
No problems in walking about (level 1) 
No problems with self-care (level 1 ) 
Unable to perform main activity (level 2) 
Unable to pursue familylleisure activities (level 2) 
Extreme pain or discomfort (level 3) 
Anxious or de~r~~sed (level 2) 
The main task of rating the health-state descriptions in the boxes on the VAS was 
preceded by the task of classifying and rating the 'own health state' of the respondent. 
Questions about bakground characteristics that might influence the rating of health 
states (including age, educational level, experience with illness, own state of health) 
were presented at the end of the questionnaire. 
9.3.4 The sample 
The questionnaire was mailed to a random sample (n~200) of the general population 
in December 1988, followed by a reminder two weeks later. Sampling was based on 
postal codes. 
9.4 Results 
Responses were obtained from 112 persons. The response rate (excluding 4 deceased 
persons) was 57%, assuming all addresses were correct, which is probably optimistic. 
Background data on the respondents are shown in Table 9.4.1. Comparison with data 
relating to the population that was sampled for the study showed some differences in 
age- and sex distribution. The relative overrepresentation of men among the respon-
dents may be due to the method of sampling, as the questionnaire was directed at the 
administrative head of each household. 
Five respondents returned their questionnaire blank. Twenty-one subjects (20%) of 
the remaining 107 clearly had not understood the task, i.e., the use of a VAS to 
express their opinion. This response was chiefly found among the older and less 
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educated respondents (Chi-square: age (2 strata) p~0.003, education p~O.OOI). These 
respondents were left out of flUiher analysis. Five of the remaining 86 completed only 
one of the two pages on which the valuation task was presented, ovelily because they 
thought the second page to be a replication of the first. Data from these five were 
included. 
TABLE 9.4.1 Background data of respondents (n=86); some background data of the population (age 
f------>-=~~-----
Variable Re~p~ndents Sarrlple population 
Age 
15-29 16 (19%) 30% 
30-44 32 (37%) 28% 
45-59 11 (13%) 19% 
60-70 42 (26%) 15% 
> = 75 5 (6%) 7% 
Sex 
Male 54 (63%) 52% 
Education 
Minimum 37 (43%) 55% 
Intermediate 34 (40%) 31% 
Higherldegree level 15 (17%) 14% 
Main activities 
Employed 46 (54%) 
Retired 19 (22%) 
Housework 15 (17%) 
Student 1 (1%) 
Incapacitated 4 (5%) 
Seeking work 1 (1%) 
Rating of own health 
< 80 18 (21%) 
80-90 29 (34%) 
> 90 32 (37%) 
Missil~1L __ 7 (8%) 
To assess aspects of the feasibility of the questionnaire, respondents were questioned 
about the difficulties they experienced in answering it. Forty-three percent of the res-
pondents judged the questionnaire as being very (6%) or rather (37%) difficult, while 
57% repOlied it to be fairly (45%) or very (12%) easy. The resp'ondents needed a 
mean time of20.3 minutes (SD 12.4 minutes) to complete the questionnaire. 
Respondents rated their own health status on the VAS (range: 0-100) with a mode of 
85, a median of 85 (interquartile range 8) and a mean of 81 (SD 18). Indeed, those 
who classified themselves on all predefined dimensions as being in the best category 
(11111) (n~52), attributed a significantly (p < 0.01) higher value to their own state of 
health (mean 89, SD 7) than those who reported a suboptimal level on any dimension 
(n~40; mean 70, SD 22). 
The results of the valuation of the 16 selected health states are sUIllmarized in Table 
9.4.2. The sequence of the states follows the median scores, as it Illay be assuIlled that 
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the measurement level of the valuations is at least ordinal. Ranking following the 
arithmetical means does not result in any change in the sequence, however. 
The dispersion of the attributed values was large, especially for 'bad' health states. 
'Being dead' yielded a heterogenous response, the range of attributed values ranging 
from 0 to 100. Seven of 80 respondents (9%) valued 'being dead' equal to or higher 
than 50. Two health states were presentend twice (112222 and 'being dead'). Scores 
were compared for both pairs (Spearman's rank correlation coefficient 0.76 and 0.95 
respectively; Pearson's correlation coefficient 0.69 and 0.94 respectively). The 
differences between the mean ratings were statistically insignificant (p > 0.05 for both 
pairs) (see Table 9.4.2). 
TABLE 9.4.2 Valuations for 14 health states 
Health state l Mode Med. I.Q.' Mean S.D. n 
111111 100 95 5 92 14 86 
111121 80 85 10 81 19 82 
111112 85 78 10 73 21 81 
111122 70 70 13 69 21 86 
112121 60 65 15 64 22 85 
112131 65 60 14 55 23 83 
112222(a)' 30 43 13 42 21 86 
112222(b) 40 40 13 41 21 82 
112232' 25 33 11 37 22 81 
212232 20 20 8 26 20 86 
being dead (a)' 0 5 23 21 26 80 
being dead (b) 0 5 20 19 25 77 
222232 5 8 6 12 15 85 
232232 0 6 4 11 16 83 
322232 0 5 5 10 17 81 
332232 0 4 5 7 12 85 
1 for clarification of representation of health states by strings of numbers see section 9.3.2 
2 Med. = median score, La. = Interquartile Range. 
3 These two states ('112222' and 'being dead') were presented twice In the questionnaire. 
4_Ihe string '112232' represen!~ the vignette pr~sented in Table 9.3.2:? 
132 the Bergen op Zoom SlI11!ey 
We then examined the logical consistency of the ratings, both at a group level and at 
an individual level. Consistency of valuations may be checked by comparing values 
attached to pairs of health-state descriptions with a logical order; i.e., the one health-
state description being dominant over the other. For example, 112222 is expected to 
be assigned a higher (or at least equal) rating than 212232. 
In the case of non-dominant pairs, e.g., 112131 and 112222, no logical ranking order 
exists. 'Being dead' was excluded from the analysis of the consistency of the ratings. 
At a group level, the median scores were completely consistent (see Table 9.4.2). 
However, at the individual level inconsistencies occurred. The 14 health states 
account for 82 dominant pairs. Overall, only 5% of the answers proved to be incon-
sistent at individual level. Illogical ranking occurred more often as pairs of health 
states were more alike, see Table 9.4.3. 
The degree of consensus alllong the respondents with respect to the ratings was 
examined, firstly by comparing individual rankings with the group ranking, as the 
measurement level was assumed to be at least ordinaL As cardinal measuring proper-
ties are conceivable, a second comparison of individual ratings with the group means 
was also carried out.The results are shown in Figure 9.4. 
TABLE 9.4.3 Consistency of the ratings, by comparing ranks assigned to 82 dominant pairs of health 
states 1-----
Distance between Number of pairs Inconsistent ratings 
2 health states 
14 16.3% 
2 14 5.9% 
3 13 2.8% 
4 12 1.8% 
5 9 1.7% 
6 8 1.7% 
7 7 1.4% 
8 4 1.2% 
~- 9 1,2% Tolal 82 5.0% 
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FIGURE 9.4 Correlation of individual scales with group scale (n=74) 
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9.5 Discussion 
We examined the feasibility of a measurement instrument to elicit valuations for a 
number of complex heallh-state descriptions from the general public. The design of 
the instrument was based on previous experience and supporting pilot studies by the 
EuroQol Group, a collaborative group of European researchers. 15•16•17 Essentially the 
task consisted of Ihe valuation of six-dimensional health-state descriptions on a 
vertical rating scale in an unsupporled situation (postal questionnaire). Arguments in 
favour of the feasibilily of the procedure are: 
the relatively high response, taking into account the demanding nature of the 
questionnaire; 
the acceptable level of experienced difficulty; 
the logical ranking of the health slates by the respondents as a group. 
We concluded that rating of health stales on a rating scale by postal questionnaire 
might be feasible. However, inappropriate response did OCClll' (20%), and Was related 
to age and level of education. Improvement of the instruction paragraph will probably 
enhance completion rates. A non-response study will be undeliaken to investigate 
whether subjects who did nol respond at all (non-respondents) and subjects who were 
willing to respond but do not succeed (unsuccessful respondents), respectively, differ 
from successful respondents with respect to the variables of interest, Le., valuations of 
health states. 
Judging from the examination of the logical consistency ofthe ratings, the valualion 
task was, in general, reasonably well understood. The finding that respondents who 
classified their own heallh better also rated it significantly higher is another indication 
that the subjects interpreted the valuation task correctly. 
The dispersion of the assigned values was fairly large. However, psychophysical 
methods typically yield higly variable observations." 
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The consensus found among respondents with respect to the ranking of the health-
states is important." It supports earlier evidence of homogeneity of society with 
regard to valuations of health states. ll However, the possibility of bias introduced by 
the response rate should be kept in mind. A comparison of the results of this pilot 
survey with preliminary results of similar studies in other European countries showed 
virtually the same ranking order of health states.8 
Though these provisional results seem to justify furtller experimentation with the 
EuroQol valuation questionnaire, there remain many questions to be answered. The 
reliability and aspects of the validity of the questionnaire should be determined. 
Validity testing should include comparison with other valuation methods (time trade-
off, standard gamble). Furthermore, the generalizability of the results to subgroups of 
the population, e.g., patients, health care workers, should be investigated. For 
application of the health-state valuations in cost-utility analysis at least an interval 
scale is required. 6.20 Therefore, the measurement level of the VAS values should be 
established. Are respondents merely ranking the states, or are the numbers on the 
scale interpreted quantitively? If the health states appear to be only ranked by the 
respondents, a scaling procedure could be performed in order to achieve cardinal 
values. Even if the measurement level is interval, the values resulting from the 
measurement procedure should probably not be used directly as a quality index in the 
computation of QAL Y s. The relation between the elicited valuations for health state 
as measured by time trade off or standard gamble Illay be e.g., logarithmic or 
linear.6,1S,2l Probably a transformation procedure should be employed before using the 
results in cost-utility analysis." More generally, the way to apply the results in QAL Y 
calculations should be determined. 
Problems remain with the valuation of 'being dead'. The presentation of 'being dead' 
as a health state seems to cause opposition in the respondents. This might be the result 
of conflicting interpretations of 'being dead'; for example 'absence of life' or 'the 
process of dying', or even an interpretation as a type of reference point ('something 
very bad'). This multi interpretability might be the cause of cognitive problems when 
comparing 'being dead' with health states during the completion of the questionnaire. 
Though many questions have yet to be answered, the first results with the EuroQoL-
instrument are sufficiently encouraging to continue its development as a standardized 
measure of obtaining valuations of health states. 
Note 
1. The 6D, 2/3 level EuroQol was changed into the present 5D, 3L after the first 
pilotstudies. 
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10.1 Abstract 
Problems. Non-response and non-usable response were found in population surveys 
on valuation of health states. If non-response is selective regarding valuations, then 
generalization of the resulting values to the whole survey population is not 
permitted. This could limit the use of empirical utility values in resource allocation 
in health care. 
Methods. Response behaviour of a sample of 1400 from the Dutch general 
popUlation to the mailed EuroQol-questionnaire was analyzed by four methods. 
I. Phoning resolute non-respondents; II. comparison of zip code characteristics of 
respondents and non-respondents (because individual data on background 
characteristics were not available for the non-respondents); III. analysis of response 
over time (wave-analysis); IV: comparison of background variables of successful 
(less than two valuations missing) and unsuccessful respondents, combined with 
analysis of the effect of these background variables on valuations. 
Results. No indications for selective non-response were found, although the 
phenomenon appeared hard to investigate. The successful response came fi'om a 
slightly younger and better educated subs ample. However, a general influence of 
age and educational level on valuations could not be shown. This finding is 
consistent with the literature. 
Conclusion. Although the existence of selective non-response cannot be excluded, 
its relevance can be considered small. This finding is encouraging for the use of 
empirical utility values in allocative decisions. 
10.2 Introduction 
Health policy makers facing explicit allocative decisions have recognized economic 
evaluation as a possible source of information. Ideally, economic evaluation 
enables health policy makers to rank health care services according to their relative 
efficiency. This information can be helpfnl in organizing the thoughts in the 
process of priority setting, although for definite choices additional information, 
e.g., about the distribution of costs and effects, is equally necessary.l 
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10.3 
10.3.1 
Cost-utility analysis (CUA) is generally the preferable form of economic analysis, 
because it takes into account the value of health outcomes in alternative pro-
grammes.' The empirical measurement of utilities is not straightforward. An 
approach in two stages is common. In the first stage, health-state descriptions are 
obtained from patients. In the second stage, these health-state descriptions are 
valued. The most important methodological choices to be made are the descriptive 
system for health status, the valuation method and the subjects who will perform 
the valuation task. The descriptive system should be non-disease specific in order to 
enable comparisons across programmes and across diagnoses. As for valuation 
methods, the feasibility of classical methods like standard gamble and time trade-
off in large popUlation surveys is questionable.' As for as whose valuations should 
be used, we think that in the case of public policy decisions the societal viewpoint 
should be taken, so the values of the general public are those we should useY 
Since 1987, the EuroQol Group has been developing an internationally standard-
ized, feasible, valid and reliable method for the measurement of the general 
public's valuations on non-disease specific health outcomes. A postal questionnaire 
for the measurement of valuations on different health states has been developed.4 
The results of pilot studies with the EuroQol instnnuent in the UK, Sweden and the 
Netherlands had several features in common."'" First of all, the questionnaire 
appeared to be practically feasible. Secondly, the resulting valuations were remark-
ably similar; the international interchangeability of valuations had not been seri-
ously investigated before. Another shared result was the fairly high percentage of 
non-response and unsuccessful response, raising the question of gcncralizability of 
the values. For the Dutch pilot survey, the non-response rate was 43%; however, 
20% of the response turned out to be unusable, despite careful questionnaire 
design.' If the valuations on health outcomes of respondents differ from those of 
non-respondents (selective non-response), serious problems arise concerning the 
generalization of the valuations. 
Non-response is found in any population survey. From an economic perspective the 
phenomenon is of special interest. If non-response is selective regarding the 
relevant variables (valuations), should we make significant effOlis to collect 
valuations on health states from non-respondents? Or should their views be disre-
garded, as they do not use the opportunity to have their say in this matter? This 
issue precedes the issue of aggregation of individual preferences.' 
[n conclusion, there appeared to be enough reasons to undertake a thorough 
investigation of the response behaviour to the EuroQol questionnaire, which is the 
principal issue of this paper. A few words will be devoted to consensus among 
respondents. 
Material & Methods 
The stlldy design 
The study population consisted of a random selection of 1400 households in 
Rotterdam, the Netherlands. Respondents were approached by a mailed question-
naire in Januaty 1991. Reminders were sent two weeks (card) and three weeks 
(whole questionnaire) later. The actual respondent in each household was randomly 
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selected by addressing the accompanying letter to the first adult (> IS years) 
member of the household who would next celebrate his or her birthday. 
Four approaches were used to analyze response behaviour. 
I. The only essentially valid method to judge selectivity of response is comparison 
of respondents and nOll-respondents on the variables of interest) i.e., valuations 
on health states. We therefore tried to obtain these from the people in the sample 
who did not respond on the mailed questionnaire, A crude response rate of at 
least 90% was pursued in a random 350 subsample by means of phoning all 
resolute non-respondents, if necessary repeatedly, 5 weeks after the first mailing 
of the questionnaire. People answering the phone were asked to complete the 
questionnaire. If they refused, we asked them why, and tried to obtain data on 
background variables. 
2. A secondary approach to the analysis of non-response is comparison of respon-
dents and non-respondents on background variables. Our study population was 
a general population sample, so we had no source of data on background 
variables on the individual level except the questionnaire, which was not 
answered by non-respondents (because if they did, they were respondents). 
However, there was external information available on both respondents and 
non-respondents on the level of zip-code areas. It is stressed here that these zip 
code characteristics are aggregated data: a zip code area in the Netherlands 
consists on average of 15 households. Examples of the zip-code characteristics 
we could dispose of are: average purchasing power index, age distribution, 
household composition etc. Because comparison of respondents and n011-
respondents on background variables was only possible on aggregate data, the 
result of this analysis should be interpreted with caution. Receutly, the validity 
of the use of zip code characteristics as proxies for individual data has been 
shown to be satisfactory (CTM Schrijvers, Department of Public Health, 
Erasmus University Rotterdam; personal communication). The method using 
zip code characteristics to analyze non-response has been applied before by De 
Leeuw.9 
3. The third approach was analysis of response over time by wave analysis. If the 
valuations of early and late respondents were different, due to, e.g" cognitive 
difficulties, and if the reasons for late response were patiially the same as for 
non-response, then the valuations of respondents and non-respondents could be 
assumed to be different. Three groups of respondents were identified by our 
mailing actions. Early respondents (questionnaire received within 3 weeks after 
the first mailing) were assumed to have responded to the first mailing, medium 
respondents (3-5 weeks) to the first reminder card and late respondents (>5 
weeks) to the second mailed questionnaire. Differences in valuations between 
these groups were analyzed by one-way analysis of variance. Because the data 
were not normally distributed and because the nature of the data is probably 
quasi-interval we used Kruskal-Wallis analysis of variance by ranks. 
4. The finding that not all people who were willing to complete the questionnaire 
in fact succeeded in doing so was recognized as a separate problem. To analyze 
selectivity of successft,l response, background characteristics as reported in the 
questionnaire by successful and unsuccessful respondents were compared. 
Successful (= usable) response was defined as only one or two valuations 
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missing, the assumption being that if only one or two states were missing the 
respondent had essentially understood the task. If non-usable response was 
selective regarding background characteristics, and if these background charac-
teristics were of influence on valuations on health states, this would be strongly 
indicative of selective non-response regarding valuations. The effects of a set of 
background characteristics (i.e., sex, age, educational level and global evalua-
tion of own health state; this last item being operationalized on a vertical visual 
analogue scale with marked endpoints, '0' labelled as 'worst imaginable health 
state' and' 100' labelled as 'best imaginable health state') of respondents on the 
valuations were studied by Kruskal-Wallis one-way analysis of variance by 
ranks because of the qualities of the data mentioned above. A limitation of this 
non-parametric technique is that it does not allow for the simultaneous estima-
tion of the effect of an independent variable (each background variable) on a set 
of dependent variables (16 health state valuations). Therefore, a multivariate 
analysis of variance (MANOVA) on the valuations was also carried out (one-
between one-within repeated measurements design; Wilks' lambda).lO,1I The 
MANOVA was performed using the sequential approach for non-experimental 
designs in the SPSS computer package. 
The El/roQol concept of health statlls 
The revised EuroQol concept of health status is shown in Table 10.3.2. With this 
concept, a healtll'State description can be composed by taking one level for each 
dimension. For example, state 11231 indicates a state of health without mobility or 
self-care problems, some problems with usual activities, extreme pain or discom-
fort, but no anxiety or depression. 
The EUI'oQol concept of health status theoretically allows for 3' or 243 composite 
health-state descriptions. 
The El/roQol qllestiollnaire 
Respondents are asked to classify their own state of health using the EUI'oQol-
concept on the first page. 
They f\re then asked to rate their own overall state of health on a 'thermometer', 
i.e., a vertical visual analogue scale (V AS) with marked endpoints: 0 ~ 'worst ima-
ginable health state' and I 00 ~ 'best imaginable health state'." 
The core task of the questionnaire is the valuation of 16 composite health-state 
descriptions, concerning 'someone like you', on a VASe as described above. The 
duration of the health states is stated to be one year; what will happen afterwards is 
stated not to be known. The 16 health-state descriptions are presented on two pages 
A and B. One page of the valuation task is shown in Figure 10.3.3. 
Data ori background characteristics (e.g., age, sex, education, experience with 
illness) were collected on the last two pages of the questionnaire. 
The standard EuroQol questionnaire contains a fixed selection of 14 different health 
states. Health states' 11111' and '33333' are presented on both valuation pages of 
the questionnaire. In the present study, 14 additional health states were selecterl to 
be valued. Two new valuation pages (C, D) were created; the additional health 
states were assigned randomly to each of them. Four versions of the questionnaire 
were constructed, namely AB (standard EuroQol), CB, AD and CD. 
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All health states occulTed in two versions of the questionnaire, except IIIII and 
33333, which occurred twice in each version. The four versions of the question-
naire were distributed randomly among the addressees in the sample. 
TABLE 10.3.2 The EuroQol concept of health (50 - 3L) 
Mobility 
1 
2 
3 
No problems in walking about 
Some problems In walking about 
Confined to bed 
Self Care 
No problems with self care 
2 Some problems washIng or dressing 
3 Unable to wash or dress self 
Usual Activities (e.g., work, study, housework, family or leisure activities) 
1 No problems with performing usual activities 
2 Some problems with performing usual activities 
3 Unable to perform usual activities 
Pain/discomfort 
No pain or discomfort 
2 Moderate pain or discomfort 
3 Extreme pain or discomfort 
Anxiety/depression 
1 Not anxious or depressed 
2 Moderately anxious or depressed 
3 Extremely anxious or depressed 
----
10.3.4 Presentation of the results 
The measurement level of a VAS is assumed to be quasi-interval. Therefore, the 
resulting valuations are presented by the median as well as by the mean. On the 
level of the respondents as a group, consensus is determined by examining the 
frequency distributions of the Spearman rank correlations between individual 
rankings and the group ranking. Only complete data could be used for this analysis. 
10.4 Results 
10.4.1 Response 
Five questionnaires were returned in the original envelope as 'undeliverable'. A 
total of 980 questionnaires were returned in the prestamped return envelope, 
yielding a 70% (980/1395) crude response rate. As III questionnaires out of 980 
'were returned blank, the non-blank response-rate was 62%. Non-blank response 
rate perversion amounted 66%, 55%, 64% and 62% for version AB, CB, AD and 
CD respectively. In the following, 'response' means 'non~blank response'. 
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11111b' 
11111a' 
11211 
11121 
11112 
12111 
21111 
11221 
11122 
21211 
12212 
21212 
32211 
21232 
23223 
22233 
33321 
22323 
32233 
22333 
23332 
32333 
33332 
33233 
23333 
33333b' 
33333a' 
Returned blank questionnaires were considered to be indicative of unwillingness to 
pm1icipate for some reason. 
Valuations; consensus 
The resulting valuations on health states are presented in Table 10.4.2. Data from 
successful respondents as defined above were used. The states are ordered accord-
ing to the medians. The data are presented pooled as no differences in valuations 
between versions of the questionnaire could be proved. 
Consensus refers to the extent to which respondents agree on the valuation of health 
states. The frequency distribution of correlations between individual rankings and 
the group ranking is shown in Figure 10.4.2. The percentage of respondents with a 
rank correlation with the group ranking lower than 0.50 was 4.5%. 
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FIGURE 10.3.3 Page 1 of the valuation part of the questionnaire 
No problems in walking about 
No problems with self-care 
Some problems wllh performing usual 
activities (e,g. work, study. housework, family or ieiS(lre 
acljvl~;'es) 
No pain or discomfort 
Not anxious or depressed 
No problems In walking about 
No problems with self-care 
No problems with performing usual 
aclivities (e.g. wotk, study, hOUSoMOli<, famflyorfeisure 
ac/J'vities) 
No pain or discomfort 
Not anxious or depressed 
Some problems in walking about 
No problems with self-care 
Some problems with performing usual 
activities (e,g. work, study, house>tlJrk, family or Ie/sum 
activities) 
Extreme pain or discomfort 
Moderately anxious or depressed 
No problems In walking about 
No problems with self-care 
No problems with performing usual 
activities (e.g. Work, study, house~~ork, lamilyof Ie/sura 
Be/Miles) 
Moderate pain or discomfort 
Moderately anxious or depressed 
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No problems in walking about 
No problems with self-care 
No problems with performIng usual 
activities (e.g. work, s/Udy. housework, 'amily or leisure 
aell.,it!as) 
Moderate pain or discomfort 
Not anxious or depressed 
Some problems in walking about 
Some problems with washIng or dressIng 
self 
Some problems with performing usual 
activities (a.g. work, study, housework, 'amilyor leisure 
aetirities) 
Extreme pain or discomfort 
Extremely anxious or depressed 
Confined to bed 
Unable to wash or dress self 
Unable to perlorm usual activities (a.g. work, 
study, housework, 'amilyor leisure Bctivities) 
Extreme paIn or discomfort 
Extremely anxious or depressed 
Conffned to bed 
Unable to wash or dress self 
Unable 10 perform usual activities (e.g. work, 
study. housework, 'amilyo( felsure Be!MIles) 
Moderate pain or discomfort 
Not anxious or depressed 
Pi.EASE CHECK THAT YOU HAVE 
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FIGURE 10.4.2 Consensus (frequency distribution of rank correlations between individual ranking and 
group ranking), n = 493 
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Analysis of response behaviour 
1. We tried to collect valuations of92 addressees ofa random 350-subsample who 
had not responded after two reminders, nor returned a blank questiollnaire, by 
means of repeated reminder phone calls. Eightteen of them did not answer their 
phone even if tried 5 times (19%) while one addressee appeared to have died. 
Twenty-one promised to return the questionllaire, of which only 9 were actually 
received. Of the remaining 52, 47 refused to answer any question about their 
age, educational level etc. As reasons for not participating they offered 'not 
seeing the sense', 'not being interested' 'principally never participating in 
surveys', 'too busy'. Eight non-respondents said they did not understand the 
questionnaire, but refused help to complete it. 
We concluded that a general unwillingness to cooperate in surveys was the main 
reason for non-response. The number of 9 extra completed questionnaires was 
considered too small to analyze separately. 
2. No relevant differences could be detected between postal area characteristics of 
people in the sample who returned a non-blank questionnaire and of those who 
returned a blank questionnaire or nothing at all. 
3. The differences in ranking order of states in three response waves (wave 
analysis) were insignificant at the 5% level. 
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The results of the wave analysis for the medians of valuations for 4 states are 
illustrated in Figure 10.4.3 (the results for the other states were analogous). No 
differences in response over time were detected. 
4. Comparison of successful respondents with unsuccessful respondents showed 
the modal successful respondent to be between 31 and 45 years of age, with 
medium level education. The modal unsuccessful respondent was older and less 
well educated, all other measured variables being the same. Among the success-
ful respondents, no significant effects of background characteristics (age, sex, 
education, valuation of own health, experience with illness) on the ranking of 
the states could be detected. 
The results of the MANOV A procedure (in which the data are treated as interval 
data) are shown in Table 10.4.3. The figures in this table can be interpreted as 
follows. 
As expected from the nature of the valuation task (stimulus scaling task), all 
tests of the main effect 'health states' are highly significant. The effect of the 
background variable 'age' in version AB of the questionnaire is the one that 
attracts attention. Both the main effect 'age' (indicating a difference in level of 
valuations between age groups for the whole range of health states) and the 
interaction effect (age * health states) are highly significant (p~0.009 and 0.008, 
respectively). When inspecting the data, it can be seen that the older age group 
generally values the health states somewhat higher than the other groups. The 
interpretation of the interaction effect age * health states is that some age groups 
value some health states differently. In version AB, the interaction effect age * 
health states is mainly the result of equal valuation of one particular state by all 
age groups. However, the finding of significant effects of 'age' on valuations is 
not con finned in the other versions of the questionnaire. 
The discrepancy of version AB with the other versions can probably not be 
explained by differences in the severity of the health states in the questionnaire 
versions, as the whole range of health states is covered in all four versions. 
Although somewhat unsatisfactOlY, the conclusion at this moment must be that 
the effect of the background variable 'age' on valuations on health states ill 
general is not unequivocal. If the findings for version AB are indicative of a 
systematic age-effect, this should be confirmed in future research. 
The other four significant p-values in Table 10.4.3 concern interaction effects. 
These findings impress as patchy, and when inspecting the data it is clear that 
they do not reflect any systematic effect. 
More detailed results of the MANOVA are available from the authors on 
request. Our conclusion of the MANOV A is that none of the background 
variables tested has unequivocal significant effects on valuations in general, 
with a possible exception for age; however, the relevance of this possible age-
effect seems to be small. 
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TABLE 10.4.3 Influence of age, sex, education and rating of own health on EuroQol valuations (per version of the 
questionnaire): one-between one-wjt~in multivariate repeated measure a~alys~s (p-Ievels). 
AB' CB AD CD 
Health States (16)' <0.001 <0.001 <0.001 <0.001 
Age (4)' 0.009 0.84 0.82 0.65 
Health States' Age 0.008 0.93 0.50 0.15 
Sex (2) 0.08 0.19 0.17 0.27 
Health States· Sex 0.87 0.14 0.75 0.05 
Education (3) 0.18 0.78 0.75 
Health States· Education 0.26 0.27 0.72 
Own Health' (3) 1.00 0.45 0.27 
Health States· Own Health 0.51 0.003 0.01 
a AS = standard Euroqol-questionnnaire; further explanation of versions, see sectidn 10.3.3. 
b Within parentheses: number of levels. 
'Classified as: level 1<31, 2=31-45, 3=46-60, 4>60 years. 
0.84 
0.04 
0.43 
0.45 
d Evaluation of own health state of the respondent on a thermometer from 0 to 100; level 1 =0-79, 2=80-90, 3=91-
100. 
This finding suggests that the selectivity of successful response regarding age and 
educational level is generally not reflected in the valuations. 
The results from approaches I to 4 can be summarized as follows: up to now, no 
selectivity of response has been proven. Successful response came from a slightly 
selective sample, but this selectivity probably did not influence the resulting 
ranking order or the mean valuations relevantly. 
10.5 Discussion 
Although a non-blank response rate of 62% is high for a postal questionnaire in a 
population that is not specially motivated or in any way rewarded, it leaves the 
investigators without data on the values for health states of the remaining 38%. 
Therefore, an analysis of non~response and response behaviour was undertaken. 
One of the results of this study is the confirmation of the fact that a valid analysis of 
non-response in a general population sample is hardly a feasible enterprise, just 
because non-respondents do not respond and external data are not available on the 
individual level. Essentially, the whole enterprise of testing selectivity of non-
response for EuroQol valuations has been unsuccessful. 
By application of a set of second-best methods, we found indications that, if non-
response is selective, the relevance is probably small. 
The percentage of usable response was 46% (643/1400), or 74% (643/869) of non-
blank retul'Iled questionnaires; the task in the questionnaire appeared to be demand-
ing. In our survey, usable response came from a subs ample which was on average 
younger and better educated. This would pose a threat to generalizability if valua-
tions on health states were influenced by age and educational level, which did not 
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appear to be the case in our data. This is an argument for the acceptability of the 
selectivity of usable response. We shall try, however, to improve the questionnaire 
further in order to enable anybody willing to complete the questionnaire to do so. 
URE 10.4.3 Response wave analysis (medians) for 4 health states 
100 
90 
.0 
70 
~ 
ID 60 ~ 
n=233 
n=73 
1111221 n=27 
• 
• • ~ 50 c 
.!!l 
'0 40 
ID 
E 30 
n=223 n=63 1232231 n=22 
A • • 
20 
10 n=456 n=137 1>333W n=49 
• • • 0 
, 3 weeks 3·5 weeks > 5 weeks 
time since first mailing 
The finding that the influence of background characteristics on valuations on health 
states is probably small, is in accordance with the literature.1l What should have 
been done if indications for selective non-response relating to valuations had been 
found? The option of 100% response is unrealistic. [frelevant background variables 
were identified, the opinions of the non-respondents could be estimated by means 
of a modelling approach. Other approaches are thinkable (e.g., using a random 
sample of elected politicians), but these are issues beyond the scope of this paper. 
As indicated in the introduction, the valuations on health states are meant to be used 
in CUA. EuroQol valuations are not to be used directly as utility weights; more 
should be known about the nature of the scores. The measurement level of a VAS is 
probably quasi-interval. For CUA, at least interval measuring level is necessary. A 
scaling procedure to establish the meaning of the distances between the numpers 
should be performed. Furthermore, the exact meaning of the scores should be 
explored. Do they represent health-state preferences? This question is difficult to 
answer, as no golden standard for health-state preferences exists, so that criterion 
validity cannot be evaluated. Constl1lct validity can be investigated by means of 
multitrait - multimethod analysis."'" Because the health-state descriptions contain a 
natural ranking order to some extent, each of them could be treated as a separate 
trait, while the methods should be accepted methods for measurement of health-
state preferences. Both the scaling procedure and the construct validity are subjects 
of current research with the EuroQol instrument. 
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10.6 Conclusions 
Data on health state preferences collected by mail among a sample of the Dutch 
general population appeared not to be very sensitive to selection bias by non-
response. This is an indication that the response-rates as encountered until now are 
acceptable, and that the results may be generalized to the whole sample, and 
consequentially, provided the sample was drawn well, to the sampled population. 
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11 
Conclusions 
This chapter presents the conclusions of this thesis in 3 sections, The first section 
provides a definition of the position of health status as an outcome measure, the 
second section relates to descriptive health status measurement and the third to 
evaluative health status measurement. 
11.1 The position of health status as an outcome measure 
The three cornerstones for the evaluation of the effects of disease and Of medical 
interventions are survival, health status and disease-specific clinical measures. 
Although survival and health status are complementary, their relative importance in 
outcome measurement is variable. Health status is essential as an outcome measure 
in the following situations: 
Effects on survival and health status occurring in opposite directions. A sur-
vival improvement may occur at the cost of an adverse effect on health status. 
Such a situation occurs for example in the treatment of chronic viral hepatitis 
with a drug that inhibits villls replication and thus progression of liver damage, 
but causes severe and lasting fatigue. 
The absence of a (substantial) survival effect. Health status improvement is the 
primary aim of treatment (for example, the h'eatment of idiopathic urinary 
incontinence by implantation of a neuromodulation device, if compared with 
napkin 'treatment'). 
The occurence of different effects within health stat/ls. For example, a dl1lg 
resulting in improved physical performance but with depression as a side-effect. 
Methods for descriptive health status assessment have passed the experimental 
stage of development. The procedures have matured to such an extent that health 
status measurement should be a standard part of any research project aiming at the 
quantification of effects of disease andlor interventions. Ignoring health status in a 
research proposal, not its inclusion, should be substantiated, This is in accordance 
with the guideline provided by the Dutch Working Group on Health Status Assess-
ment. 
Standardization of research methodology is a prerequisite for use of the results of 
empirical outcome studies in health policy making. Intended users of empirical 
outcome results, including health policy makers might play a decisive role in 
achieving the necessary level of standardization. If outcome data were increasingly 
used as a basis for decision-making, the imperative need for standardization 1V0uid 
become obvious. For example, if the minimal effectiveness of an intervention 
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required by the 'funnel of Dunning>i for inclusion in the basic health insurance 
package was operationalized as a given improvement in scores from particular 
health status measures, there would be an obvious impetus to include. these mea-
sures in medical evaluation studies. 
11.2 Descriptive health status measurement 
Several instruments for descriptive health status measurement are currently avail-
able. The perspective of a study determines what type of instrument is the most 
appropriate. The health-care policy perspective requires comparability between 
patient groups and across diagnostic groups. The general impOliance of this 
perspective in the evaluation of medical interventions underlies the practical 
recommendation to employ a combination of measures. A generic measure should 
be complemented by disease andlor domain specific measures. 
For disease- and domain specific health status measurement, use of standard 
measuring instruments is efficient, for example because the need for norm studies 
decreases. For generic instruments and QAL V-type measures, standardization of 
the choice of measures is essential. Their lraison d'ctre' is the demand for compara-
bility between studies, interventions and patient groups. 
The generic instruments currently available are different, firstly, with respect to 
their operationalization of physical, psychological and social functioning; secondly, 
to 'testing performance' in different populations of patients; thirdly, to practicality; 
and fourthly, to specific characteristics (e.g., a link to health status values). From 
the viewpoint of standardization, implementation of the 'common core' concept 
(Le., that all evaluation studies should have at least one measuring instrument in 
common) may prove to be feasible. A common core measure garantuees a minimal 
level of comparability. 
There is a lack of information about the relative behaviour of the available generic 
instruments. Parallel research, employing two or more generic measures simulta-
neously, is one of the methods to provide empirical evidence of the relative value 
of the instruments. 
Sufficiently reliable and validated disease specific instnllnents to complement 
generic measures for health status are not easily detected or do not exist for many 
diseases. In this area a considerable amount of developmental work has to be 
carried out. A standardized, modular approach, preferably in relation to generic 
measures, is recommended. Such an approach has been taken, for example, by the 
developers of the EORTC QLQ-C30, which includes the development of modules 
specific for certain cancers (e.g., breast cancel', prostatic cancer) and celiain 
treatments (e.g., radiation therapy) to be employed alongside with the 'generic' 30-
item core questionnaire,2 Other examples are available.) 
The issue of which health status measure(s) should be used generally receives much 
more attention than other aspects of research design. For example, the importance 
of the timing of assessments is often underestimated. 
Many empirical studies have investigated the health status of relatively 'easy' 
patient groups: e.g., not too seriously ill, in a chronic, stationary state, not too old, 
not too young, no cognitive impairments et cetera. Problems in health status 
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assessment occur with respect to, for example, diseases manifesting in attacks (e.g., 
asthma, migraine); to children; and to psychiatric patients. In fact, attack-type 
diseases offer a special case with respect to the period of time for which a health 
status assessment is considered to be representative. The effects of the attacks 
themselves should be measured as well as their effects on the functioning between 
attacks, for example by combining 'attack measurement' (by self-assessment 
immediately afterwards, or assessment by proxy) with measurement of general 
functioning. 
A special characteristic of children compared with adults with respect to health 
status measurement, is childrens' heterogeneity as a group due to age-related 
development. This has important consequences, firstly for the operafionalizafioll of 
the contents of the physical, psychological and social domain, and secondly for the 
method of data collection that has to be adapted to the level of communicative and 
cognitive development. Assessment by (a combination of) proxies and direct 
observation are the methods available until the child is able to communicate 
adequately.'" The prognostic value of health status is an issue of special importance 
in outcome assessment in children. 
A similar situation exists with respect to health status assessment among psychiatric 
patients. Not the concept of health status itself, but its operationalization may be 
different in somatic and psychiatric patients. The distorted perception of reality, 
which is part of psychotic disease to some extent precludes collection of valid data 
on functioning from the patients themselves during psychotic episodes. This 
situation is to some extent comparable to the relative impossibility to collect 
empirical ,health status data from patients themselves during attacks in somatic 
attack-type diseases. The feasibility, reliability and validity of 'somatic' generic 
instruments in the psychiatric context remains largely to be investigated.6 The value 
of the generally recommended approach regarding the choice of health status 
measures (Le., complementing generic measures with disease specific ones to focus 
on specific aspects of psychiatric patients and psychiatric care) deserves to be 
investigated. 
11.3 Evaluative health status measurement 
Comprehensive outcome measurement implies combining health status and survival 
effects. In the current practice of the disaggregated operationalization of the QAL Y 
or QAL Y type concept [including the disability-adjusted life-year (DALY) used in 
the 'Global Burden of Disease' project'], 'timeless' health status values are com-
bined with life-years. Many authors have questioned the validity of the assumptions 
underlying this disaggregation. The question at stake is whether the current opera-
tionalization violates the assumptions to such an extent that the QAL Y concept has 
to be abandoned. Attempts to develop demonstrable superior alternative opera-
tionalizations have remained futile for years. Potential users of QAL Y data should 
be aware of the consequences of the apparent simplicity of the current opera-
tionalization and consequentially of its limitations. They should also realize that 
cost-effectiveness data expressed as cost per QAL Y do not yield clear-cut decisions 
as to how to allocate resources. Such data may be used as one of the sources of 
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information to organize the thoughts in the decision-making processes of policy 
makers. 
The demand for health status values to be applied in the evaluation of medical 
interventions and in public health models is increasing'·9 Because of the lack of a 
superior alternative, the practical approach of incorporating valuation data on 
health states in an economic analysis as illustrated in section 8.5 may be defended. 
This approach was also used in a study evaluating the quality of life effects of 
breast cancer screening. lo The application of health status values should be provi-
sionally standardized. The consequent incorporation of the same systematic error in 
study results is to be preferred above different sources of variability that cannot be 
disentangled. 
This should not detract from the view that evaluative outcome measurement 
requires fUliher development and refmement, especially with respect to the role of 
'time' and to the aggregation of values if different groups in the popUlation are 
shown to have different value patterns. 
Clearly, the empirical work in evaluative health status measurement has not yet 
reached the same stage of development as descriptive health statlls measmement. A 
major mUltidisciplinary research effort is required, concerning the whole range of 
conceptual development, empirical testing and the standardization of procedures. 
References 
Committee on Choices in Health Care. Choose or/oose (Commissie Kcuzen in de zorg. 
Kiezen en dclen). Department of Health, 1992. 
2 Sprangers MAG, Cull A, Bjordal K, Groenvold M. Aaronson NK. The E1Iropean 
Organization for Research and Treatment of Cancer approach to quality of life 
assessment: guidelines for developing questionnaire modules. Qual Life Res 
1993;2:287-295. 
3 Cella OF, Bonomi AE. Fllnctional Asssessmellt of Cancer 111erapy (fllCT) Scales. 
Manual. Chicago: Rush Cancer Institute, 1994. 
4 Verhulst FC, Koot M. Child psychiatric epidemiology. New York: Sage Publications, 
1992. 
5 Oemke RJBl, Bonsel OJ. Reliability and validity of a comprehensive health siatus 
measure ill a heterogenous population of children admitted to intensive care. Accepted 
for publication in 1 Clill Epid, 1995. 
6 McHorney CA, Ware lE, Lu JFR, Sherbourne CD, The MDS 36-ilem Short-Form Health 
Survey (SF-36): Ill. Tests 0/ data quality, scaling assumptions, and reliability across 
diverse paliellt groups. Med Care 1994;32( 1 ):40-66. 
7 Murray ClL, Lopez AD (eds), Global comparative assessments in the health ca/'e sector. 
Geneva: WHO, 1994. 
156 Conclusions 
8 World Bank. World Development Report 1993: investing in health - world development 
indicators. Oxford University Press, 1993. 
9 Ruwaard D, Kramers PON, eds. Volksgezondheid Toekomst Verkellning. Den Haag: 
SDU,1993. 
to Haes JCJM de, Koning HJ de, Oortmarssen GJ van, Agt HME van, Bruyn AE de, Maas 
PJ van der. The impact of a breast cancer screening programme 011 QALYs. Int J Cancer 
1991 ;49:538-544. 
Conclusions 157 

Summary 
Disease can ultimately result in a decrease in life span, a decrease in quality of life or a 
combination of both. Medical care aims at prevention or cure of disease, and when the 
disease has passed the curable stage, at palliation of the suffering. The ultimate 
objectives of medical care can be summarized as 'adding years to life and life to years'. 
In industrialized countries there has been a decrease in the manifestations of acute, Iife~ 
threatening diseases. Life expectancy at birth is high. Chronic diseases have become an 
important public health problem. Consequentially, the improvement of quality of life 
has become the primary objective of medical interventions. 
Mortality used to be an imp011ant measure to describe the consequences of disease and 
the effects of treatment. Mortality will of course continue to play an important role as 
an outcome measure of disease and treatment. However, mortality, or its complement, 
survival time, as a single outcome measure is often not so informative. 
Examples of situations in which the quality of life is at least equally important as an 
outcome measure can be found easily. If an intervention primarily aims at prolonging 
life, for example treatment of cancer, a situation may occur where the gain in life 
expectancy must be weighted against a temporary or permanent decrease in the quality 
of life. Another example occurs in situations where interventions emerge that aim at 
saving life, for example certain organ transplantations, and the treatment of children 
with (otherwise lethal) congenital anomalies. The technical possibilities to prolong life 
with such interventions inevitably evoke questions about the quality of that life 
afterwards. 
This thesis addresses quality of life measurement in the evaluation of the effecls of 
disease and of medical care. The notion of 'quality of life' in this context has been 
limited to 'health-related quality of life', or 'health status', defined as quality of life 
relating to disease and/or treatment. This implies that determinants of quality of life 
that are not directly related to health or medical treannent are not considered. Compre-
hensive domains of health status currently include physical, psychological and social 
functioning. 
Chapter 2 provides a global overview of the scientific field of health status measure-
ment. The relationship between conventional clinical parameters (e.g., blood pressure, 
blood chemistry, E.C.G., X-rays) and health status measures can be described as 
complementary, each useful in their own context. 'Conventional' medical techniques 
can, for example, be used to detennine the diagnosis of a disease and, because they 
provide prognostic information, to supp011 treatment decisions. Patient functioning is 
the variable of interest in the assessment of the ultimate consequences of disease and 
the effectiveness of interventions (complementalY to life span). This applies when 
doctors treat individual patients as well as when medical interventions are evaluated at 
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an aggregate level. 
Health status can be measured from different perspectives, We distinguished the 
following: the individual patient's perspective, where the issue is a choice between 
treatment alternatives; the perspective of groups of patients with similar disease 
characteristics, where health status measurement provides insight into the effects that 
are generally to be expected from such interventions; and a societal perspective, where 
health status information is used to support the decision-making process in resource 
allocation, mainly in health care, Medical Technology Assessments (MTA) are 
conducted from a societal perspective, a classical clinical trial from a patient group 
perspective, It is recognized that research to evaluate the effectiveness of medical 
interventions purely from the patient group perspective, 'no matter what it costs', is 
gradually becoming less important. 
The perspective (or stated otherwise, the research question) determines the choice of 
health status measures, We distinguished three main types of health status measures, 
i.e. generic, disease-specific and domain-specific instnllnents. Generic measures allow 
for comparisons of health status irrespective of diagnosis or intervention. Generic 
health status measurement is a prerequisite in evaluation research from a societal 
perspective, 
Chapter 2 ends by underlining the imp0l1ance of standardization of health status 
measurement. Without standardization research results are incomparable, The conse-
quence may be that the results of health status studies in different disease groups 
cannot be used to rank these diseases according to the relative burden they cause, or 
that the results of MTAs of different intervention programmes cannot be used to rank 
these programmes according to their relative (cost-)effectiveness, Another conse-
quence of incomparability of research results is a suboptimal contribution of individual 
studies to the scientific 'body of knowledge', Standardization is essential if health 
status information is to be used in the preparation of and the decision-making in health 
policy, It is the aim of a nationwide network of researchers engaged in health status 
assessment, the Dutch Working Group on Health Status Assessment, to promote the 
standardization process, 
Chapters 3 to 7 relate to descriptive health status assessment, 
Chapter 3 compares 6 generic health status measures that are available in Dutch, i.e. 
the SIP, the NHP, the MOS-20, the SF-36, the COOP/WONCA charts and the EuroQol 
instrument. The concept of health status was operationalized somewhat differently in 
these instruments, A comparison of testing properties (reliability, validity) based on the 
literature was not possible due to the population-specificity of testing propel1ies and 
because the design and reporting of research on testing propel1ies often appeared to be 
incomparable, However, none of the available measures is superior to the others in all 
respects. There is a growing need for empirical comparisons of health status measures. 
Chapter 4 presents the results of an empirical comparison of the NHP and the SIP 
when employed in a cross-sectional description of the health status of a group of renal 
patients treated with haemodialysis, The NHP was found to be more feasible, The NHP 
scales showed somewhat higher levels of internal consistency, Common factor analysis 
showed that NHP and SIP data could be efficiently summarized in two higher-order 
factors - one reflecting physical health, the other mental health, Physical health is 
emphasized in the SIP, whereas the NHP emphasizes mental fimctioning, 
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Chapler 5 presents a similar study involving a sample of migraine sufferers and a 
control group, in which we compared the feasibility, internal stmcture, internal 
consistency, constmct validity and 'known groups' validity of 4 generic health status 
measures (the NHP, the SF-36, the COOP/WONCA charts and the EuroQol instm-
ment). In general, all 4 instruments exhibited a good performance profile. However, 
both instruments with a multi-item structure performed better than the COOP/WONCA 
charts and the EuroQol instrument. Test-retest reliability and responsiveness to change 
over time were not subjects of the comparison. In this study it also appeared to be 
possible to efficiently summarize the measures in a physical and a mental factor. 
Chapler 6 provides an example of applied descriptive health status measurement. The 
impact of migraine on health status was investigated employing the NHP, the SF-36, 
the COOP/WONCA charts and the EuroQol instnunent in a controlled cross-sectional 
design. The health status of migraine sufferers appeared to be significantly impaired in 
comparison to the control group. The difference could only pali1y be attributed to a 
higher prevalence of comorbidity, especially self-repOlied depression, in the migraine 
group. Migraine has an independent, moderately deteriorating effect on the daily 
functioning of individuals, in addition to the presumed effects of the attacks. 
Chapler 7 reports on the evaluation of the health status effects of liver transplantation 
in a longitudinal design. For those who survived the hazardous procedure itself, liver 
transplantation contributed velY positively to their health status. Empirical health status 
assessment in these sometimes very ill patients appeared to be feasible provided the 
procedure was extremely user friendly and adequate information was supplied to 
patients, doctors and nursing staff. 
Most of the available health status measures, including the NHP and the SF-36, are 
descriptive instruments. This implies that scores take the form of a profile of sCores 
across the different dimensions of the instnnneht. We have to go a step further, i.e. to 
summarize profile scores, if we wish to aggregate the consequences for health status 
and survival time into one outcome measure. Such a combined outcome measure is 
needed, for example, in cost-utility analysis and in public health modelling. Summary 
scores are currently obtained through a procedure in which health status descriptions 
are valued. 
Chapler 8 provides an overview of the field of empirical valuation of health states. The 
current three-stage approach is illustrated. Patients' health status descriptions (obtained 
in step I) are valued in the second step. In the third step valuations and survival time 
are combined. The results can be expressed as, for example, Quality Adjusted Life-
years (QALYs). Important issues of choice in the procedure are addressed. For 
example, the choice of the group of subjects who perform the valuation task is deter-
mined by the research perspective. If a societal viewpoint is adopted, the valuations 
should reflect this. This is commonly operationalized by obtaining the valuations from 
a representative sample of the general population (including patients). The valuation 
method provides another important issue of choice. Visual analogue scaling is advanta-
geous from a practical point of view. Time trade-off may be preferable from the 
viewpoint of validity. Simple transformation from values obtained by one method into 
another is theoretically possible if the ordinal ranking of health states is similar. 
The operationalization of the QAL Y or QAL Y type concept in the current three-stage 
approach is essentially a disaggregation of the outcomes ofa disease or an intervention. 
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The outcome space can be represented by a tree, where each branch is characterized by 
a duration, a sequence of health states and a probability of occurrence. The current 
disaggregated approach is based (among others) on the following two assumptions that 
are probably seldom completely valid. Firstly, it assumes that the valuation of a health 
state is independent of what preceded (history) and what will follow (prognosis). It is 
also assumed that valuation is independent of the duration of the state. Yet a valuation 
procedure which takes account of history, prognosis and duration is more likely to 
reflect reality than one which values health states independently. The apparent simplic-
ity of the present operationalization of the QAL Y concept is one of its strengths. 
Moreover, a demonstrable superior alternative still has to be developed. We believe 
that further development and refinement of the approach is justified, provided re-
searchers and potential users of research findings are aware of the limitations such as 
those described above. 
Chapters 9 and 10 present empirical valuation studies in the general population. Both 
were part of the research programme of the intemational EuroQol Group, a European 
network of researchers aiming at scientific methodological progress in the field of the 
valuation of health states by means ofa standardized empirical approach employing the 
EuroQol instnllnent. Chapter 9 presents a pilot study investigating the feasibility of 
measuring valuations of health states among the general population in a postal survey. 
The results were promising. However, the rates of non-response and unsuccessful 
response (especially from elderly and less educated subjects) were considerable. This 
prompted us to conduct the non-response survey that is presented in chapter 10. 
A \though the phenomena of selective non-response and unsuccessful response ap-
peared hard to investigate, the relevance of such effects for the use of results in policy 
decision-making seemed to be small. Relevant effects of background variables (age, 
educational level) on valuations were not found. 
Chapter 11 addresses the most important conclusions of this thesis. Health status is the 
third cornerstone of medical evaluation research, complementaty to survival time and 
disease-specific clinical measures. Methods for descriptive health status assessment 
have passed the experimental stage. The procedures have matured to such an extent 
that health status measurement should be a standard part of any research project aiming 
at the quantification of effects of disease and/or interventions. Ignoring health status 
measurement, not its inclusion, should be substantiated. Standardization of research 
methodology is a prerequisite for the comparability and consequently for the use of the 
results of empirical outcome studies in health policy making. The Dutch Working 
Group on Health Status Assessment and (potential) users of health status research 
results, including the government, should cooperate to reach the required level of 
standardization. 
A different picture arises for evaluative health status measurement. Important ques-
tions, for example relating to the roles of ltime' and 'sequence', and to the existence of 
popUlation subgroups with deviating valuation profiles, still need to be answered 
empirically. The routine use of empirical valuations of health states cannot be recom-
mended without reservations. A major multidisciplinary research effOlt is still required, 
covering the whole range of conceptual development, empirical testing and the 
standardization of procedures. 
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Samenvatting 
Ziekte kan een verkorting van het leven, een vermindering van de kwaliteit van leven, 
of een combinatie van be ide tot gevolg hebben. De geneeskunde beoogt door middel 
van interventies ziekte te voorkomen of te genezen, en als dat niet kan de schade te 
beperken en het lijden te verlichten. De uiteindelijke doelstellingen van de geneeskun-
de kunnen dan oak worden samengevat als 'het toevoegen van jaren aan het leven en 
van leven aan de jaren'. 
In de westerse wereld zijn de manifestaties van acute, levensbedreigende aandoeningen 
sterk afgenomen. De levensvelwachting bij de geboOlle is hoog. Chronische, niet acuut 
levensbedreigende ziekten vormen een belangrijk volksgezondheidsprobleem. Daar-
mee is verbetering van de kwaliteit van leven het prima ire doe I van veel medische 
interventies geworden. Traditioneel was sterfte een belangrijke maat om de gevolgen 
van ziekte en het effect van behandeling in kaart te brengen. Natnurlijk blijft sterfte een 
belangrijke uitkomstmaat van ziekte en zorg. Ais enige uitkomstmaat is sterfte, of het 
complement ervan, overlevingsduur, echter vaak niet meer zo informatief. Toevoeging 
van gegevens over de kwaliteit van leven maakt het beeld vollediger. 
Voorbeelden van situaties waarin kwaliteit van leven als uitkomstmaat belangrijk is 
zijn er legio. In situaties waar levensverlenging wei het primaire doe I is, zoals bij 
sommige kankerbehandelingen, kan het voorkomen dat vanwege het ingrijpende 
karakter van interventies de venvachte winst in levensduur moet worden afgewogen 
tegen een tijdelijke of duurzame vennindering van de kwaliteit van leven. Een andere 
situatie doet zich voor bij nieuwe levensreddende behandelingen, zoals bepaalde 
orgaantransplantaties of de behandeling van kinderen met tot voor kOll dodelijke 
aangeboren afwijkingen. De technische mogelijkheden het leven met dergelijke 
ingrepen te verlengen roepen onmiddelijk de vraag naar de kwaliteit van dat leven op. 
Dit proefschrift gaat over het meten van de kwaliteit van leven als uitkomstmaat van 
ziekte en zorg. Het begrip 'kwaliteit van leven' in die context is afgegrensd tot 
'gezondheid-gerelateerde kwaliteit van leven', samengevat als 'gezondheidstoestand'. 
Hiermee wordt aangegeven dat factoren die invloed kunnen hebben op de kwaliteit van 
het leven maar die niet direct verband houden met de gezondheid of met medische 
behandeling, buiten beschouwing worden gelaten. Gezondheidstoestand wordt in dit 
proefschrift geoperationaliseerd als het functioneren van de pati~nt op fysiek, psy-
chisch en sociaal gebied. 
Haa/dslllk 2 geeft een overzieht van het wetenschappelijke veld van meting van de 
gezondheidstoestand. De plaats van gezondheidstoestand ten opzichte van conven-
tionele klinische variabelen (zoals bloeddruk, bloedonderzoek, ECG, r6ntgenfoto's en 
dergelijke) kan worden omschreven als elkaar aanvullend, met elk een ander gebruiks-
doe!. Klinische parameters worden bij voorbeeld gebruikt am een diagnose te stellen 
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en, vanwege prognostische waarde, om behandelbeslissingen te onderbouwen. Voor de 
bepaling van de uiteindelijke effecten van ziekte en interventies is het belangrijk te 
kijken naar het dagelijks functioneren van patienten (en natuurlijk ook naar overle-
ving). Dit geldt zowel voor individuen als voor patienten als groep. 
Gezondheidstoestandmeting kan plaats vinden vanuit verschillende perspectieven. 
Onderscheiden worden het perspectief van een individuele patient, bij wie het gaat om 
de keuze tussen behandelingsaiternatieven; het perspectief van groepen patienten met 
vergelijkbare ziektekenmerken, waarbij onderzoek van de gezondheidstoestand een 
indruk geeft van de effecten van een interventie bij dergelijke patienten in het alge-
meen; en ten slotte een maatschappelijk perspectief, waarbij gezondheidstoestandinfor-
matie wordt gebruikt tel' ondersteuning van beslissingen over de verdeling van 
(schaarse) middelen, met name binnen de gezondheidszorg. Medische Technology 
Assessment (MTA) gaat uit van een maatschappelijk perspectief, een klassieke 
klinische trial van het perspectief van de patientengroep. Opgemerkt wordt dat 
onderzoek naar de effectiviteit van interventies uitsluitend vanuit het perspectief van 
een patientengroep ('no matter what it costs') naar de achtergrond lijkt te verdwijnen. 
Het perspectief (anders gezegd: de onderzoeksvraag) bepaalt onder meer de keuze van 
meetinstnunenten voar de gezondheidstoestand. Meetinstnllnenten voor gezond~ 
heidstoestand kunnen worden onderverdeeld in 3 hoofdgroepen, te weten generieke, 
ziektespecifieke ell domeinspecifieke instrumenten. Generieke instnllnenten zijn, 
doordat ze niet ziekte- of ziektestadium specifiek zijn, bij uitstek geschikt voor 
vergelijkingen over de grenzen vau diagnoses en interventies heen. Generiek meten 
van de gezondheidstoestand is noodzakelijk in onderzoek dat plaatsvindt vanuit een 
maatschappelijk perspectief. 
Tenslotte wordt in hoofdstuk 2 het be lang van standaardisatie van methoden voor 
meting van de gezondheidstoestand onderstreept. Zonder standaardisatie zijn onder-
zoeksresultaten onvergelijkbaar. Het gevolg van deze onvergelijkbaarheid kan zijn dat 
resultaten van studies van verschillende ziekten niet kunnen worden gebruikt om deze 
ziekten te ordenennaar de ziektelast die zij veroorzaken, of dat met behulp van MTA's 
van verschillende interventieprogramma's geen uitspraak kan worden gedaan over de 
relatieve effectiviteit van deze interventies. Onvergelijkbaarheid heeft ook een subopti-
male bijdrage van individuele studies aan de wetenschappelijke 'body of knowledge' 
tot gevolg. Standaardisatie is essentieel om gebruik te kunnen maken van gezondheids-
toestandinformatie bij beleidsvoorbereiding en beleidsbeslissingen. Een landelijk 
onderzoekersnetwerk, de Werkgroep Onderzoek Gezondheidstoestandmeting, beoogt 
een bijdrage te leveren aan het proces van standaardisatie. 
De hoofdstukken 3 tot en met 7 gaan over beschrijvende gezondheidstoestandmeting. 
HooJdsluk 3 vergelijkt 6 in het Nederlands beschikbare generieke meetinstrumenten, 
namelijk de SIP, de NHP, de MOS-20, de SF-36, de COOP/WONCA kaarten en het 
EuroQol instrument. Het concept gezondheidstoestand blijkt gedeeitelijk verschillend 
geoperationaliseerd in deze instrumenten. Een vergelijking van testeigenschappen 
(betrouwbaarheid, validiteit) bleek op grond van Iiteratuurgegevens nog niet goed 
mogelijk, omdat testeigenschappen populatie-afhankelijk zijn en omdat de uitvoering 
en rapportage van onderzoeken naar testeigenschappen vaak onvergelijkbaar bleken. 
Geen van de beschikbare instrumenten is echter in aile opzichten superieur aan aile 
andere. Er is behoefte aan empirisch vergelijkend onderzoek van meetinstrumenten 
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voor gezondheidstoestand. 
Hoofds/uk 4 doet verslag van een empirische vergelijking van de NHP en de SIP bij 
cross-sectionele beschrijving van de gezondheidstoestand van een groep nierdialyse-
patienten. De NHP bleek eenvoudiger om in te vullen. Oak waren de NHP-schalen 
intern consistenter. Met behulp van factoranalyse bleken NHP en SIP effici~nt samen 
te vatten in twee factoren, namelijk een fysieke en een psychosociale. In de SIP wordt 
fysiek functioneren benadrukt, terwijl de NHP meer ingaat op psychisch functioneren. 
Hoofds/uk 5 bevat een s00l1gelijke studie. Hier worden de NHP, de SF-36, de COOPI 
WONCA kaarten en het EuroQol instrument empirisch vergeleken ten aanzien van 
toepasbaarheid ('feasibility'), betrouwbaarheid, construct validiteit en onderscheidend 
vermogen tussen klinisch verschillende groepen, bij taepassing in een groep lijders aan 
migraine en een controle groep. Elk van de 4 instrumenten bleek gaed te presteren, met 
dien verstande dat de multi-item instrumenten (NHP en SF-36) voor gezondheidstoe-
stand meting in beschrijvende zin meer geschikt bleken dan de c1assificatie-instnunen-
ten (COOP/WONCA en EuroQol). Sensitiviteit voor veranderingen in gezondheids-
toestand over de tijd was geen onderwerp van vergelijking. Ook in dit onderzoek 
bleken de instrumenten effici~nt samen te vatten in een fysieke en een psychosociale 
factor. 
Hoofds/uk 6 is een voarbeeld van een toepassing van beschrijvende gezondheidstoe-
standmeting. Het betreft een gecontroleerd dwarsdoorsnede onderzoek naar de invloed 
van migraine op de gezondheidstoestand, gemeten met de NHP, SF-36, de COOPI 
WONCA kaarten en het EuroQol instnnnent. De migrainegroep toonde consistent een 
iets slechtere gezondheidstoestand dan de controlegroep. Dit verschil kon slechts 
gedeeltelijk worden toegeschreven aan het meer voorkomen van comorbiditeit (m.n. 
depressiviteit) in de migrainegroep. Migraine heeft een niet zo sterk, maar onafhank-
elijk negatief effect op het dagelijks functioneren buiten de aanvallen zelf. 
In hoofds/uk 7 wordt verslag gedaan van een longitudinaal opgezet onderzoek naar de 
effecten van levertransplantatie op de gezondheidstoestand. Yoar hen die de interventie 
zelf overleven heeft level1ransplantatie een zeer gunstig effect op de gezondheids-
toestand. Ais gezorgd wardt voor adequate infonnatie van pati~nten en behandelaars, 
en voor uiterste gebl1liksvriendelijkheid, blijkt empirische gezondheidstoestandmeting 
ook bij deze soms zeer zieke pati~nten mogelijk. 
De meeste bekende instrumenten voor meting van de gezondheidstoestand, zaals de 
NHP en de SF-36, zijn beschrijvend van aard. Dit betekent dat een score op zo'n 
instnunent de vonn heeft van een profiel: een score is samengesteld uit een score voal" 
bijvoorbeeld fysiek functioneren, een score voor psychisch functioneren en een score 
voar sociaal functioneren. Voor een aantal toepassingen van gezondheidstoestandme-
ting, zoals in kosten-utiliteitsanalyse en in volksgezondheidsmodellen, is het nodig 
profielscores samen te vatten in een getal, teneinde effecten op de duur en de kwaliteit 
van de overleving te kunnen combineren. Een waarderingsprocedure voor gezond-
heidstoestanden is een methode om profielscores voar gezondheidstoestand samen te 
vatten in een getal. 
Hoofds/uk 8 beoogt een overzicht te geven van de stand van de wetenschap op het 
gebied van het waarderen van gezondheidstoestanden. De op dit moment gangbare 3-
staps procedure wordt toegelicht. Beschrijvingen van de gezondheidstoestand van 
pati~nten (verkregen in stap I) worden in de tweede stap gewaardeerd, waarna in de 
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derde stap de waarderingen worden gecombineerd met overlevingsduur. De uitkomsten 
worden uitgedrukt in bijvoorbeeld Quality Adjusted Life-years (QAL Y's). Belangrijke 
keuzen in de procedure worden besproken. Zo wordt betoogd dat de keuze van het 
groep die de waarderingen geeft bepaald wordt door het perspectief van het onderzoek. 
In het geval van een maatschappelijk perspectief dienen de waarderingen het maat-
schappelijk gezichtspunt te representeren; dit kan worden geoperationaliseerd door de 
waarderingen te Iaten uitspreken door een representatieve steekproef uit de algemene 
populatie (waarin dus ook patienten veltegenwoordigd zijn). Een andere belangrijke 
keuze betreft de waarderingsmethode. Een visueel ana loge schaal biedt praktische 
voordelen. Time trade-off is mogelijk te prefereren uit een oogpunt van validiteit. 
Directe transfonnatie van resultaten van de ene methode naar de andere is in principe 
mogelijk ais de rangorde van de gezondheidstoe-standen dezelfde is. 
In de operationalisatie van het QAL Y -concept in de beschreven 3-staps procedure 
worden de uitkomsten van een ziekte of een interventie in feite opgeslitst. De uitkomst-
ruimte kan worden voorgesteld als een boom met verschillende takken, die elk worden 
gekenmerkt door een duUf, een sequentie van gezondheidstoestanden en een frequentie 
van voorkomen. De huidige QAL Y -benadering gaat uit van onder andere de volgende 
2 aannames, die vermoedelijk zelden geheel juist zijn. Ten eerste wordt verondersteld 
dat de waardering voor een gezondheidstoestand niet aflJangt van wat eraan voorafgaat 
(historie) en wat voIgt (prognose). Theoretisch zou het waarderen van 
gezondheidstoestandsequenties ('belopen') realistischer zijn. Ten tweede wordt ver-
ondersteld dat de ,vaardering voor een gezondheidstoestand onafl13nkelijk is van de 
duur ervan. 
Indien onderzoekers en gebruikers (beleidsmakers) zich bewust zijn van de beperking-
en en de kracht van het QAL Y -concept is het echter gerechtvaardigd door te gaan met 
het ontwikkelen en verfijnen van de operationalisatie ervan. Er is bovendien nog geen 
alternatief dat aantoonbaar beter is. 
De hoofdstukken 9 en 10 betreffen empirische waarderillgsstudies in de algemene 
populatie. Beiden waren deel van het onderzoeksprogramma van de EuroQol groep, 
een Europees netwerk van onderzoekers dat tot doe I heeft om door middel van een 
gestandaardiseerde empirische aanpak (met behulp van het EuroQol instrument) een 
methodologische bijdrage te leveren op het gebied van waarderingen van gezondheids-
toestanden. Hoofdslllk 9 beschrijft een onderzoek naar de haalbaarheid van het 
verzamelen van waarderingen in de algemene populatie met een postenquete. De 
resultaten waren veelbelovend. Er waren echter een aanzienlijke non-respons en niet-
geslaagde respons (van respondenten voor wie de vragenlijst blijkbaar te moeilijk was; 
met name ouderen en lager opgeleiden). Dit was aanleiding een non-respons onderzoek 
te doen, dat wordt beschreven in hoofdslllk 10. Hoewel de effecten van selectieve non-
respons en niet-geslaagde respons lastig te evalueren bleken, lijkt de relevantie van 
dergelijke effecten in verband met het gebruik van resultaten bij beleidsbeslissingen 
gering. Relevanle effecten van achtergrondvariabelen (leeftijd, opleiding) op de 
waarderingen werden niet aangetoond. 
De belangrijkste conclusies van dil proefschrift komen aan de orde in Hoofdsluk 11. 
Gezondheidsloesland is, naasl overlevingsduur en klinische parameters, de derde pijler 
van medisch evalualieonderzoek. Voor beschrijvende gezondheidstoestandmeling zijn 
de melhoden zodanig gerijpl dal dil een standaardonderdeel van elk evalualie onder-
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zoek moet uitmaken: niet het opnemen van gezondheidstoestandmeting in de onder-
zoeksopzet, maar juist het emit laten ervan zou beargumenteerd moeten worden, 
Standaardisatie van methoden is noodzakelijk ten behoeve van de vergelijkbaarheid en 
daal'mee de bmikbaarheid van onderzoeksresultaten ten behoeve van beleid, In het 
bereiken van het gewenste niveau van standaardisatie is een belangrijke rol weggelegd 
voor de Werkgroep Onderzoek Gezondheidstoestandsmeting en voor de gebmikers van 
gezondheidstoestandinformatie, bij voorbeeld de overheid, 
Voor het waarderen van gezondheidstoestand is de situatie anders, Op dit gebied 
wachten nog belangrijke vragen, bijvoorbeeld naar de rol van 'tijd' en 'beloop', en het 
bestaan van subgroepen in de populatie met afwijkende waarderingsprofielen, op een 
empil'isch antwoord, Routinematig gebmik van waarderingsuitkomsten vereist daarom 
op dit moment nog enig voorbehoud, Systematisch methodologisch onderzoek op 
terrein van de waal'dering van uitkomsten verdient krachtige steun, 
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Dankwoord 
Het schrijven van een welgemeend dankwoord zonder al te veel cliche's is misschien 
wei lastiger dan de produktie van een wetenschappelijke tekst. Natuurlijk is dit 
proefschrift met hulp van velen tot stand gekomen. Ik wil de gelegenheid gebruiken 
om enkelen van hen hier speciaal te noemen. 
Oat is in de eerste plaats mijn promotor, Prof.Dr. PJ. van del' Maas. Beste Paul, ik wil 
je danken voor het feit dat je me in de gelegenheid hebt gesteld mijn proefschrift te 
schrijven. Dit 'in de gelegenheid stellen' slaat natuurlijk op de inhoudelijke begelei-
ding en de organisatorische voorwaarden. Het slaat ook op je flexibiliteit en begrip als 
baas, die naar mijn mening veel hebben bijgedragen aan het feit dat ik een wetenschap-
pelijke carriere tot nu toe heb kunnen combineren met een thuissituatie die veel energie 
vraagt. 
Met mijn co-promotor Dr. GJ. Bonsel heb ik vele jaren samengewerkt in de onder-
zoeksprojecten waarop dit proefschrift is gebaseerd. Beste Gouke, laat ik volstaan met 
te zeggen dat ik zeer veel van je heb geleerd. Woorden schieten tekort - aileen, 'grijs' 
was het nooit. 
Een belangrijk deel van mijn wetenschappelijke activiteiten heeft zich in iMTA-
verband afgespeeld. Prof.Dr. F.F.H. Rutten, beste Frans, en natuurlijk aUe iMTA 
collega's met wie ik heb samengewerkt, ik denk met veel plezier aan het werk voor 
iMTA terug. Oat geldt in het bijzonder voor drs. L. van Roijen. Beste Leona, het 
migraineproject, de ontwikkeling van de 'Ziekte & Werk' vragenlijst - het waren 
succesvolle en leuke ondernemingen. Ik hoop dat er ondanks de fysieke scheiding 
tussen iMTA en iMGZ mogelijkheden zuUen blijven bestaan om in deze lijn verdeI' 
samen te werken. 
De leden van de Werkgroep Onderzoek Gezondheidstoestandmeting dank ik voor hun 
medewerking en inzet, zonder welke een netwerk van onderzoekers niet kan functione-
reno Prof. Dr. J. Passchier, beste Jan, de Werkgroep heeft in jou een goede voorzitter. 
AIs de harmonie waarin het 'besturen' van de Werkgroep tot nu toe is verlopen 
voorspellende waarde heeft voor haar toekomst, heb ik goede hoop. Daarnaast dienen 
zich ook gezamenlijke projecten voor iMGZ en het Instituut voor Medische Psycholo-
gie en Psychotherapie aan buiten Werkgroepverband. Prof.Dr. J.e.J.M. de Haes, beste 
Hmmeke, jou wil ik in het bijzonder bedanken voor je bijdrage aan hoofdstuk 2. 
Mijn naaste collega's in de loop del' jaren waren of zijn drs. H.M.E. van Agt, drs. 
P.F.M. Krabbe, drs. E.N.T.M. van Lin, Dr. M.E.A. Stouthard, en de student-assistenten 
M. Palmen en A. Bandel. Beste Heleen, Paul, Emile, Marlies, Maurice, Arjan: bedankt 
voor al het werk, de goede ideeen, de kritische reflectie en, wederom, de prettige 
samenwerking. 
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Dr. E.M. ten Vergert, beste Els, drs. K. Stronks, beste Karien, ik wi! jullie bedanken 
voor het kritisch commentaar op delen van het proefschrift die niet als wetenschappe-
lijk al1ikel gepubliceerd zijn. 
Inhoudelijk is dit proefschrift mijn verantwoordelijkheid; Mw. I. Philips heeR de rest 
gedaan. Beste lise, als de inhoud even mooi is als het uiterlijk hebben we samen goed 
werk geleverd. Daarnaast dank ik Paul Krabbe voor de lay-out van de figuren. 
I am grateful to Ms. R. Rabin, deal' Rosalind, whose knowledge of the topic was most 
helpful in facilitating the accurate correction of the English. 
Ten slotte de mensen zander wie er eeht niets van terecht zou zijn gekOlllen. Dat zijn 
de directie, leidsters en andere medewerkers van kinderdagverblijf 't Kinderparadijs te 
Rotterdam. Anita, Astrid, Inge, Jacqueline, Jeannette, Jolanda, Judith, Karin, Margriet, 
Maria, Nuria, Sarinke, Simone, Urmi, en aile anderen - de Hefde en het verantwoorde-
lijkheidsgevoel waarmee jullie je werk doen zijn echt bijzonder. 
Lieve Jan, Bas en Erik. Waarom maakt mama eigenlijk boeken en kranten in de witte 
flat? Jullie relativeren ongewild een hoop 'moeten' en daar ben ikjilllie dankbaar voor. 
De gezondheidstoestand en de kwaliteit van leven van Erik zijn een bijzondere 
motivatie voor het werk juist op het terrein van gezondheidstoestandmeting. 
Lieve Rob: ik hoop dat we ons 'teamwork' in de toekomst op een iets minder hectische 
manier kunnen YQol1zetten. 
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